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Abstract 
 
Natural products constitute an extensive family of organic molecules with more than 200,000 compounds 
discovered in several natural sources (plants and microbes). Most of these compounds have a very complex 
structure, multiple chiral centers and can have different biological activities. These biological activities can 
be of interest for use in different sectors of chemical industry, in particular pharmaceutical industry where 
several drugs are derived or inspired by natural products structure.  
However, the large scale production of natural products is hindered by its relatively poor abundance in 
nature, which makes extraction from natural sources an economically unfeasible technology in most of the 
cases. Chemical synthesis is also very difficult given the structural complexity and chirality of the molecules.  
Synthetic biology offers very promising tools for production of natural products. Genetic engineering allows 
expressing the genes responsible for the biosynthesis of these natural products and to insert them into 
fermentable organisms like yeast or bacteria. And protein engineering offers the possibility to engineer the 
enzymes that perform the natural products’ biosynthesis, which allows the production of these complex 
molecules in single or multi-steps biocatalytic reactions.  
In this thesis, a systematic approach for route selection and screening of the different process options to 
manufacture a natural product is presented. This methodological approach includes a set of evaluation tools 
to assess processes both from an economic and environmental perspectives and it is demonstrated with two 
case-studies. For each case-study different tools are used to evaluate the process. 
The first case-study consists of the bioconversion of (R)-limonene to (R)-perillic acid by Pseudomonas putida 
GS1. (R)-perillic acid is a monoterpenoic acid with antimicrobial properties. It has a strong inhibitory effect 
on bacteria and fungus, which makes it an attractive compound to be used as a preservative for instance in 
cosmetic industry, but on the other hand makes the biosynthesis a complicated process to develop. An 
environmental assessment of the different synthetic routes for (R)-perillic acid production showed that 
biosynthesis represents the most promising option. This process was further explored through an economic 
assessment and process modelling including a sensitivity analysis on key process metrics, which allowed the 
identification of the main process bottlenecks. Product inhibition and substrate loss were identified as some 
of the main process limitations and strategies for improving them were suggested. 
The second case-study describes the production of a recombinant protein, brazzein, by fermentation of the 
yeast Pichia pastoris. Brazzein is a natural sweetener found in the fruits of the African plant Pentadiplandra 
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brazzena Baillon, which is sweeter than regular sucrose by several orders of magnitude. Here different tools 
were applied to evaluate the environmental profile of the process in comparison with other sweeteners.  
The main benefit of this early-stage evaluation is putting the biosynthesis of natural products into context in 
relation to demands of an industrially feasible chemical process. Moreover, it can give very meaningful insight 
into process development and provides a good overview of the whole reaction and process. The proposed in 
silico approach can guide research and development and ultimately contribute to the implementation of 
more bioprocesses for the production of natural products.  
 
 
 
 
 
  
iii 
 
Resumé 
 
Naturlige produkter er en stor familie af organisk molekyler der indeholder mere end 200.000 forbindelser 
opdaget i natur (planter og mikroorganismer). De fleste af disse forbindelser har en kompleks struktur og 
flere kiralecentre og kan have forskellige biologiske aktiviteter. Disse biologiske aktiviteter kan være 
interessante for forskellige sektorer af kemi industri, især for den farmaceutiske industri hvor mange 
lægemidler er afledt eller inspireret as naturlige produkters struktur.  
Industriel produktion af naturlige produkter er begrænset af deres lave koncentrationer i naturen, der gør 
ekstraktion en økonomisk umulig teknologi. Kemisk syntese er også en meget vanskelig opgave på grund af 
den strukturelle kompleksitet og den molekylære asymmetri. 
Syntetisk biologi tilbyder mange lovende værktøjer til produktion af naturlige produkter. Genteknologi gør 
det muligt at udtrykke generne der er ansvarlig for biosyntese af disse naturlige produkter og indsætter dem 
i fermenterbare mikroorganismer, som gær og bakterier. Og proteinoptimering gør det også muligt at 
syntetisere naturlige produkter i enkelt- eller flertrins biokatalytiske reaktioner.   
Arbejdet i denne afhandling præsenterer en systematisk metode til udvælgelse af ruter og processer til 
produktion af naturlige stoffer. Denne metodiske fremgangsmåde inkuderer værktøjer for økonomisk og 
miljømæssig evaluering af bioprocesser og er blevet valideret gennem to forskellige eksempler.  
Det første eksempel er produktionen af (R)-perillic acid fra (R)-limonene ved brug af Pseudomonas putida 
GS1. (R)-perillic acid er en monoterpen syre med antibakteriel aktivitet. Det er interessant at bruge (R)-perillic 
acid som en konserveringsmiddel i den kosmetiske industri, men dens biosyntese er en vanskelig opgave. En 
miljømæssig evaluering af forskellige processer til produktion af (R)-perillic acid viste at biosyntesen er det 
mest lovende alternativ. De økonomiske aspekter af processen blev også undersøgt baseret på en 
procesmodel der inkluderer en sensitivitetsanalyse af de væsentlige parametre. Dette muliggjorde 
identifikationen af de primære flaskehalse i processen. Produktinhibering og substrattab blev identificeret 
som de største begrænsninger for processen, og en række strategier blev foreslået for at udbedre disse. 
Det andet eksempel er produktionen af det rekombinante protein, brazzein, ved fermentering af gæren 
Pichia pastoris. Brazzein er et naturligt sødemiddel som findes i frugterne af den afrikansk plante 
Pentadiplandra brazzena Baillon, der er adskillige gange sødere end sukrose. I dette eksempel blev en 
miljømæssig evaluering anvendt til at sammenligne forskellige processer for sødemiddel.  
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Den største fordel ved denne type evaluering er at kunne sætte kravene for en industriel biosyntese af 
naturlige produkter i perspektiv. Den kan også give meningsfuld indsigt i procesudviklingen og et overblik 
over reaktionssystemet og processen. Denne in silico fremgangsmåde kan guide procesudviklingen og 
bidrage til introduktionen af flere bioprocesser i produktionen af naturlige produkter. 
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1. Introduction 
 
This thesis attempts to create a bridge between science, engineering and economy and apply different 
concepts of these areas to the development of processes for the biosynthesis of natural products. Thus, 
different methods for the assessment of the sustainability of bioprocesses at early stages of development, 
both from an economic and environmental perspectives, as well as technologies for its intensification are 
explored throughout the thesis.  
In the following sections some background information on the type of processes and products under study 
is given.  
 
1.1 Background 
 
Over the past years, there has been a generalized perception of the emergence and expansion of a so-called 
bioeconomy. Government policies and industry sustainability programs are driving a bio-based economy all 
over the world, supported by a growing concern about sustainability from consumers.  
But what is this bioeconomy? According to European Commission, the bioeconomy encompasses the 
production of renewable biological resources and their conversion into food, feed, bio-based chemical 
products and bioenergy. It thus includes agriculture, forestry, fisheries and food production as well as parts 
of the chemical, biotechnological and energy industries. Bioeconomy sectors are expected to have a strong 
innovation potential, using a wide range of sciences (life sciences, agronomy, social sciences, etc.) and 
technologies (biotechnology, nanotechnology, information and communication technologies) (European 
Commission, 2014).  
The EU estimates that the sectors that comprise the bioeconomy account for 22 million jobs, which is 
approximately 9% of the EU’s workforce (European Commission, 2013). One of the goals of the European 
commission on research, science and innovation is to move from a fossil-based economy to a bioeconomy. 
And bio-based chemicals are expected to constitute the largest segment of potential growth for industrial 
bio-based products. The bio-based chemical sector achieved a market value of $3.6 billion in 2011 and it is 
estimated that by 2021 the global market for bio-based chemicals will have increased to $12.2 billion. While 
this represents a significant increase, there is the potential to produce two-thirds of the total volume of 
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chemicals from bio-based material, which represents over $1 trillion annual global market (Golden and 
Handfield, 2014). Such bio-based chemicals can be produced either by bioprocesses or by conventional 
chemical processes using a bio-based feedstock. Therefore, there are good opportunities for the 
development of novel bioprocesses for the production of chemicals in the coming years with an increasing 
number successfully applied at an industrial scale. Different types of bioprocesses and examples of 
bioprocesses that have been successfully applied in industry are given in section 1.2.  
The increasing interest in bio-based products and the definition of a bioeconomy strategy by European 
Commission is explained by the many challenges that Europe and the world is nowadays facing, such as an 
increasing world population; depletion of many natural resources, namely fossil fuels; the impacts of 
increasing environmental pressures and climate change (European Commission, 2013). But it is clear that one 
driver for the expansion of bioeconomy is also the consumers demand for product transparency. 
Governments are pushing for sustainability labeling of products, for instance, the Grenelle Law II in France 
covers the quantification of environmental impacts and the communication of the environmental footprint 
of the products to the consumers via labeling. And major multinational retailers and brands are also 
undertaking life cycle assessments of their entire supply chain (Golden and Handfield, 2014). Hence, 
improved environmental performance of industrial and consumer goods is a significant driver of the 
development of bio-based chemicals. 
However, there is also a need for more effective quantification of how the expansion of bioeconomy might 
impact the environment, namely land use and water quantity and quality. A study by Weiss and co-workers 
compared 44 LCA studies of bio-based materials and showed that bio-based materials saves, relative to 
conventional materials, 55±34 gigajoules of primary energy and 3±1 CO2 equivalents of greenhouse gases. 
However, bio-based materials may also increase eutrophication by 5±7 kilograms of phosphate equivalents 
and stratospheric ozone depletion by 1.9±1.8 kg of nitrous oxide equivalents. The significant errors 
associated to this values, as well as the variability in the results of LCA studies stresses difficulties in drawing 
general conclusions but in any way it is important to take these environmental aspects into account when 
developing processes for production of bio-based chemicals (Weiss et al., 2012). Different tools for 
assessment of sustainability of bioprocesses are further described in Chapter 2.   
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1.2 Bioprocesses 
 
Bioprocesses include both fermentation and biocatalytic processes and in some cases it might not be 
straightforward to distinguish them.  
In the context of this thesis biocatalytic processes are those applying enzymes as catalysts in the conversion 
of one main substrate to a product in one or more steps. The biocatalyst can be used in two different forms: 
i) isolated enzymes, or ii) whole-cells, which can be growing or resting. These two forms of biocatalysts can 
then be used in different formulations - liquid formulations or immobilized on or into larger particles of inert 
support materials.  
Fermentation processes on the other hand correspond to the production of products associated with cell 
growth, which are produced by primary or secondary metabolic pathways. Primary metabolic pathways 
produce compounds with low molecular weight, such as alcohols, aldehydes, ketones and carboxylic acids. 
Examples of products of secondary metabolic pathways are amino acids, proteins or antibiotics (Villadsen, 
2015).  
Examples of both types of bioprocesses are given in the following sections. 
 
1.2.1 Biocatalytic processes 
 
Biocatalytic processes are those that apply enzymes, which can be isolated or used as whole-cells, as catalysts 
for the synthesis of chemical products.  
Enzymes have an exquisite advantage over chemical catalysts, - they have a very high selectivity (enantio-, 
regio- and chemoselectivity).  As a result of this excellent selectivity, enzymes can be used in complex 
reactions without the need of blocking and deblocking steps that are common in conventional organic 
synthesis. This further results in fewer by-products and consequently reduced waste production (Schmid et 
al., 2001).  
Biocatalytic processes also operate at milder reactions conditions, with moderate temperatures, pH and 
pressures and generally run in aqueous media, preventing large consumption of organic solvents. Unlike 
many of the metal and organometallic catalysts conventionally used in chemical industry, enzymes are non-
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toxic catalysts and are produced by fermentation from renewable feedstocks. All these features can make 
biocatalysis an environmentally friendly alternative to conventional chemical catalysis.  
But the most promising advantage of biocatalysis over conventional chemical catalysis is the possibility of 
modifying the catalyst and improve it to have a set of desired properties. When using a biocatalyst there is 
the freedom to improve the selectivity, stability and activity of the enzyme, and therefore improve reaction 
rate and reaction yield. The initial phase of enzyme discovery involves screening available microbial culture 
collections or libraries of enzymes from a variety of sources in order to identify an enzyme with activity 
towards the substrate of interest. In some cases the wild-type enzyme may have the required activity and 
selectivity to be applied in a reaction system, but the most likely scenario is that it will require some 
improvements in catalytic activity, selectivity and stability under process conditions that are required for 
practical applications. Directed evolution of enzymes by iterative cycles of random mutagenesis, protein 
expression and screening or selection of the desired activity emerged as a powerful technology that allows 
significant improvements of an existing enzyme (Turner, 2009). Enzyme improvement and optimization is 
however a time consuming process and it can take between 3 to 15 months to develop a new biocatalyst 
employing a team of skilled scientists (Tufvesson et al., 2010). Still, in many cases improvement of the 
biocatalyst is essential to ensure an industrial application of the biocatalyst and there are several examples 
where this has been successfully achieved, particularly in pharmaceutical industry (Bornscheuer et al., 2012). 
Table 1.1 shows some examples of biocatalytic processes that have been successfully developed and applied 
in industry. 
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Table 1.1 Some examples of industrial biocatalytic processes.  
Product Enzyme Class Technology Reference 
 
 
 
(S)-ethyl-4-chloro-3-
hydroxybutyrate, an 
intermediate for atorvastatin 
(API of the cholesterol lowering 
drug Lipitor®) manufacture. 
 
 
Ketoreductases 
(KREDs) 
EC 1.1.1.2 
Various protein engineering 
approaches, including directed 
evolution, to increase activity, 
stability and coenzyme 
specificity. The volumetric 
productivity per biocatalyst 
loading was improved 2500 
fold, resulting in a 14-fold 
reduction in reaction time, a 7-
fold increase in substrate 
loading, 25-fold reduction in 
enzyme use and 50% 
improvement in isolated yield. 
(Ma et al., 
2010) 
 
 
The product is sitagliptin, an 
antidiabetic drug. 
Transaminases 
EC 2.6.1.X 
Protein engineering to develop 
enzyme with initial activity, 
followed by activity 
improvement in increasing 
DMSO, substrate and 
isopropylamine, as well as 
increased thermostability. 
(Savile et al., 
2010) 
 
 
 
L-fluoro-leucine, an 
intermediate in odanacatib 
manufacture. Odanacatib is a 
cathepsin K inhibitor, which is 
an important class of 
antiresorptive agents that help 
prevent bone loss. 
Hydrolases 
EC 3.X 
Enzyme immobilization and 
reaction engineering increased 
stability and activity under 
process conditions. The 
process has been 
demonstrated several times at 
100 kg scale (>90% yield and 
88% ee). 
(Truppo and 
Hughes, 2011) 
 
Biocatalysis also shows an exquisite advantage over fermentation processes, which is the possibility to run a 
reaction with unlimited space-time yield. Typically in aerobic fermentations, space-time yield is limited by 
the oxygen consumption required for cell growth. But by disassociating the desired reaction from cell growth 
it is possible to achieve a much higher space-time yield.  
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1.2.2 Fermentation processes 
 
Fermentation processes involve de novo production of a molecule from a carbon and energy source, such as 
glucose via primary metabolism, rather than conversion of a precursor molecule to the desired product by 
enzymes or whole cells (Straathof et al., 2002). 
Fermentation processes can be used to produce a wide range of products in all sectors of chemical industry 
– bulk, fine and pharmaceutical chemicals, with varying production prices and volumes and some examples 
are given in Table 1.2. 
 
Table 1.2 Examples of industrial products produced by fermentation (adapted from (Heinzle et al., 2008)). 
Product Annual production (tons/year) Price range (€/kg) 
Ethanol 99,000,000 0.2 
Citric acid 1,700,000 1 
Proteases 100,000 3 
Aspartame 10,000 5 
Tetracyclines 5000 55 
Insulin 8 120,000 
 
According to their size, fermentation products can be sub-divided into small molecules and large molecules. 
Small molecules have a molecular weight of 30-600 Da and a radius smaller than 1 nm. Examples of small 
molecules are sugars, amino acids, organic acids or vitamins. Large molecules include proteins, nucleic acids 
and polysaccharides and have a molecular weight of 103-1010 Da and a radius typically larger than 1 nm. 
Among small molecules, a distinction can also be made between primary and secondary metabolites. Primary 
metabolites, e.g. organic alcohols and acids are produced in the primary growth phase of the 
microorganisms, while secondary metabolites are formed at or near the stationary phase. One classic 
example of secondary metabolites are antibiotics. However, in many cases the distinction between primary 
and secondary metabolites is not straightforward (Heinzle et al., 2008). 
The microorganisms used as production hosts for fermentative production of chemicals can also be 
numerous, being filamentous fungi, the yeast Saccharomyces cerevisiae or the bacteria E. coli some of the 
most common ones.  
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Some fermentation processes, such as the production of citric acid or ethanol show remarkably high yields, 
productivities and product concentrations and have become the conventional method for production of 
these chemicals, overcoming chemical production methods. Some successful examples of fermentation 
processes are shown in Table 1.3. 
 
Table 1.3 Some examples of commodity chemicals produced by fermentation technology. The achieved 
yield, product concentration and space-time yield correspond to the highest values that have been 
reported in scientific literature (adapted from (Straathof, 2014)). 
Product 
Production 
organism 
Production by 
fermentation 
(million 
tons/year) 
Theoretical 
yield (g/g) 
Achieved 
yield 
(g/g) 
Product 
concentration 
(g/L) 
Space-time 
yield 
(g/(L.h)) 
Citric acid Aspergillus niger 1.7 1.07 0.88 240 1.4 
Ethanol 
Saccharomyces 
cerevisiae 
99 0.51 0.50 170 82 
Lactic 
acid 
Lactobacillus sp. 0.37 1.00 1.00 231 150 
 
Developing a commercially relevant fermentation process is a challenging task, especially if the product is a 
bulk chemical. Space-time yield, product concentration and the yield of product on carbon source determine 
the economy of these processes.  
One of the main difficulties when developing a fermentation process is to be able to transfer the required 
amount of oxygen for cell growth. The rate of cells growth is often limited by the rate of dissolution of oxygen 
from air bubbles into the liquid and this topic has been subject of research for decades (Tsao and Lee, 1975). 
The oxygen transfer limitations is translated in the differences in space-time yield between aerobic and 
anaerobic fermentations. Ethanol and lactic acid production are good examples of anaerobic fermentation 
processes, where the space-time yield that is achieved is extremely high (see Table 1.3). On the other hand, 
citric acid is a typical example of an aerobic fermentation where space-time yield does not exceed 2 g/(L.h).  
Further limitations in the development of fermentation processes are the cost and availability of feedstocks, 
and a lot of research has been done in the development of fermentation processes from alternative 
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feedstocks, e.g. lignocellulosic materials; and metabolic engineering of the cells so that more products can 
be produced from renewable bio-based materials by fermentation (Woodley et al., 2013). 
 
1.3 Natural products 
 
Natural products constitute an extensive family of diverse organic molecules with more than 200,000 
compounds discovered and extracted from a variety of natural sources. (Pearsall et al., 2015).  
Natural products can be sub-divided into two categories – primary and secondary metabolites. Primary 
metabolites are essential for all types of living cells (plants, microbial and animal) and include sugars, fatty 
acids, amino acids, nucleic acids as well as all the chemicals considered ubiquitous for plants growth and 
development, such as regulators, cell wall components and metabolites unique to photosynthetic organelles 
like chloroplasts. Secondary natural products are structurally and chemically much more diverse than primary 
natural products, they outnumber primary natural products by orders of magnitude and are named 
secondary because they have no established role in growth and development (Wu and Chappell, 2008). There 
are several different classes of natural products, that can be either primary or secondary metabolites: 
polyketides; non-ribosomal peptides; alkaloids; phenylpropanoids, which include flavonoids, coumarins, 
lignans and stilbenes; fatty acids and terpenoids, also known as isoprenoids (Pearsall et al., 2015). 
Natural products are compounds that are structurally very complex, have multiple chiral centers and can 
have different biological activities. The vast number of secondary natural products is thought to be a result 
of evolution, for instance, for development of plant defense responses to predators, parasites and diseases. 
For example, capsidiol is an antimicrobial sesquiterpene biosynthesized by tobacco cells and tissues in 
response to microbial threats (Wu and Chappell, 2008). 
Natural products can have several interesting properties and they have been particularly important for 
pharmaceutical industry, delivering novel antibiotics, hormones and antitumor agents to the list of 
therapeutic drugs. Over the last 25 years, nearly two-thirds of all newly approved drugs (between 1981 and 
2012) were derived or inspired by natural products structure (Newman et al., 2003) (Newman and Cragg, 
2007). 
The richness of natural products lies within the structural complexity associated with these compounds. The 
possible benefits of natural products to modern society are however hindered by their relatively poor 
abundance in nature, which restricts their use in research and development as extraction from natural 
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sources has very low yields. Besides the low concentration of natural products in plants, they tend to 
accumulate over long growth periods, often as mixtures of hundreds of different compounds, and the 
quantity and quality of natural products also varies with geographical location and climate conditions (Wu 
and Chappell, 2008). All these features make the extraction of natural products economically unfeasible in 
most cases.  
Moreover, the structural complexity of these compounds presents challenges for chemical synthesis and 
most conventional organic chemistry methods are impractical for the synthesis of natural products (Pearsall 
et al., 2015). Synthetic chemists have developed means to synthesize some natural products, but often with 
relatively low yields and resulting in racemic mixtures at each step in multistep synthesis. Coupling together 
multiple synthetic routes of such complexity results in very low yields.  
Expressing the genes responsible for the biosynthesis of these natural products and inserting them into 
fermentable organisms like yeast and bacteria represent an interesting alternative to meet these production 
limitations. Thus metabolic engineering is one of the areas where great success on the biosynthesis of natural 
products has been achieved - namely the production of terpenoids, carotenoids, vitamin E and flavonoids 
(Ajikumar et al., 2010) (Martin et al., 2003) (Anthony et al., 2009) (Pfeifer et al., 2001) (Katsuyama et al., 
2007) (Hawkins and Smolke, 2008) (Minami et al., 2008) (Lee and Schmidt-Dannert, 2003) (Das et al., 2007). 
Enhancement of the production of natural products may involve the import of heterologous genes and 
overexpression of required native enzymes; increasing the cell uptake of essential substrates; optimizing 
pathways by minimizing alternative product formation; increasing cofactor availability and augmenting 
substrate usage; optimizing enzyme activity and specificity by protein engineering or directed evolution of 
enzymes and optimizing access to the final products by secretion or cell lysis methods. Examples of tools that 
are typically used to tackle these aspects include overexpression of enzymes mediating rate-limiting 
reactions, deregulation of gene expression, introduction of regulatory transcription factors, heterologous 
pathway construction, optimizing codons for efficient protein expression, use of feedback-resistant enzymes, 
exclusion of opposing pathways to minimize by-product formation and prevention of product degradation 
(Yadav et al., 2012).   
The three possible routes for production of natural products are represented in Figure 1.1.
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Figure 1.1 Schematic representation of all the possible routes for natural products manufacturing.
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One particular class of natural products where there has been a lot of focus on research are the isoprenoids 
or terpenoids. This is the largest class of natural products with more than 40,000 different molecules 
identified. Many terpenoids are commercially interesting because they can be used as flavors or fragrances 
in foods and cosmetics, e.g. menthol; they can have medicinal properties, e.g. paclitaxel, an anti-cancer drug; 
or have agricultural significance, e.g. cucurbitacins have shown to be involved in insect resistance (Aharoni 
et al., 2005). 
Two examples of successful natural products production by heterologous gene expression are i) the 
production of the antimalarial drug artemisinin; and ii) the production of paclitaxel, a powerful anti-cancer 
drug.  
Starting with paclitaxel, also known as Taxol, this is a natural diterpenoid alkaloid that was first isolated from 
the bark of the pacific yew tree Taxus brevifolia. It is a powerful anti-cancer drug that was first prescribed for 
the treatment of ovarian and breast cancer, but later on was found to be effective in the treatment of other 
types of cancer. It is nowadays commercialized by Bristol-Myers Squibb under the name Taxol®. As for most 
natural products, extraction from the natural sources is not a viable option – the extraction yield is only 1 
gram of paclitaxel per 10 kg of dry barks (Fatima et al., 2014). Taxol’s structural complexity limited its 
chemical synthesis. It was first synthesized in 1994 by Nicolaou and co-workers  in 51 steps but with a final 
yield of 0.002% (Nicolaou et al., 1994). Later on a method for plant-cell based culture has been developed 
and Taxus plant cell cultures have been scaled-up up to 7,500 liters and are currently commercially employed 
by the company Phyton Biotech (Germany). However, Taxus plant cell cultures are still limited for large-scale 
commercial use because of the low and unstable yield of paclitaxel, high production cost and low selectivity 
over unwanted by-products. Moreover, plant cell cultures display a large degree of heterogeneity in 
secondary metabolite production capabilities (Frense, 2007). Recent developments in metabolic engineering 
and synthetic biology allowed the expression of the metabolic pathway for Taxol precursor, taxadiene, in 
yeast (Engels et al., 2008) and in E.coli, the last with a very promising titer of approximately 1 g/L (Ajikumar 
et al., 2010).  
Another interesting progress made in the production of natural products is the biosynthesis of artemisinin, 
an antimalarial drug. Artemisinin is naturally produced by the plant Artemisia annua, which has a long history 
of use in traditional Chinese medicine. The antimalarial properties of A. annua extracts were rediscovered in 
the 1970s and later on the active compound artemisinin was identified as well as its structure. Artemisinin 
derivatives were recognized as anti-malarial drugs by World Health Organization in 2002, but artemisinin 
extraction from the plants showed several complications, namely fluctuations in artemisinin availability and 
price which is a major concern given the fact that malaria is predominantly a disease of the developing world. 
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Thus, the Semi-synthetic artemisinin project was born as a partnership between the University of California 
(Berkeley, USA), Amyris Inc. and the Institute for OneWorld Health and funded by Bill and Melinda Gates 
Foundation. The project has been able to successfully engineer both E. coli and yeast Saccharomyces 
cerevisiae to produce artemisinic acid, which can later on be converted to artemisinin by conventional 
organic chemistry conversion. The engineered yeast was selected as the production host and is able to 
produce 25 g/L of artemisinic acid. Industrial production of semi-synthetic artemisinin (semi-synthetic 
because the last steps are accomplished by organic chemistry) by the company Sanofi has already successfully 
started (Paddon and Keasling, 2014).  
The biosynthesis of the antimalarial drug artemisinin is a very successful case of heterologous gene 
expression for microbial production of natural products. However, the number of natural products that are 
commercially available is still very limited and more efforts are required for the development of synthetic 
approaches for scaling up the production of bioactive natural products (Fatima et al., 2014). 
 
1.4 Scope of the thesis 
 
Even though there is an enormous potential in natural products and a big interest in their commercialization, 
the task of developing an industrial process for manufacturing of natural products is very challenging. This 
thesis aims at defining some tools for benchmarking of processes for natural products production, as well as 
guidelines for the development of biosynthetic processes for a successful intensification and implementation 
at industrial scale. 
The set of tools established in this thesis can be used to evaluate processes for natural products production 
in an early stage of development, both from an economic and an environmental point of view. These 
evaluation tools allow benchmarking of different routes and process screening of the different alternative 
processes for production of a given natural product, as well as determination of the main process bottlenecks 
which can provide guidance for research and development.  
This systematic evaluation approach is illustrated with two different case-studies that involve the production 
of two different natural products – i) the bioconversion of (R)-limonene to (R)-perillic acid by a whole-cell 
biocatalyst, and ii) the fermentation of Pichia pastoris for brazzein production.  
The main components of this thesis are schematically represented in Figure 1.2. 
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Figure 1.2 Schematic representation of the scope of the thesis. 
 
1.5 Thesis outline 
 
The thesis is organized into three main parts, as described below. 
 
Part I (Chapter 2) – Provides an introduction and background to the different tools for economic and 
environmental assessment of bioprocesses at different stages of development. 
Part II (Chapter 3-4) – Focuses on all the work developed for the two case-studies.  
 Chapter 3 is dedicated to case-study 1 – the bioconversion of (R)-limonene to (R)-perillic acid by a 
whole-cell biocatalyst.  
It includes the route selection for perillic acid production and an evaluation of the process both from 
an economic and an environmental perspective. Additionally, experimental work for characterization 
of the reaction system is also presented as well as a discussion of the main bottlenecks of the process 
and strategies to improve it. 
 Chapter 4 is dedicated to case-study 2 – the fermentation of Pichia pastoris for brazzein production.  
Case-studies
(R)-perillic acid
Brazzein
Economic
Process metrics
Process modelling 
Environmental
Green Chemistry 
metrics
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This chapter is focused on the comparison of different processes for sweeteners production from an 
environmental perspective. It aims to provide guidelines for implementation of environmental 
assessment of bioprocesses in early stages of development as a tool for process development. 
Part III (Chapter 5-7) – Includes a general discussion of the methodology for evaluation of bioprocesses for 
natural products biosynthesis in an early stage of development. A discussion of the applicability of the 
different evaluation tools is included, as well as conclusions and future perspectives for this work.  
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Evaluation tools 
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2. Sustainability assessment of bioprocesses 
 
Sustainability focuses on a triple bottom line - the integration of environmental integrity, social responsibility 
and economic viability, represented in Figure 2.1. This triple bottom line is also known as the three Ps: Profit, 
Planet and People. The three pillars of sustainability complement each other and when talking about 
sustainability one must take all the three parts into consideration.  
 
 
Figure 2.1 Interaction between the three parts of sustainability: economic, environmental and social 
(adapted from (Heinzle et al., 2008)). 
 
The interactions between the three parts of sustainability are many and complex. For instance, the raw 
material availability depends on the depletion of natural resources (environmental issue). On the other hand, 
the availability of a certain raw material affects its price, which in turn affects the economy of the process.  
Both economic and environmental assessments, which are further developed in the following sections, were 
applied to the case-studies considered in this thesis. The social aspects of sustainability have not been 
included in neither of the two case-studies.  
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2.1  Economic assessment 
 
2.1.1 Process metrics 
 
The economic feasibility of a biocatalytic process is of vital importance and it determines if a process can be 
scaled-up to industrial manufacturing or not. The performance of a bioprocess, either a biocatalytic or a 
fermentation process, can be assessed using a set of metrics that can guide biocatalyst and process 
development in early stages of development (Lima-Ramos et al., 2014b) (Van Dien, 2013). 
In the case of biocatalytic processes these metrics are reaction yield, biocatalyst yield, space-time yield or 
volumetric productivity and product concentration. The target values for these metrics are influenced by the 
market value and annual production of the product of interest, which determine the scale of the production 
process. The minimum values for each process metric are case specific. They depend on the type of catalyst 
used, whether it is an isolated enzyme or a whole-cell biocatalyst, the biocatalyst formulation (liquid or 
immobilized) and the type of product and it is therefore difficult to define general targets for biocatalytic 
processes.  
Reaction yield measures the amount of product formed per amount of substrate consumed and it should be 
expressed on a molar basis (% mol product/mol substrate). Reaction yield has been inaccurately defined as 
a ratio between the mass of product and the mass of substrate in previous work from Lima-Ramos and co-
workers and Lundemo and co-workers (Lima-Ramos et al., 2014b) (Lundemo and Woodley, 2015). However, 
reaction yield should always be defined as a molar ratio and in the particular case of natural products, it does 
not make sense to calculate a mass ratio since most of the times the product has a higher molecular weight 
than the substrates and therefore using a mass ratio could lead incorrectly to a reaction yield higher than 
100%. Reaction yield represents a measurement of raw materials cost contribution and therefore this metric 
is of greater importance for bulk chemicals, which have a low selling price and therefore the gap between 
the cost of raw materials and a profitable product cost is low. The production costs are often dominated by 
the cost of raw materials which puts pressure on reaction yield. The other situation where reaction yield can 
be of major importance is if the substrate is a high-value chemical and the price difference between substrate 
and product is low. The reaction yield is determined by the substrate concentration in the reaction media 
and by the enzyme specificity. High reaction yields might be difficult to achieve in many biocatalytic reactions 
due to catalyst inhibition or instability (Lima-Ramos et al., 2014b) (Ramesh et al., 2016).  
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Product concentration measures the downstream processing costs, given that for lower product 
concentrations, a high volume of reaction mixture is sent for product recovery and purification. Therefore, 
there will be a high cost for removing a high amount of solvent from the reaction mixture for product recovery 
(Lima-Ramos et al., 2014b).  
Demands on reaction yield and final product concentration are relevant in processes with isolated enzymes 
or whole-cells. Space-time yield (STY) is however more important for processes with growing whole-cells in 
the same way as it is for fermentation processes. Space-time yield or volumetric productivity corresponds to 
the mass of product formed per reaction volume per reaction time and is typically expressed in g/L/h. It 
accounts for capital costs, namely for the reactor cost, and energy and labor related costs during the reaction 
(Lundemo and Woodley, 2015).  
For resting cell processes or processes with purified and isolated enzymes, biocatalyst yield is applied instead. 
This metric represents the total amount of product that can be produced per mass of biocatalyst, similarly to 
the total turnover number. It reflects the cost of biocatalyst production (fermentation and biocatalyst 
purification and formulation) on the biocatalytic process. Hence, its values are influenced by the final cell 
density and protein expression of the fermentation process for enzyme production. Catalyst recycle is one of 
the possible strategies to improve the biocatalyst yield (Lima-Ramos et al., 2014b) (Ramesh et al., 2016) 
(Lundemo and Woodley, 2015).  
Several successfully implemented industrial biocatalytic processes show product concentrations higher than 
50 g/L or space-time yields higher than 1 g/L/h. Straathof and co-workers reviewed 134 biotransformation 
processes for production of fine chemicals, both with isolated enzymes or whole-cells as catalysts, and 
reported space-time yields well over 1 g/L/h, reaction yields typically well over 80% and mostly over 90% 
(exceptions are kinetic resolutions which give yields close to 50%) and final product concentrations well 
above 50 g/L. Product concentrations varied from 50 g/L to above 200 g/L for carbohydrates and amides. The 
differences in product concentrations correlated with product solubility, toxicity and/or stability (reaction 
systems where product inhibition was seen showed a lower product concentration) (Straathof et al., 2002). 
The biocatalyst yield is dependent on the enzyme formulation. For immobilized enzymes or immobilized 
resting cells, yields of 102-104 kg per kg of catalyst have been reported (Thomas et al., 2002). 
In order to achieve process metrics that allow an economically feasible implementation of the process, it is 
clear that in most cases a strategy for biocatalyst improvement (via targeted protein engineering) should be 
complemented by the implementation of process intensification strategies into the reaction and process of 
interest (Ramesh et al., 2016). The development of a biocatalytic process should then be done in two main 
20 
 
steps - first by process intensification followed by process scale-up and increase of the production volume. 
In the process intensification stage, the process is kept at a small scale but the process metrics are improved 
by enzyme modification and reaction and process engineering tools. Once the process metrics have achieved 
the desired values, there is confidence that the process is indeed scalable and the volume of production can 
be scaled-up (Lima-Ramos et al., 2014a). 
Regarding fermentation processes, product concentration and space-time yield are also critical metrics to 
evaluate them and are in the same range of values as for biocatalytic processes with growing cells 
(Oudshoorn et al., 2010). The third metric that is used to assess fermentation processes is the yield of product 
on the carbon source, measured in %(C-mol/C-mol) or %(g/g). In this case, the rule of thumb is that the yield 
needs to be higher than 80% of the maximum theoretical yield (calculated from the metabolic pathway) for 
bulk chemicals (Van Dien, 2013). 
Several examples of microbial cells whose metabolism is engineered to produce chemicals and/or fuels, as 
well as novel enzyme-based reaction systems are described in scientific literature. However, it is still a 
relatively small number of them that reaches commercialization. At early stages of research, cost calculations 
and understanding the influence of process metrics on the production cost are critical to estimate targets to 
obtain an economically feasible process with a given production organism (van’t Riet, 1986). It is difficult to 
estimate the cost and research intensity necessary to modify the production microorganism or enzyme. But 
having that, one can weight it against the targets for the key process metrics and estimate the cost and 
development time necessaries to achieve industrial implementation. 
 
2.1.2 Full cost estimation 
 
Economic evaluation is a tool that is often used in chemical engineering to quantitatively estimate the costs 
and the expected profitability of a given chemical process. It includes cost estimation, revenue estimation 
and profitability analysis.  
Typically cost estimation is made throughout the development process of a chemical process and the 
accuracy of the estimations increase in later development stages. Cost estimation in a preliminary design 
stage involves the application of rules-of-thumb and rough estimations (e.g. for equipment cost), which 
means that the accuracy of estimations at this stage of development is somehow dependent on the 
experience of the engineer working on this task. Typically in early-stages of development the accuracy is 
about ±20-30%. As the project design is refined, the estimates become more detailed and accurate. But even 
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with a certain degree of uncertainty it is extremely useful to estimate the costs of a chemical process during 
its development stages since it facilitates process debottlenecking and can guide research (Lima-Ramos et 
al., 2014b).  
Cost estimation is divided into two categories: estimation of capital expenditure or capital investment 
(CAPEX) and operating expenditure or operations cost (OPEX).  
CAPEX corresponds to the costs of getting the industrial plant into operation. It includes the fixed-capital 
investment (FCI), which refers to the capital necessary for all the equipment and accessories required in the 
process operation and start-up; and working capital, which corresponds to the sum required for day-to-day 
operation of the plant, including the cost of inventories and supplies.  
Operation costs (OPEX) consist of variable production costs; fixed charges and plant overhead costs. Variable 
production costs include raw materials costs; labor costs; utilities; patents and royalties; waste treatment 
and disposal; laboratory, quality control and quality assurance. Fixed charges or fixed costs include 
depreciation of equipment and buildings, local taxes, property insurances and rent and interests. Finally, 
plant overhead costs include general expenses, such as administrative costs, distribution and marketing, and 
research and development (R&D) costs (Peters et al., 2004). Figure 2.2 includes a scheme of all categories 
and sub-categories of cost estimation. 
Since in early stages of development the level of uncertainty is high, it is also necessary to evaluate the effect 
of certain modifications to the original process on the total process environmental and economic profile by 
performing a sensitivity and/or uncertainty analysis (Lima-Ramos et al., 2014b). Developing a process model 
even in early stages of development can be extremely useful, since it can be a tool to evaluate the influence 
of certain process parameters on the final production cost (OPEX). 
There are several different softwares for process design and simulation that facilitate cost estimation, since 
they incorporate an estimator of equipment prices. Examples of these softwares are Aspen Plus®, from Aspen 
Technology, Inc.; SuperPro Designer®, from Intelligen Inc.; or SimSci PRO/II from Schneider Electric. In this 
thesis SuperPro Designer® (version 9.5) was selected as the software for process design, mass and energy 
balances and cost estimation.  
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Figure 2.2 Cost estimation different categories and sub-categories. 
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2.2  Environmental assessment 
 
Over the past decades there has been a rise in public awareness of health and environmental issues of 
consumer goods. Most companies recognize this trend and feel continued pressure to find greener 
alternatives. Policy makers are also increasingly concerned with sustainability, which is translated in one hand 
on tighter regulations on the use of certain raw materials and on the emissions resulting from chemical 
production processes, and on the other hand in an increase of interest for research projects aiming to 
develop sustainable and “green” chemicals. This trend has led many companies to evaluate the sustainability 
of their products and production processes and to include environmental concerns as a driver for product 
and process development.  
Both companies and academia are today faced with the challenge of having to evaluate the environmental 
impact of a certain chemical synthetic route and/or production process. Hence, there is the need for 
developing methods for assessing the environmental profile of chemical production processes in different 
development stages, which is a rather complex task. Different tools for the environmental assessment of 
chemicals processes, with varying degrees of detail and complexity have been developed and are nowadays 
applied by many chemical companies, in particular pharmaceutical companies, to assess their processes. On 
one hand there are reaction- and process-related metrics, which try to comparatively assess processes from 
a green chemistry and green engineering perspectives. On the other end of complexity we have the Life Cycle 
Assessment (LCA) methodology – see Figure 2.3. 
24 
 
 
Figure 2.3 Correlation between process development stage and the complexity of the environmental 
assessment. 
 
Given the complexity of these different tools and the amount and type of data required for each of them, 
they should be applied in different stages of development of the chemical process.  
Green Chemistry metrics try to quantify and measure the “greenness” of a given process or reaction by 
translating it in terms of simple metrics which should be easy to understand and apply. The amount of data 
required is relatively low, which makes it an appropriate tool for synthetic route selection and early stages 
of research and process development. These simple metrics lack however a holistic view of the 
environmental impacts of the product in its whole life cycle and do not distinguish the different types of 
waste and emissions generated.  
LCA on the other hand is a very detailed tool for evaluation of the product environmental burden in its entire 
life cycle (including raw materials manufacturing, manufacturing process of the desired product, use, 
transportation and final disposal). It is a very work intensive, complex and time-consuming tool and is 
therefore adequate for later stages of development, such as the process implementation and marketing.  
Some methodologies aiming to guide the environmental assessment of chemical processes in its different 
development stages have been published. Examples of these are the metrics toolkit resulting from the 
CHEM21 project for evaluating the “green credentials” of a certain reaction, developed by McElroy and co-
workers (McElroy et al., 2015), or the methodology to guide the development of biocatalytic processes 
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developed by Lima-Ramos and co-workers (Lima-Ramos et al., 2014b). There are slight differences in the 
methodologies but it is widely accepted that the level of detail of the environmental assessment should 
increase with the level of development of the chemical process.  
The different tools for environmental assessment are described in more detail in the following sections. 
 
2.2.1 Green Chemistry  
 
Green chemistry is a concept and guiding principle which aims to encourage the development of 
manufacturing processes and products with the lowest possible environmental impact. The twelve principles 
of green chemistry were introduced in 1998 by Anastas and Warner and are summarized in Table 2.1 (Anastas 
and Eghbali, 2010).  
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Table 2.1 The twelve principles of green chemistry (adapted from (Anastas and Eghbali, 2010)). 
Prevention 
It is preferable to prevent waste than to treat or clean up 
waste after it is formed. 
Atom economy 
Synthetic methods should be designed to maximize the 
incorporation of all materials used in the process into the 
final product. 
Less hazardous chemical synthesis 
Whenever possible, synthetic methods should be designed 
to use and generate substances that pose little or no toxicity 
to human health and the environment. 
Designing safer chemicals 
Chemical products should be designed to preserve efficacy of 
the function while reducing toxicity. 
Safer solvents and auxiliaries 
The use of auxiliary substances (e.g. solvents) should be 
avoided whenever possible and, when used, innocuous. 
Design for energy efficiency 
Energy requirements of chemical processes should be 
recognized for their environmental and economic impacts 
and should be minimized. If possible, synthetic methods 
should be conducted at ambient temperature and pressure. 
Use of renewable feedstocks 
A raw material or feedstock should be renewable rather than 
depleting whenever technically and economically feasible. 
Reduce derivatives 
Unnecessary derivatization (use of blocking groups, 
protection/deprotection, temporary modification of 
physical/chemical processes) should be minimized or 
avoided if possible, since such steps require additional 
reagents and can generate waste. 
Catalysis 
Catalytic reagents (as selective as possible) are superior to 
stoichiometric reagents. 
Design for degradation 
Chemical products should be designed so that at the end of 
their function they break down into innocuous degradation 
products and do not persist in the environment. 
Real-time analysis for pollution 
prevention 
Analytical methodologies need to be further developed to 
allow for real-time, in-process monitoring and control prior 
to the formation of hazardous substances. 
Inherently Safer Chemistry for accident 
prevention 
Substances and the form of a substance used in a chemical 
process should be chosen to minimize the potential for 
chemical accidents, including releases, explosions and fires. 
 
These principles go hand in hand with the economy of a process, since the more efficient a process is, the 
lower waste production is. Figure 2.4 relates waste production, expressed as the difference between the 
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total mass of materials used in the production process (M) and the mass of final product (P), with process 
efficiency, which is expressed as the ratio P/M. An ideal process (which is thermodynamically impossible) 
would have “zero waste production”, i.e. all the material used in the process would be converted into the 
final product (P/M=1 and M-P=0). A real process can improve its efficiency and therefore reduce waste 
production by means of technological improvements to the process and/or change of the raw material used 
(Lapkin and Constable, 2009). 
 
 
Figure 2.4 Relation between waste produced and process efficiency (adapted from (Lapkin and Constable, 
2009)). M represents the total mass of materials used in the production and P the mass of final product. 
 
2.2.1.1 The natural fit of biocatalysis with green chemistry 
 
Biocatalysis fits most of the goals and principles of green chemistry. The high selectivity of enzymes and their 
ability to carry out difficult chemical reactions eliminate synthesis steps, the associated waste in multistep 
reactions and the need for protective groups and for resolutions involving chemical derivatives. It also allows 
most of the starting material atoms to be converted to the product, contributing in this way to a maximization 
of atom economy. 
The preferential solvent used in biocatalytic reactions is water, which eliminates organic solvent waste. The 
reactions typically run at neutral pH and room temperature, which reduces energy consumption. Mild 
reaction conditions also minimize the potential for explosions, fires and accidental spills. Furthermore, 
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enzymes are biodegradable catalysts and are manufactured using renewable feedstocks (Tao and Kazlauskas, 
2011). 
An evidence that biocatalysis can contribute to green chemistry is the fact that many of the recent winners 
of the US Environmental Protection Agency’s Presidential Award in Green Chemistry have used biocatalysis 
as the key improvement technique. For instance, in 2012 Codexis, Inc. and Professor Yi Tang from the 
University of California, Los Angeles received the award for developing a biocatalytic process to manufacture 
Simvastatin, a drug for treating high cholesterol, (US Environmental Protection Agency) (Xie et al., 2006). 
The “green label” given to biocatalysis is often used as a “selling argument”. However as appropriately argued 
by Ni and co-workers, biocatalysis is not green per se and there is a big gap between the statement of such 
green claims and the environmental profiles of reaction systems reported in scientific literature (Ni et al., 
2014). In many cases, reactions that are reported in scientific literature take place in very diluted solutions, 
conditions which are not consistent with an environmentally friendly process. In these conditions large 
amounts of wastewater are generated, whose treatment consumes additional reagents and energy and can 
have a negative contribution to the environment (de María and Hollmann, 2015). Moreover, they often face 
problems of low productivities or space-time yield, which are caused by problems of substrate and/or 
product inhibition, reactant availability, biocatalyst activity and stability, etc. (Wenda et al., 2011). Claiming 
that such reactions are “green” just because they fulfill one of the twelve principles of green chemistry (in 
most cases atom economy) is not truthful since the 12 principles of green chemistry are intended to be used 
as a cohesive system (Ni et al., 2014). 
These reactions that are reported in scientific literature are still under early stages of development and 
consequently in most of the times they show very high E-factors. In fact, a lot of times these biocatalytic 
reactions show an E-factor higher than their conventional chemical alternative, as opposed to what would 
be expected by many researchers. For instance, Kuhn and co-workers compared the biocatalytic production 
of (S)-styrene with three different options of chemical catalysis and it was shown that the biocatalytic option 
showed an E-factor of 3.42 kg/kg which is lower than two of the chemical options (i) ferric phenanthroline as 
catalyst with 6.58 kg/kg and ii) manganese sulfate as catalyst with 5.72 kg/kg), but higher than the chemical 
option using titanium silicate as the catalyst (E-factor of 1.71 kg/kg). This option was also the one with the 
lowest PMI (3.04 kg/kg) as opposed to the biocatalytic option with a PMI of 21.07 kg/kg (Kuhn et al., 2010).  
But in reality, enzymes did not evolve to be an environmentally friendly catalyst. Enzymes have evolved to 
catalyze a vast number of reactions that contribute to the survival and reproduction of the organisms that 
produce them. The fact that they can be used for our benefit in industrial production of several types of 
chemicals is remarkable, but that is not enzymes primary purpose. In fact, many of the characteristics they 
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have developed during their evolution are not desirable from an industrial perspective. For instance, the fact 
that many enzymes face product inhibition at certain concentrations of product is what allows them to 
regulate the flow of metabolites inside the cells, which is fundamental for the cells metabolism. However, 
for industrial applications this feature is unwelcome since the industrial goal is to produce high 
concentrations of product in a short period of time (Arnold, 2001). Researchers force enzymes to work in 
conditions that are completely different from the conditions they have evolved to work on. In nature 
enzymes have evolved to work in dilute solutions, with low substrate and product concentrations, so it is not 
surprising that so many enzyme-based reactions show high E-factors.  
It is extraordinary to see so many novel enzyme-based reactions being reported and even though most of 
them do not show an environmentally friendly profile, experience has shown that if the process is successfully 
intensified by means of biocatalyst modification combined with reaction and process engineering, it is 
possible to attain enzymes full potential and develop an industrial chemical process with a “green” profile. 
Several examples have been reported in literature of such processes, and are shown in Table 2.2. 
The biocatalytic synthesis of (S)-ethyl-4-chloro-3-hydroxybutyrate, an intermediate for atorvastatin 
production, which was previously mentioned in Chapter 1, shows a total E-factor of 5.8 kg waste/kg product. 
If water is included E-factor increases to 18 kg/kg, which is still a remarkably low E-factor (Ma et al., 2010). 
The biocatalytic synthesis of pregabalin also shows a very low E-factor and PMI. Pregabalin is a lipophilic γ-
aminobutyric acid analogue that was developed for the treatment of several nervous system disorders, such 
as epilepsy or anxiety, and is commercialized under the name Lyrica® by Pfizer. Pregabalin was first 
synthesized with chemical catalysts, which produced a racemic mixture of pregabalin. The right enantiomer 
was obtained by classical resolution with a very low efficiency of 30%. The E-factor of this process was 
therefore relatively high – 86 kg/kg. The chemical synthetic route was then substituted by a biocatalytic route 
with two lipases. The biocatalytic route reduced the E-factor to 17 kg/kg and the process was still further 
improved by recycling the wrong enantiomer, (R)-cyanodiester, which further reduced E-factor to 8 kg/kg 
(Dunn et al., 2010) (Dunn, 2012). 
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Table 2.2 E-factors for some examples of biocatalytic reactions at industrial scale. The E-factors shown only 
refer to the reaction (DSP is not included) and do not include water.  
Product E-factor (kgwaste/kgproduct) Reference 
(S)-ethyl-4-chloro-3-hydroxybutyrate 5.8 (Ma et al., 2010) 
(S)-cyanodiester (Pregabalin) 8 (Dunn, 2012) 
(R)-tetrahydrothiophene-3-ol 2.5 (Liang et al., 2010) 
 
A quantitative evaluation of these green chemistry metrics at early stages of research and comparison with 
similar processes at industrial scale can give some valuable insight to the reaction development and provide 
guidance to researchers working on these reactions in the laboratory. The scientific community working on 
biocatalysis can greatly benefit from knowledge sharing and reporting of more quantitative studies of the 
environmental profile of biocatalytic reactions in early stages of research.  
 
2.2.1.2 Green Chemistry metrics 
 
The first green chemistry metrics to be introduced were atom economy by Trost in 1991 (Trost, 1991) and E-
factor by Sheldon in 1992 (Sheldon, 1992). Ever since the 90s green chemistry metrics have proliferated in 
number, several new metrics were introduced (Curzons et al., 2001) (Hudlicky et al., 1999) and a considerable 
amount of reviews of various metric systems and methodologies on how to assess chemical processes from 
a green chemistry perspective have been published (Constable et al., 2002), (McElroy et al., 2015), (Jimenez-
Gonzalez et al., 2011), (Shonnard et al., 2003), (Roschangar et al., 2015), (Lima-Ramos et al., 2014b).  
However, the green chemistry community has not benefited from the introduction of so many new metrics. 
In contract, there is now an excess of metrics without standardized definitions or boundaries, which inhibits 
its wide integration in industrial process research and development. There is a lack of unified metrics that 
researchers both from academia and industry can easily apply in early stages of research, which is a barrier 
for the fulfillment of green chemistry’s full potential (Roschangar et al., 2015). 
It is however, a very complex task to select a set of key metrics that have the greatest relevance to evaluate 
the “greenness” of a given process. It is difficult to find just a few metrics that are able to describe the 
complexity of a given chemical/biochemical process. 
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Environmental metrics must be adapted for their context and continuously evaluated as to their utility, 
applicability and relevance/appropriateness to the process under study.  They should be easily understood 
and accepted by key stakeholders (scientists, engineers, managers, etc.). Overall they should promote 
strategic analysis and continuous improvement of a process. They should be routinely questioned, assessed, 
evaluated and evolved to help make strategic decisions and make them useful to a business (Lapkin and 
Constable, 2009).  
Green metrics can be divided into two main groups: i) metrics that are based on the stoichiometric equation 
of the chemical reaction under study and evaluate its potential environmental impact and ii) metrics that 
address the amount of waste generated in the entire process (upstream and downstream processing 
included).  
 
Reaction-related metrics 
 
Atom Economy 
 
The first group of metrics includes atom economy (AE), which was introduced by Trost in 1991 (Trost, 1991). 
Atom economy (Equation 2.1) is based on a theoretical maximum yield of 100% and it assumes that reactants 
are used in stoichiometric amounts, disregarding also the use of solvents, acids or bases. It measures how 
much of the starting material ends in the desired product, assessing in that way the stoichiometry of the 
reaction. The driver behind this metric is to ensure that chemists design and select a production route where 
as many as possible of the atoms of the substrate are included in the final product, i.e. a synthetic route with 
a high mass yield and low waste (Lima-Ramos et al., 2014b).  
 
Equation 2.1 
𝐴𝐸 (%) =
𝑀𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑝𝑟𝑜𝑑𝑢𝑐𝑡  
∑ 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑟𝑒𝑎𝑐𝑡𝑎𝑛𝑡𝑠  
 × 100 
 
 
 
32 
 
Carbon Efficiency 
 
Carbon efficiency (CE) (Equation 2.2) was first developed by GlaxoSmithKline (GSK). It is merely a refinement 
of AE that takes into account the yield and the amount of carbon in the reactants that is incorporated into 
the final product. It is defined as the percentage of carbon in the reactants that remain in the final product 
(Constable et al., 2002). A high carbon efficiency is desired, given that in a reaction system with a low CE 
there is a greater amount of carbon that will eventually end in waste streams or as emissions (Lima-Ramos 
et al., 2014b). 
 
Equation 2.2 
𝐶𝐸 (%) =
𝑀𝑎𝑠𝑠 𝑜𝑓 𝑐𝑎𝑟𝑏𝑜𝑛 𝑖𝑛 𝑡ℎ𝑒 𝑝𝑟𝑜𝑑𝑢𝑐𝑡
∑ 𝑚𝑎𝑠𝑠 𝑐𝑎𝑟𝑏𝑜𝑛 𝑝𝑟𝑒𝑠𝑒𝑛𝑡 𝑖𝑛 𝑟𝑒𝑎𝑐𝑡𝑎𝑛𝑡𝑠
 × 100 
 
Reaction Mass Efficiency 
 
Reaction mass efficiency (RME) is a metric that was also developed by GSK. RME (Equation 2.3) takes into 
account both the concepts of atom efficiency, reaction yields and the molar quantities of reactants. It 
corresponds to the percentage of the mass of reactants that remain in the product. RME combines key 
elements of chemistry and process and represents a simple, objective, easily derived and understood metric 
for use by chemists, process chemists or chemical engineers (Constable et al., 2002). 
 
Equation 2.3 
𝑅𝑀𝐸(%) =
𝑀𝑎𝑠𝑠 𝑜𝑓 𝑓𝑖𝑛𝑎𝑙 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 
∑ 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑟𝑒𝑎𝑐𝑡𝑎𝑛𝑡𝑠
 × 100 
 
Both atom economy and reaction mass efficiency can be very useful for comparison of different routes for 
production of a given chemical and complement each other well. Atom economy is a metric that is very 
simple to calculate and one only needs to know the stoichiometric equation to calculate this metric. It tells 
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the user if the synthetic route is designed in a way that maximizes the incorporation of all the starting 
materials used in the reaction into the final product. If so, atom economy should be high (ideally 100%) and 
the synthetic route has a good potential to be a sustainable synthetic route. Since most of the starting 
material is incorporated into the final product, the waste and emissions that are generated from this reaction 
should be low.  
However, this metric does not take into account the reaction yield and it disregards the use of auxiliary 
substance (solvents, acids, bases etc.). Therefore, it can be misleading to look only to atom economy and this 
is often the case in biocatalytic reactions. Many of these reactions show a very high atom economy and in 
theory these synthetic routes have a very good potential to be “greener” when compared to conventional 
chemical synthesis. However, it is also often the case that these reactions have a low reaction yield and run 
in very diluted aqueous solutions. It is therefore important to complement atom economy with RME, since 
this metric takes into account the reaction yield and the “real” amounts of reactants and auxiliary chemicals 
used in the reaction, hence giving a more realistic picture of the environmental profile of the reaction. The 
biggest disadvantage of RME is the fact that it requires experimental work to be performed prior to its 
calculation.  
 
Process-related metrics 
 
E-factor 
 
On the group of metrics that assess the environmental impact of the overall process, E-factor is a widely 
accepted and useful metric, which was first proposed by Roger Sheldon. E-factor (Equation 2.4) is the ratio 
of waste produced per unit of final product, considering that waste includes all the reactants, solvents, etc., 
basically all the chemicals used in the process, except the desired product. The higher E-factor is, the higher 
waste production is and consequently, the environmental impact is greater. Ideally, E-factor should be zero.  
E-factor has been widely adopted in chemical industry, particularly in pharmaceutical industry, being widely 
used by companies such as GlaxoSmithKline, Pfizer or AstraZeneca.  
 
34 
 
Equation 2.4 
𝐸 𝑓𝑎𝑐𝑡𝑜𝑟 =
𝑡𝑜𝑡𝑎𝑙 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑤𝑎𝑠𝑡𝑒 
𝑚𝑎𝑠𝑠 𝑜𝑓 𝑓𝑖𝑛𝑎𝑙 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 
 
 
According to Sheldon definition of E-factor, water is excluded from its calculations since in many cases its 
inclusion can lead to exceptionally high E-factors that can hinder a meaningful comparison of chemical 
processes. In many instances, water by itself does not constitute a significant environmental impact. 
However, in certain industries, such as pharmaceutical industry, the use of highly purified water and the use 
of high amounts of water in fermentation and biocatalytic processes, can result in a considerable 
environmental impact. Therefore, there is a trend in the pharmaceutical industry towards the inclusion of 
water in E-factor. Also because water usage becomes increasingly problematic due to shortage of potable 
water in certain parts of the world (Lapkin and Constable, 2009). 
In Table 2.3 typical values for E-factor for the different sectors of chemical industry are shown. Waste 
production is typically greater in pharmaceutical industry, since the products are complex molecules whose 
production involves multistep synthesis (Roschangar et al., 2015).  
 
Table 2.3 E-factor (excluding water) for different sectors of chemical industry (adapted from (Tao and 
Kazlauskas, 2011)).   
Industry sector Annual production (ton/year) E factor (kg waste/kg product) 
Bulk chemicals 104-106 < 1-5 
Fine chemicals 102-104 5 to >50 
Pharmaceutical chemicals 10-103 25 to >100 
 
E-factor has demonstrated a strong positive correlation to process economics. A lower E-factor has been 
shown to be indicative of reduced manufacturing costs, reduced costs from hazardous and toxic waste 
disposal, improved manufacturing capacity utilization and reduced energy demand in the pharmaceutical 
industry, which shows how industry has strong economic incentives to integrate green chemistry into process 
research, development and manufacturing (Leahy et al., 2013) (Roschangar et al., 2015).  
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Process Mass Intensity (PMI) 
 
Process mass intensity (PMI) (Equation 2.5) takes into account the reaction yield, stoichiometry, solvents, 
reagents, etc., and expresses this on a weight/weight basis. It includes all the materials used in the process 
or in a specific process step. Water may or may not be included in the calculation of PMI. Similarly as to E-
factor, the trend in the pharmaceutical industry is to include it (Constable et al., 2002).  
 
Equation 2.5 
𝑃𝑀𝐼 =
∑ 𝑚𝑎𝑠𝑠 𝑖𝑛𝑝𝑢𝑡 𝑚𝑎𝑡𝑒𝑟𝑖𝑎𝑙𝑠 
𝑚𝑎𝑠𝑠 𝑜𝑓 𝑓𝑖𝑛𝑎𝑙 𝑝𝑟𝑜𝑑𝑢𝑐𝑡
 
 
The American Chemical Society Green Chemistry Institute’s Pharmaceutical Roundtable (ACS GCIPR) has 
adopted PMI as the key metric for evaluating and benchmarking processes and uses it to drive more efficiency 
and innovation in the pharmaceutical and fine chemical industries (Jimenez-Gonzalez et al., 2011). 
PMI and E-factor are similar metrics and one can argue that they give the same type of information. However, 
while in a broad sense one can argue that it does not matter which of these metrics is used, Jimenez-Gonzalez 
and co-workers argues that increasing efficiency, translated in PMI, is more likely to capture management 
attention than waste reduction, translated by E-factor and therefore, PMI should be preferred over E-factor. 
In the business context, efficiency metrics, e.g. PMI, have an advantage over waste metrics, such as E-factor, 
since they communicate and frame sustainability in terms of adding value, by adding productivity, instead of 
managing costs, by waste reduction. Metrics such as PMI allow chemists and engineers to focus on how to 
make a process more efficient instead of solving the problem of waste management. Focusing on waste 
reduction can help chemical companies to reduce costs, whereas focusing on efficiency enables innovation 
to create additional value. If the focus is on maximization of value and efficiency, waste reduction will also 
consequently be one of the benefits. Hence, PMI can promote a philosophy of efficiency and innovation 
instead of an end-of-pipe focus on waste (Jimenez-Gonzalez et al., 2011). 
When calculating PMI one can also breakdown total PMI in its different contributors and analyze which one 
of the different materials categories (solvents, reactants, water, etc.) contributes the most to total PMI and 
this gives an indication of which process unit of operation requires further development and optimization.  
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It has been shown by the ACS GCIPR that PMI is improved over the course of a pharmaceutical product 
development. At the transition to an advancing development phase, a decrease in PMI is observed. From the 
pre-clinical studies until commercial production of an API, PMI is decreased from values in the range of 1405 
kg materials/kg API to 168 kg materials/kg API (Roschangar et al., 2015).   
 
Solvent Intensity (SI) 
 
From the assessment of several synthetic routes of different chemicals, solvents have been found to 
commonly be one of the biggest contributors to mass intensity. This is particularly relevant in the 
pharmaceutical sector, where Constable and co-workers reported that solvents constitute 56% of total 
materials mass used to manufacture an API and 80-90% of the total non-aqueous mass of materials 
(Constable et al., 2007).  
Therefore, solvent intensity (SI) (Equation 2.6) was defined as a metric to analyze and quantify the amount 
of solvents used in a given process.  
 
Equation 2.6 
𝑆𝐼 =
∑ 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑠𝑜𝑙𝑣𝑒𝑛𝑡𝑠
𝑚𝑎𝑠𝑠 𝑜𝑓 𝑓𝑖𝑛𝑎𝑙 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 
 
 
Since solvents are one of the biggest mass contributors to a chemical process, limiting the amount of solvents 
used and selecting the “greenest” ones can result in a significant reduction of the environmental impact of a 
pharmaceutical product. The selection of the greenest solvent is a compromise between different 
constraints. On one hand, safety, health and environmental criteria should be considered, but also industrial 
constraints (e.g. boiling point, freezing temperature, density, quality) need to be met (Prat et al., 2014).  
Solvents are not directly responsible for the composition of a reaction product, nor are the active component 
of a formulation. Therefore, the use of toxic, flammable and environmentally damaging solvents would seem 
unnecessary because these characteristics have no impact on the function or progress of the system in which 
the solvent is applied. However, these non-benign characteristics are often linked to the beneficial attributes 
of the solvent needed for the application. For instance, the volatility of the solvents permits simple recovery 
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and purification of the solvent by distillation, but it also creates unwanted air emissions and the risk of worker 
exposure. Amide solvents have the high polarity required to dissolve a broad range of substrates and 
accelerate reactions, but this attribute often implies reproductive toxicity. Hydrocarbon solvents provide the 
ability to dissolve oils in extractions and perform separations, but at the same time they are highly 
combustible and their low water solubility is related to bioaccumulation and water toxicity. In attempts to 
eliminate undesirable solvents, replacement strategies often seek structurally related compounds not yet 
covered by the legislative and regulatory measures that are usually required to force solvents substitution. 
But even though, solvents that are similar structurally can be an easy and obvious first choice for 
replacement, they are likely to present many of the same environmental, health and safety (EHS) problems. 
One example of these substitutions is benzene and toluene. Benzene was recognized as a carcinogen 
compound in the mid-twentieth century and has generally been replaced by toluene. However, toluene is 
now suspected of damaging the unborn child and of organ damage through prolonged exposure and is 
included in the list of “substances of very high concern” by European Union and is likely to be banned by 
REACH regulation in the future (Byrne et al., 2016).  
In an attempt to categorize solvents with respect to their EHS profile, several solvent selection guides have 
been published - (Tobiszewski et al., 2015), (Byrne et al., 2016), (Prat et al., 2016), (Prat et al., 2014), 
(Henderson et al., 2011), including the solvent selection guides from several pharmaceutical companies, such 
as GSK’s (Henderson et al., 2011), Pfizer (Alfonsi et al., 2008) and Sanofi (Prat et al., 2013). These intend to 
promote the substitution of conventional organic solvents with greener solvents by academics and 
researchers giving more information on solvent selection than the regulatory assessments do.  
 
Water Intensity (WI) 
 
A particular case of solvent intensity is water intensity (WI) (Equation 2.7), which aims to analyze the amount 
of water used in the process. WI is particularly relevant in biocatalytic and fermentation processes, since it is 
one of the biggest mass contributors to these processes. Even though water is an environmentally benign 
solvent, it is becoming a scarce and overexploited natural resource. Furthermore, bioprocesses generate a 
large amount of wastewater that needs to be treated, which is usually very energy intensive. Therefore, 
water usage should also be optimized and WI appears as a metric that intends to promote a critical thinking 
on water usage (Lima-Ramos et al., 2014b).  
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Equation 2.7 
𝑊𝐼 =
∑ 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 
𝑚𝑎𝑠𝑠 𝑜𝑓 𝑓𝑖𝑛𝑎𝑙 𝑝𝑟𝑜𝑑𝑢𝑐𝑡
 
 
There are several other metrics that have been proposed to evaluate the environmental profile of a chemical 
process, such as Effective Mass Yield (EMY).  
Effective Mass Yield (EMY) is a metric proposed by Hudlicky and co-workers that tries to highlight the 
environmental effect of the reagents. It is defined as the percentage of the mass of product relative to the 
mass of all non-benign materials used in its synthesis (Equation 2.8). Hudlicky defines benign as “those by-
products, reagents or solvents that have no environmental risk associated with them” (e.g. water, dilute 
ethanol, etc.) (Hudlicky et al., 1999).  
 
Equation 2.8 
𝐸𝑀𝑌(%) =
𝑚𝑎𝑠𝑠 𝑜𝑓 𝑓𝑖𝑛𝑎𝑙 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 
∑ 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑛𝑜𝑛 − 𝑏𝑒𝑛𝑖𝑔𝑛 𝑟𝑒𝑎𝑔𝑒𝑛𝑡𝑠 
× 100 
 
However, this definition lacks clarity and objectivity. The applicability of this metric is also limited since there 
is no information on human toxicity and ecotoxicity for all the chemicals. Besides, depending on the situation 
even water, ethanol and other “benign chemicals” can have a significant environmental impact (Constable 
et al., 2002). 
Table 2.4 shows a summary of the most commonly used green chemistry metrics for assessment of chemical 
and/or biocatalytic processes.  
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Table 2.4 Summary of green chemistry metrics (adapted from (Roschangar et al., 2015)). 
Green 
chemistry 
metric 
Abbreviation Equation Units 
Consideration for  
Optimum 
value 
First 
introduced 
by 
Reaction 
yield 
Stoichiometry Solvents Water 
Reaction-related metrics 
Atom economy 
 
AE 
 
𝑀𝑊 𝑜𝑓 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 
∑ 𝑀𝑊 𝑜𝑓 𝑟𝑒𝑎𝑐𝑡𝑎𝑛𝑡𝑠 
× 100 % X X X X 100% 
(Trost, 
1991) 
Carbon 
efficiency 
 
CE 
 
𝑚(𝑐𝑎𝑟𝑏𝑜𝑛 𝑖𝑛 𝑡ℎ𝑒 𝑝𝑟𝑜𝑑𝑢𝑐𝑡)
∑ 𝑚 (𝑐𝑎𝑟𝑏𝑜𝑛 𝑖𝑛 𝑟𝑒𝑎𝑐𝑡𝑎𝑛𝑡𝑠)
× 100 %   X X 100% 
(Curzons et 
al., 2001) 
Reaction mass 
efficiency 
 
RME 
 
𝑚𝑎𝑠𝑠 𝑜𝑓 𝑓𝑖𝑛𝑎𝑙 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 
∑ 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑟𝑒𝑎𝑐𝑡𝑎𝑛𝑡𝑠
 × 100 %   X X 100% 
(Curzons et 
al., 2001) 
Process-related metrics 
Environmental 
impact factor 
 
E-factor 
 
𝑡𝑜𝑡𝑎𝑙 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑤𝑎𝑠𝑡𝑒 
𝑚𝑎𝑠𝑠 𝑜𝑓 𝑓𝑖𝑛𝑎𝑙 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 
 kg/kg    X 0 
(Sheldon, 
1992) 
Process mass 
intensity 
 
PMI 
 
∑ 𝑚𝑎𝑠𝑠 𝑖𝑛𝑝𝑢𝑡 𝑚𝑎𝑡𝑒𝑟𝑖𝑎𝑙𝑠 
𝑚𝑎𝑠𝑠 𝑜𝑓 𝑓𝑖𝑛𝑎𝑙 𝑝𝑟𝑜𝑑𝑢𝑐𝑡
 kg/kg     1 
ACS GCIPR 
(2007) 
Solvent 
Intensity 
 
SI 
 
∑ 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑠𝑜𝑙𝑣𝑒𝑛𝑡𝑠
𝑚𝑎𝑠𝑠 𝑜𝑓 𝑓𝑖𝑛𝑎𝑙 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 
 kg/kg X X  X 0 
(Curzons et 
al., 2001) 
Effective mass 
yield 
 
EMY 
 
𝑚𝑎𝑠𝑠 𝑜𝑓 𝑓𝑖𝑛𝑎𝑙 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 
∑ 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑛𝑜𝑛 − 𝑏𝑒𝑛𝑖𝑔𝑛 𝑟𝑒𝑎𝑔𝑒𝑛𝑡𝑠 
× 100 %    X 100% 
(Hudlicky 
et al., 
1999) 
Water intensity 
 
WI 
 
∑ 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟
𝑚𝑎𝑠𝑠 𝑜𝑓 𝑓𝑖𝑛𝑎𝑙 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 
 kg/kg X X X  0 
(Curzons et 
al., 2001) 
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Most of these reaction-related and process-related metrics have the big advantage of being simple to use 
and can give instant feedback of a change made in the process or in the synthetic reaction, and therefore can 
easily be used for modelling and comparison of different scenarios. Thus there is a great interest in using 
environmental metrics in the process development stage. However, it obviously also presents some 
drawbacks and limitations. One evident limitation is the fact that the same weight is given to all different 
types of waste generated. For instance, when calculating E-factor the same weight is given to 1 kilogram of 
sodium chloride (NaCl) and to 1 kilogram of hexane, when clearly the health and safety hazards of both 
chemicals is completely different resulting in different impacts on the environment (Tufvesson et al., 2012). 
This is the reason why the calculation of these green chemistry metrics should be combined with an analysis 
of the health and safety hazards of the chemicals used in the process.  
In this thesis atom economy and carbon efficiency in combination with reaction mass efficiency were selected 
for the comparison of the environmental profile of the different synthetic routes for (R)-perillic acid 
production (section 3.3).  
For the environmental assessment of an entire process a combination of several process-related metrics 
were used in (R)-perillic acid and brazzein case-studies, but PMI was selected as the preferred metric to guide 
process development. 
 
2.2.2 Environmental, Health and Safety hazards 
 
Assessing health and safety of the chemical inventories is an important part of an environmental assessment. 
Besides human toxicity it is also important to take into account the hazards to the environment. 
EHS aspects of the chemicals should be assessed based on the globally harmonized system of classification 
and labelling of chemicals (GHS) and certain chemical hazard categories should be avoided (e.g. carcinogens, 
mutagens, endocrine disrupting substances, flammable, explosive, etc.). 
In addition to the health and safety of the chemicals, acute and chronic toxicity data should also be gathered 
in response to legislation such as REACH. “Registration, Evaluation, Authorization and Restriction of 
Chemicals” (REACH) is a regulation of the European Union, adopted to improve the protection of human 
health and the environment from the risks that can be posed by chemicals, while enhancing the 
competitiveness of the EU chemicals industry. It affects the import and usage of a wide range of chemicals 
in Europe, and any products found to not comply with the conditions established in REACH are removed from 
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the market through the “Rapid Alert System for Dangerous Non-food Products” (RAPEX) information scheme 
(Byrne et al., 2016). As a result of REACH, in 2015 several products containing toluene, chloroform or benzene 
have been banned from EU, and several solvents are currently under scrutiny, such as N,N-
dimethylformamide (DMF), N,N-dimethylacetamide (DMAc), N-methylpyrrolidinone (NMP) as well as certain 
hydroxyethers and chlorinated solvents (Byrne et al., 2016).  
There are highly respected and trustworthy databases which compile information on the hazards of chemical 
substances and help with the often complicated task of substituting a certain chemical. Examples of these 
databases are the SIN LIST and the SUBSPORT, the Substitution Support Portal. The SIN (Substitute it Now!) 
List is a globally used database of chemicals likely to be banned or restricted in a near future. The chemicals 
on the SIN List have been identified by ChemSec (International Chemical Secretariat) as Substances of Very 
High Concern based on the criteria established by the EU chemicals regulation REACH (http://sinlist.org, 
accessed on 22.09.2016). SUBSPORT, the Substitution Support Portal, is a database/search engine on 
hazardous substances that are legally or voluntarily restricted or subject to public debate (www.subsport.eu, 
accessed on 22.09.2016).  
These portals aim to support companies in fulfilling substitution requirements within EU legislation, as well 
as being a useful resource for scientific institutions interested in substituting hazardous chemicals. It is 
imperative that researchers look into the health, safety and environmental hazards of the chemicals used in 
a certain process in an early stage of development, since substituting chemicals in later stages of research 
and development is much more costly and complicated.  
 
2.2.3 Life Cycle Assessment  
 
In comparison with green chemistry metrics, Life Cycle Assessment (LCA) is at the other end of the spectrum 
in terms of complexity and comprehensiveness (Lima-Ramos et al., 2014b). LCA is defined as “the compilation 
and evaluation of the inputs, outputs and potential environmental impacts of a product system throughout 
its life cycle” (European Comission for Standardization, 2006a). Life cycle thinking is an approach covering all 
life cycle stages of a process, product or service system, from extracting and processing of raw materials, 
manufacturing, transportation and distribution, use/reuse, recycling and disposal. This is often called a 
“cradle to grave” approach, represented in Figure 2.5. 
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Figure 2.5 Life cycle thinking - a cradle to grave approach. 
 
Unlike green chemistry metrics, LCA is a methodology that is not specific for chemical and/or biochemical 
processes. It was developed to be suitable for the environmental assessment of all types of products, 
processes or services (Lima-Ramos et al., 2014b).  
LCA is a methodology that has been standardized by the International Standard Organization (ISO) – 
ISO14040:2006 and ISO14044:2006 (European Comission for Standardization, 2006a) (European Comission 
for Standardization, 2006b). The level of detail and the boundaries of an LCA study depend on the subject 
and goal of the study, but the ISO standards need to be followed. The LCA methodology comprises of four 
phases. The first phase is the goal and scope definition, where the system boundaries and goal of the study 
are defined. This step is followed by the Life Cycle Inventory (LCI). This is the most time-consuming step and 
consists of performing mass and energy balances to all the different steps in the product life cycle, in order 
to quantify the material and energy inputs into the system as well as wastes and emissions from the system. 
Then comes the Life Cycle Impact Assessment (LCIA) where all the inventory data is processed and aggregated 
into a limited set of recognized environmental effects. The inputs and outputs quantified during the LCI step 
are related to different impact categories, which include Global Warming Potential (GWP), Stratospheric 
Ozone Depletion Potential (SOP), Photochemical Ozone Creation Potential (POCP), Acidification Potential 
(AP), Nutrient Enrichment Potential (NEP), Eco-toxicity Potential (ETP), Human Toxicity Potential (HTP) and 
Hazardous Waste Potential (HWP) (Lima-Ramos et al., 2014b). The last step consists of the interpretation of 
Raw materials 
extraction
Transportation
Manufacturing
PackagingTransportation
Use
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the results obtained within the Life Cycle Inventory and/or Life Cycle Impact Assessment in the light of the 
goal and scope defined. This last step typically includes a sensitivity and/or uncertainty analysis of the results 
obtained in order to draw conclusions and make recommendations (Lapkin and Constable, 2009).  
There are multiple commercially available software tools for the implementation of the LCA methodology, 
e.g. SimaPro or GaBi. The biggest asset of these software tools is the inclusion of comprehensive inventory 
databases, which facilitate the mass and energy balances of up- and downstream stages of the process under 
investigation. One of the most comprehensive databases is the ecoinvent database (latest version is 
ecoinvent 3.3) (www.ecoinvent.org accessed on 20.09.2016). 
LCA provides a framework for reporting the environmental impacts reflecting the whole life cycle of a given 
product and is therefore a valuable tool to support the implementation and marketing of a given product. 
However, on the research and development stage of a process or product, a full LCA is too time-consuming, 
laborious and complicated. The methodology is too comprehensive and there are difficulties in finding all the 
necessary inventory data, which makes its applicability reserved to late stages of development when all this 
information and data is certain and available. For these reasons, LCA does not enjoy widespread practice for 
environmental assessment of bioprocesses, with the exception of biofuels (Tufvesson et al., 2012).  
Given the complexity of the LCA methodology, several chemical companies have developed simplified in-
house LCA methods, based on the guidelines in the ISO standards for evaluating the sustainability of its 
products. Examples of these methods are the FLASC-tool developed by GlaxoSmithKline to systematically 
evaluate synthetic organic reactions and processes (Curzons et al., 2007), or the Eco-Efficiency Analysis 
method developed by BASF (Shonnard et al., 2003).  
 
2.3 Concluding remarks 
 
There is a large number of available tools to assess the economic and environmental profile of a given 
bioprocess and the selection of the most appropriate ones is not a straightforward task.  
Regarding the assessment of the economic feasibility of a given process, process metrics such as product 
concentration, space-time yield and reaction yield can provide meaningful information while being simple 
and easy to calculate.  
Similar metrics also exist for the environmental assessment of processes in early stages of development. 
These metrics, commonly designated as Green Chemistry metrics, can be grouped into reaction-related or 
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process-related metrics and provide a quick assessment of the environmental profile of a chemical or 
biochemical process.  
Given the inherent differences in the processes, different tools should be used to evaluate biocatalytic and 
fermentation processes, which are further explored throughout the thesis.   
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Part II 
 
Case-studies 
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3. Case-study I: Bioconversion of (R)-limonene to (R)-perillic 
acid by a whole-cell biocatalyst 
 
3.1  Introduction 
 
In this first chapter the work done for the first case-study is presented, including benchmarking of the 
different routes for perillic acid production, economic and environmental assessment and development of 
different improvement strategies for the process. 
This case-study corresponds to the bioconversion of (R)-limonene to (R)-perillic acid by Pseudomonas putida 
GS1. Perillic acid is a monoterpenoic acid that is naturally present in some plants of the genus Perilla, namely 
in Perilla frutescens. It has a strong growth-inhibitory effect on bacteria and fungus, which makes it an 
attractive candidate to be used for preservation purposes, e.g. in cosmetic industry (Mirata et al., 2009) (Rieks 
et al., 2004). It has also been shown that perillic acid has anti-cancer properties, namely as an inhibitor of 
metastic progression of melanoma cells, and could potentially be of interest to the pharmaceutical industry 
(von Kitzing et al., 1994) (Yeruva et al., 2007).  
The bioprocess for (R)-perillic acid production is presented in section 3.2. Section 3.3 corresponds to the 
benchmarking of the bioprocess with other routes for perillic acid production. Section 3.4 corresponds to an 
economic and environmental assessment of the bioprocess from both an economic and an environmental 
perspective. Section 3.5 includes an experimental characterization of the process and section 3.6 a discussion 
of the possible process technologies that can be used to improve this bioprocess. 
 
3.2  Bioprocess description 
 
(R)-Limonene is converted to (R)-perillic acid in a three-steps reaction represented in Figure 3.1. In the first 
step (R)-limonene is converted to (R)-perillyl alcohol by a monooxygenase, which is then converted to (R)-
perillyl aldehyde by an alcohol dehydrogenase, and finally the aldehyde is converted to (R)-perillic acid by an 
aldehyde dehydrogenase. This reaction is part of the degradation pathway for p-cymene that is naturally 
expressed in Pseudomonas putida GS1 metabolism. This degradation pathway is an adaptation mechanism 
that is induced in the presence of toxic solvents. Limonene is the monocyclic monoterpenoic analogue to the 
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aromatic p-cymene and it also activates the p-cymene degradation pathway. In this degradation pathway, p-
cymene is oxidized to p-cumate in three steps, which are catalyzed by a monooxygenase, an alcohol 
dehydrogenase and an aldehyde dehydrogenase, which are also active towards limonene and its derivatives, 
perillyl alcohol and perillyl aldehyde. But in contrast to p-cumate, perillic acid is not further catabolized and 
it is secreted into the medium as a result of the narrow substrate specificity of the cumate dioxygenase that 
further degrades p-cumate (Speelmans et al., 1998). 
 
 
Figure 3.1 Bioconversion of (R)-limonene to (R)-perillic acid by P. putida GS1: (A) monooxygenase; (B) 
alcohol dehydrogenase; (C) aldehyde dehydrogenase. 
 
As most organic solvents (R)-limonene is toxic to most bacterial strains, but Pseudomonas putida GS1 is able 
to grow with concentrations of (R)-limonene as high as 500 mM since solvent tolerance mechanisms are 
activated. On the other hand, (R)-perillic acid inhibits cell growth and the biocatalytic reaction and feedback 
inhibition was claimed to determine the maximum product concentration achievable in batch cultures 
(Speelmans et al., 1998). Previous work by Mirata and co-workers determined the critical inhibitory 
concentration of (R)-perillic acid to be 165±7 mM. Product inhibition was confirmed experimentally and total 
inhibition of growth of P. putida GS1 was observed with a concentration of 167 mM of (R)-perillic acid 
(cultivations in TB media at pH 10). (Mirata et al., 2009). 
A process for biotechnological production of (R)-perillic acid with a wild-type strain of Pseudomonas putida 
GS1 was developed and established at BRAIN AG. Since the reaction system faces product inhibition, there is 
the need of having an in situ product removal (ISPR) step to alleviate product inhibition. 
49 
 
3.3  Benchmarking of different routes for perillic acid production 
 
In the first place, an evaluation of the environmental profile of different routes for perillic acid production 
was made, with the purpose of identifying the most promising route for industrial production of perillic acid.  
In the case of (R)-perillic acid all the three possible production routes represented in Figure 1.1 – extraction 
from natural sources, chemical synthesis and biosynthesis – are theoretically possible. The routes for (R)-
perillic acid production that were identified in literature are: i) extraction from the plant Perilla frutescens; ii) 
chemical synthesis starting from β-pinene, and iii) biocatalytic conversion of (R)-limonene to (R)-perillic acid 
by Pseudomonas putida GS1. 
Perillic acid has been identified as a monoterpene glucoside in the plant Perilla frutescens (Fujita and 
Nakayama, 1993). However, it is only found in nature in very low concentrations as most terpenoids. There 
are several oxyfunctionalised monoterpenes and sesquiterpenes which are industrially interesting to be used 
as flavor and fragrances. But they are present in the essential oils of plants, which constitute around 0.1 to 
5% of the plant. In the specific case of Perilla frutescens leaves, they are constituted by 1.04 %(w/w) of 
essential oil (Yu et al., 1997). The extraction of minor compounds, such as perillic acid, from the essential oils 
is only in very rare cases economically feasible (Berger, 2007). For this reason and since it was not found in 
the literature the exact amount of perillic acid in the leaves of Perilla frutescens, this route for perillic acid 
production was not included and it was not further analyzed.  
On the other hand, terpene hydrocarbons such as (R)-limonene and pinenes are abundantly available in 
nature as the main component of citrus and turpentine oils, respectively. Orange oil contains more than 90% 
of (R)-limonene and turpentine oil up to 75-90% pinenes, which makes these compounds as an interesting 
starting material for oxyfunctionalizations that lead to industrially relevant terpenoids, such as perillic acid 
(Berger, 2007). 
The biocatalytic conversion of (R)-limonene to (R)-perillic acid by Pseudomonas putida GS1 (Mars et al., 2001) 
(Speelmans et al., 1998) (Mirata et al., 2009) described in section 3.2 and the chemical synthesis of perillic 
acid starting from β-pinene (Wang et al., 1993) were therefore compared from an environmental point of 
view. 
The biocatalytic conversion of (R)-limonene to (R)-perillic acid by Pseudomonas putida GS1 is shown in Figure 
3.1.  
The chemical synthesis of perillic acid starting from β-pinene is shown in Figure 3.2. 
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Figure 3.2 Chemical synthesis of perillic acid starting from β-pinene (Wang et al., 1993). 
 
Based on the mass balances of both routes, the key reaction-related green chemistry metrics were calculated 
for both synthetic routes and are shown in Table 3.1. For easier interpretation, Figure 3.3 shows a graphic 
representation of these green chemistry metrics for both synthetic routes.  
 
Table 3.1 Comparison of reaction-related green chemistry metrics for the biocatalytic and chemical 
synthetic routes for perillic acid production. 
 Biocatalytic route Chemical route 
Atom Economy (%) 99 25 
Carbon Efficiency (%) 100 59 
Reaction Mass Efficiency (%) 20 3 
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Figure 3.3 Reaction-related green chemistry metrics for the biocatalytic and chemical synthetic routes for 
perillic acid production. 
 
From Table 3.1 and Figure 3.3 it is clear that the biocatalytic route has the potential to be a “greener” process, 
since all the three metrics are considerably superior to the chemical route. Carbon efficiency is 100%, which 
corresponds to the ideal value, and atom economy is also extraordinarily close to the ideal. The starting 
material for the biocatalytic route, (R)-limonene is chemically very similar to the final product, (R)-perillic acid 
and only oxygen is consumed as a reactant in this oxyfunctionalization. Therefore, this is a very good example 
of a synthetic route that obeys to the principles of atom economy – the synthetic route maximizes the 
incorporation of the starting materials into the final product.  
However, the situation is a little different when it comes to RME. This metric also has a higher value for the 
biocatalytic route, but in both routes its value is very low which indicates that both synthetic routes require 
further development and optimization. 
Another important issue to take into account when selecting a synthetic route is the qualitative analysis of 
EHS aspects of the chemicals and solvents used in the reaction. McElroy and co-workers grouped several 
solvents that are typically used in the pharmaceutical industry and attributed green, yellow or red flags to 
the use of hazardous and highly hazardous solvents, problematic and recommended solvents, respectively. 
The same procedure was adopted for the safety and health of the reactants used, based on the H-statements 
defined by the globally harmonized system of classification and labeling of chemicals (GHS) (McElroy et al., 
2015). This flags system is very simple, illustrative and easy to interpret and has therefore been followed to 
compare the chemical properties of the chemicals used in both routes.  
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Table 3. 2 Analysis of the environmental, health and safety hazards of the reactants and solvents used in 
the biocatalytic and chemical synthetic routes. 
 Green flag Yellow flag Red flag 
Biocatalytic 
route 
Solvents    
No solvents used. X   
Reactants    
(R)-Limonene 
H410: Very toxic to aquatic life with 
long lasting effects 
  X 
Chemical 
route 
Solvents    
Nitromethane – highly hazardous   X 
Hexane - hazardous   X 
Methanol X   
Water X   
Reactants    
Hydrogen peroxide (H2O2) 
H330: Fatal if inhaled 
  X 
Manganese dioxide (MnO2) 
H373: May cause damage to organs 
through prolonged or repeated 
exposure 
 X  
 
Analyzing Table 3. 2 one can see that the chemical synthesis shows more EHS concerns (translated by the 
number of red and yellow flags) than the biocatalytic route. The chemical synthesis consists of four different 
steps, each one with different reactants, solvents and catalysts. So in total, the number of chemicals used in 
the chemical route is considerably higher than the biocatalytic route. Two of the solvents used in the chemical 
route are hazardous. Nitromethane is highly hazardous, since it is a flammable liquid and vapour (H226) and 
highly explosive, and hexane is also a hazardous solvent which shows several health, safety and 
environmental issues – it is a highly flammable liquid and vapour (H225), it is suspected of damaging fertility 
(H361), may cause damage to organs through prolonged or repeated exposure (H373) and is toxic to aquatic 
life with long lasting effects (H411). Hexane has also been considered a chemical of very high concern by 
ChemSec and it is part of the SIN List because it is classified as a possible reprotoxic chemical (R3) and has 
been reported to have endocrine and neurological effects (sinlist.org accessed on 18.09.2016). The reactants 
and catalysts also show EHS hazards, for instance manganese dioxide (MnO2) may cause damage to organs 
through prolonged or repeated exposure (H373). Another environmental issue of the chemical route is the 
fact that each synthetic step takes place at a different temperature in a range from 0 °C to 80 °C, which is 
undesirable from an energetic point of view.   
On the other hand, the biocatalytic route also shows some EHS concerns. (R)-limonene is very toxic to aquatic 
life with long lasting effects (H410) and it is therefore not the “greenest” starting material. Moreover, when 
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making the chemical inventory of the biocatalytic route, CoSO4 has been identified as a chemical of very high 
concern, present in the SIN List since it has been classified as carcinogenic, mutagenic, reprotoxic (CMR) 
according to Annex 1 of Directive 67/548/EE (sinlist.org accessed on 20.08.2016). However, cobalt sulphate 
is only used in the trace metals solution and it is present in the reaction media in a concentration in the range 
of nanograms per liter. Since, the concentration of cobalt sulphate used is so low, this should not be a major 
health and safety concern. When assessing the EHS hazards of the different chemicals used in a chemical 
reaction it is also important to analyze the EHS hazards of the final product. However that was not possible 
since data on the safety and toxicology of (R)-perillic acid could not be found in scientific literature.  
The use of a biocatalyst is preferable from an environmental point of view, as opposed to the use of excess 
of reagents in the chemical route. And the fact that the reaction takes place at a constant temperature close 
to room temperature (30 °C) is also a positive point from an environmental and an economic perspective.  
In conclusion both the reaction-related green chemistry metrics and the EHS hazards of the chemical 
inventory point towards the selection of the biocatalytic route as the most promising to be investigated for 
industrial application. The economic and environmental profile of the biocatalytic reaction were further 
investigated in the following sections of the thesis. 
 
3.4  Bioprocess evaluation 
 
3.4.1 Economic assessment 
 
3.4.1.1 Process metrics 
 
In order to make an initial assessment of the economy of the bioprocess for (R)-perillic acid production, the 
process metrics that are relevant in this case, i.e. product concentration, space-time yield and reaction yield, 
were calculated based on the mass balances of the process. The process metrics for are shown in Table 3.3. 
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Table 3.3 Process metrics for the bioprocess for (R)-perillic acid production. The reaction yield is calculated 
on a molar basis. 
Process metrics (R)-perillic acid bioprocess 
Product concentration (g/L) 4.81 
Space-time yield (g/(L.h)) 0.17 
Reaction yield (%) 20.6 
 
 
Figure 3.4 Process metrics for the (R)-perillic acid bioprocess presented along with typical values for an 
economically feasible process. 
 
Characterization and identification of the limitations of a bioprocess is the first step towards development of 
an economically feasible process. Translating the performance of the bioprocess into process metrics and 
benchmarking against quantitative targets is a very valuable tool. In Figure 3.4 typical values for a biocatalytic 
pharmaceutical process implemented at industrial scale are represented together with the process metrics 
for the bioprocess for (R)-perillic acid production. Pharmaceutical chemicals can be used as an appropriate 
benchmark given the low annual production that is expected for (R)-perillic acid. Since it is a novel chemical 
product that is not commercially available in the cosmetic, food, pharmaceutical or any other market, it is 
assumed a very low initial annual production of (R)-perillic acid in the range of 1 ton/year.  
As shown in Figure 3.4 all the three process metrics for the bioprocess for (R)-perillic acid production are far 
from reasonable values for an economically feasible process. The process undoubtedly needs further reaction 
and process development for its intensification and it is still far from economic feasibility.  
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Furthermore, all of the three process metrics are approximately equally far from the targets, i.e. none of 
them is significantly better than the others. And all the process metrics are equally important for the 
economy of a biocatalytic process. So the question that is raised from this simple economic assessment is – 
which metric should be improved in first place? Which metric has a greater influence on the overall economy 
of the process and should therefore be tackled first? 
In order to further explore this question a process model and a full cost estimation were developed which 
are shown in section 3.4.1.2. 
 
3.4.1.2 Process model 
 
Economic feasibility was assessed by means of a method designed for utilization at early development stages 
of chemical processes (Heinzle E.; Weirich and K., 1998) (Heinzle et al., 1998). A process model for the 
chromatography-based process was developed in the commercial process simulation software SuperPro 
Designer®, version 9.5 (Intelligen Inc., Boston, USA).  
The model is based on experimental data collected at 10L scale and scalability to 5 m3 was assumed.  
The bioconversion reaction was described as in equation Equation 3.1 and a reaction yield of 20.6% was 
assumed. It was assumed that the remaining (R)-limonene that is fed to the fermenter is lost in the exhaust 
gas, a phenomenon that is observed at laboratory scale. 
 
Equation 3.1 
𝐶10𝐻16 + 1.5 𝑂2 →  𝐶10𝐻14𝑂2 + 𝐻2𝑂 
 
The annual production was assumed to be 1 ton (R)-perillic acid per year and the annual production time is 
only 3 months/year. It is assumed that the final product would be stored in storage facilities for the remaining 
time of the year.  
The scheduling of the process was done in order to maximize equipment usage. Total batch time is 
approximately 139 hours (6 days) and 17 batches run in one production year.  
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SuperPro Designer® software comprises comprehensive databases for the calculation of numerous economic 
parameters. These values were used for the economic assessment unless otherwise stated. Raw material 
costs were complemented with industrial market prices from the ICIS webpage (www.icis.com accessed on 
15.07.2016) or, if necessary, by division of the lab-scale prices from Sigma-Aldrich (www.sigmaaldrich.com 
accessed on 20.10.2016) by a factor of 10.  
Basic labor costs are estimated from the labor requirements of each operation step in the factory and 
assuming a standard wage of 30 $/h (approximately 28 €/h) for an operator (excluding benefits) (Kuhn et al., 
2010). It was also assumed that the industrial facility would be a multi-purpose plant with shared utilities and 
services, which would be rented for (R)-perillic acid production.  The facility-dependent costs, which 
represent a rental fee for the use of the equipment, are calculated based on equipment usage. Wastewater 
treatment costs were not included in the cost assessment.  
Based on this process model, which includes mass as well as energy balances, an economic assessment of 
the process including a full cost estimation was made. 
The economic assessment that was performed focused solely on the production cost (€/kg product). Capital 
cost (CAPEX) and depreciation of the equipment were not considered in the economic assessment.  
The results of the economic assessment revealed that the production costs are higher than what would be 
desired, which confirmed the previous conclusions from the assessment of the process metrics that the 
process needs to be further intensified. 
Figure 3.5 shows the contribution of different elements to the total annual operation cost. These different 
elements are raw materials, labor, facility-dependent costs, utilities and consumables, which include resins, 
filters, etc. 
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Figure 3.5 Annual operation cost breakdown for the chromatography-based production process. 
 
Facility-dependent costs are the biggest contributor to the total operations costs, which is not uncommon 
for bioprocesses. Bioprocesses typically produce high-value products in small quantities in relatively 
expensive facilities,  with equipment that is more sophisticated, e.g. fermenters and chromatographic 
columns, than equipment that is used in conventional chemical processes (Harrison et al., 2015). That is 
precisely the case here where (R)-perillic acid is produced in a very small scale (1 ton/year), therefore it is 
expectable that facility-dependent costs contribution to total operation cost is substantial. 
Biocatalytic processes are typically capital intensive because large and complex fermenters are required. The 
main reasons for this are usually dilute reaction systems and complex requirements for process control to 
guarantee optimal growth of microorganisms (Straathof and Adlercreutz, 2000). Sterilization and 
biocontainment are also extra features of fermenters (when compared with chemical reactors) that result in 
an additional cost. The comparably dilute product concentrations in the fermenter are the reason why the 
equipment has to be designed larger as compared to chemical plants to achieve similar product amounts. 
This results in a higher cost of the equipment, which can be alleviated if the equipment is rented, as it 
happens in this case. The considerably high facility-dependent costs stress the importance of process 
intensification by different process technologies and/or biocatalyst modification. (Woodley, 2008) (Chotani 
et al., 2000).  
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(R)-perillic acid production at a 1 ton/year scale was clearly dominated by fixed costs (facility-dependent and 
labor costs), which account for 78% of the total operation costs. That is a similar scenario to other published 
economic assessments of biocatalytic processes, e.g. (S)-styrene biocatalytic production where fixed costs 
account with 63% of total operations costs (Kuhn et al., 2010) (Kuhn et al., 2012).  
The high fixed costs and the low variable production costs (raw materials and utilities) of the biocatalytic 
process would clearly favor larger annual production volumes, as the contribution of the fixed costs with 
respect to total costs decreases with increasing scale (economy of scale). This was confirmed by running a 
sensitivity analysis on the volume of annual production, whose results are shown in Figure 3.6. 
 
 
Figure 3.6 Relative unit production cost (€/kg) as a function of annual production (ton/year). 
 
But more interesting than merely calculating the production cost and the weight of its different contributors 
is to analyze what influences it. Therefore a sensitivity analysis on the different process metrics was made 
and the variation of production cost was analyzed.   
The sensitivity analysis was performed by analyzing the influence of reaction yield and reaction time 
(expressed by the space-time-yield) on unit production costs (€/kg).  
For the sensitivity analysis on reaction yield, the annual production was kept constant at 1 ton/year and the 
results are shown in Figure 3.7.  
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Figure 3.7 Relative production cost as a function of increase in reaction yield. 
 
Increasing the reaction yield up to 4 folds, only decreased the production cost by 0.5%, which is an 
insignificant difference from an economic perspective. This minor decrease can be explained by the substrate 
low selling price. By increasing the reaction yield, the raw materials cost contribution to total operation costs 
is reduced. But since the substrate is a low-value chemical, the cost contribution of the raw materials is 
anyway low (around 5% of total operation costs as shown in Figure 3.5). So increasing reaction yield does not 
have a significant impact on total operation costs.  
On the other hand, the sensitivity analysis to the space-time yield revealed a different picture. Figure 3.8 
shows the results of this sensitivity analysis, where space-time yield was varied by only changing the reaction 
time (reaction yield was kept constant). The results show that the production cost is very sensitive to space-
time yield. For instance, when reducing transformation time by 80%, total operation costs can be reduced up 
to 40%, which is a very significant reduction. 
In this sensitivity analysis, annual production was also kept constant as 1 ton/year. The reduction in 
production cost can be explained by the fact that if the transformation time is reduced, the total batch time 
is also reduced. Hence, to produce 1 ton of (R)-perillic acid a lower annual production time is necessary, which 
reduces the cost of equipment usage and labor. Since the facility-dependent costs are the biggest contributor 
to total production costs, reducing the reaction time can have a very significant effect on the economy of the 
process.  
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Figure 3.8 Relative production cost and increase in space-time yield as a function of reduction in 
transformation time. 
 
In conclusion, the sensitivity analysis on different process metrics allowed the identification of the space-
time yield, or more specifically the reaction time, as one of the parameters that mostly affect the economic 
feasibility of this process. Therefore, the focus of process development should be on increasing space-time 
yield and accelerating the reaction.  
The process model and subsequent full cost estimation proved to be a very useful tool in ranking the 
importance of the different process metrics and identifying the space-time yield as the process metric that 
mostly affects the economy of this bioprocess.  
 
3.4.2 Environmental assessment 
  
The environmental profile of the biotechnological production of (R)-perillic acid was also assessed in terms 
of process-related green chemistry metrics. The green chemistry metrics (PMI, E-factor and SI) for the 
bioprocess for (R)-perillic acid production were calculated based on experimental data at 10L scale and are 
shown in Table 3.4. 
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E-factor of the bioprocess for (R)-perillic acid production is relatively high, but within the typical range of 
values for pharmaceutical chemicals (25 to >100). PMI is also very similar in both cases and relatively high, 
which again demonstrates that the process needs further intensification.  
 
Table 3.4 Process-related green chemistry metrics for the bioprocess for (R)-perillic acid production. 
Process-related metrics 
(R)-perillic acid 
bioprocess 
SI (kgsolvent/kgproduct) 109.8 
E-factor (kgwaste/kgproduct) 226.9 
PMI (kgmaterials/kgproduct) 
USP 83.1 
DSP 219.8 
Total 302.8 
 
Figure 3. 9 shows the contribution of different materials to total PMI of the bioprocess for (R)-perillic acid 
production. 
 
 
Figure 3. 9 Composition by mass of the type of materials used in the bioprocesses for (R)-perillic acid 
production.  
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The biggest contributor to PMI is water, which is typical of bioprocesses. Solvents contribute with 37% to PMI 
due to ethanol consumption in the downstream processing section of the bioprocess. Even though ethanol 
is not a hazardous solvent, solvents use should always be minimized. 
 
3.5  Experimental characterization of the bioprocess 
 
In the previous sections an economic and environmental assessment of the bioconversion of (R)-limonene to 
(R)-perillic acid was done. One of the conclusions from the economic assessment was that space-time yield 
or volumetric productivity (g/L/h) greatly affects the economy of the process.  
Here, as an addition to the in silico analysis of the bioprocess, some experiments to characterize it were done 
in order to investigate the reasons for the low space-time yield and better understand the limitations of this 
reaction system. 
 
3.5.1 Materials and methods 
 
3.5.1.1 Determination of the reaction rate 
 
To determine the reaction rate of (R)-limonene conversion to (R)-perillic acid, a fermentation following the 
same process conditions as the ones followed by BRAIN AG was run. 
 
Chemicals, strain and media 
(R)-limonene (99% purity) was purchased from Erich Ziegler (Aufsess, Germany), (S)-perillic acid (95% purity) 
and all other chemicals have been purchased from Sigma-Aldrich (Seelze, Germany).  
P. putida GS1 was purchased from DSMZ (German Collection of Microorganisms and Cell Cultures, 
Braunschweig, Germany). Minimal media with glycerol as the main carbon source was used both for pre-
cultivation and cultivation in the fermenter.  
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Fermentation  
The bioconversion of (R)-limonene to (R)-perillic acid was performed according to standard procedures 
(Mirata et al., 2009). 
 
Analytical methods 
The concentration of (R)-perillic acid was measured by HPLC analysis. Samples from the fermentations were 
centrifuged at 13,000 rpm for 10 minutes and the supernatant was diluted in an equal volume of acetonitrile. 
The sample was again centrifuged at 13,000 rpm for 10 minutes for protein removal and further diluted with 
acetonitrile until a concentration that fits the calibration curve was reached (calibration curve shown in 
Appendices). Commercially available (S)-perillic acid (Sigma-Aldrich, Germany) was used as an external 
standard, since commercially available (R)-perillic acid could not be acquired.  
The HPLC analysis was performed on a Dionex UltiMate 3000 HPLC equipped with a Photodiode Array 
Detector (Dionex, Thermo Scientific). The column used in the HPLC was a Luna 3μm C18(2) 100 Å, 150x4.6 
mm. The mobile phase was 70:30 (v/v) acetonitrile/water containing 0.1% formic acid, at 0.8 mL/min and 40 
°C. The UV detector wavelength was selected at 217 nm.  
 
Measurement of cell concentration 
To measure growth kinetics, cell concentrations were analyzed photometrically at 600 nm (OD600nm). Before 
measuring cell concentrations in limonene conversions, 1 mL samples were centrifuged at 13,000 rpm for 10 
minutes and cell pellets were resuspended in a sterile saline solution (0.9 %(w/v) NaCl) after removing the 
supernatant and limonene phase. 
For determination of cell dry weight, 1 mL of cell culture was transferred into a pre-weighed and pre-dried 
Eppendorf tube. The sample was then centrifuged at 13,000 rpm for 10 min in an Eppendorf centrifuge. The 
supernatant was carefully extracted and the cell pellet was washed with a sterile saline solution 0.9 %(w/v) 
and centrifuged again (13,000 rpm; 10 min). The cell pellet was then dried at 80°C for more than 24 hours 
and placed in a desiccator to cool to room temperature until a constant weight at four decimal places was 
measured.  
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3.5.1.2 Measurement of substrate loss under fermentation conditions 
 
Limonene loss under fermentation conditions was measured in two different sets of experiments. In the first 
set, aeration rate was fixed and limonene loss in the exhaust gas was measured over time. In the second set 
of experiments, the aeration rate was varied using a flow control valve and limonene loss was measured for 
a fixed period of time.  
These measurements were made in an experimental setup simulating the fermentation conditions but 
without cells.  The temperature was kept constant at 30 °C, agitation was constant at 600 rpm and 2 %(v/v) 
of limonene was added to the fermentation media at the beginning of the experiment. The experimental 
setup, represented in Figure 3.10, consisted of a reactor vessel with an incorporated sparger at the bottom 
(a ring sparger, the same type of spargers used in the fermenter). The off-gas was collected in a Viton tube, 
which is impermeable to limonene and condensed using dry-ice as the cooling agent. For the experiments 
with variable aeration rate, the air flow was controlled and measured with a flow control valve. Aeration 
rates between 200 mL/min and 1000 mL/min were tested. 
To measure the remaining limonene in the fermenter after a certain period of time, limonene was extracted 
from the fermentation media with methyl tert-butyl ether (MTBE) and measured in a UV-VIS 
spectrophotometer (Shimadzu, Japan). It was not possible to take reproducible samples from the reactor 
vessel since limonene is poorly-soluble in water (solubility in water is 0.1 mM) and droplets of limonene are 
dispersed in the aqueous media. Therefore, the entire volume of media was used in a liquid-liquid extraction 
with MTBE to collect the remaining limonene in the fermenter after a certain time of operation. UV-VIS 
measurements were possible because limonene is slightly yellow. Different wavelengths were tested and it 
was seen that the UV-VIS absorption spectrum of MTBE and glycerol do not overlap the limonene absorption 
peak. A calibration curve at 254 nm was made for concentrations of limonene in the range of 0.1-2 %(v/v) 
limonene. 
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Figure 3.10 Experimental setup for experiments measuring limonene stripping from the fermenter.  
 
3.5.2 Results 
 
3.5.2.1 Determination of the reaction rate 
 
To determine the rate of the conversion of (R)-limonene to (R)-perillic acid the reaction was followed for 48 
hours. The progress curve for the reaction is shown in Figure 3.11. and Figure 3.12 shows the progression of 
biomass growth and (R)-perillic acid formation for the entire time frame of the experiment.  
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Figure 3.11 Progress curve of the conversion of (R)-limonene to (R)-perillic acid in 1 L fermenter. A pulse of 
(R)-limonene was added to the fermenter at time 0 h and a second pulse was added after 24 hours of 
reaction (represented by the grey line).  
 
 
Figure 3.12 Biomass growth (   ) and product formation (●) kinetics in 1 L fermenter. The grey lines 
represent the time of (R)-limonene addition (first addition 17h after inoculation and the second addition is 
24h after the first addition). 
 
In Figure 3.11 one can observe that after (R)-limonene addition to the fermenter there is a lag phase of 
approximately 3 hours where the production of (R)-perillic acid is negligible. This suggests that some time is 
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required to activate the induction of cellular adaptation mechanisms in response to the toxic effect of (R)-
limonene. After this adaptation phase, the conversion of (R)-limonene to (R)-perillic acid takes place at a 
given rate for the following 5 hours until a concentration of approximately 20 mM is reached. The reaction 
reaches then a plateau and the concentration of (R)-perillic acid remains constant until the addition of a 
second pulse of (R)-limonene. Then the concentration of (R)-perillic acid increases again but at a lower rate 
than before and again reaches a plateau at a concentration of 25 mM. 
Taking into account only the first 8 hours of reaction (after which the concentration of (R)-perillic acid remains 
approximately constant) the conversion takes place at an average rate of 2.3 mM/h, which corresponds to 
0.38 g/L/h. This value is slightly higher than the ones reported by Mirata and co-workers that report a 
conversion rate of 1.8 mM/h (0.30 g/L/h) in the first 4 days of operation of the bioprocess developed by them 
(Mirata et al., 2009).  
The plateau of (R)-perillic acid concentration could be explained by either i) issues on substrate availability, 
ii) product inhibition, or a combination of both problems.  
Regarding substrate availability, it was easily detected that a significant part of (R)-limonene that is fed to 
the fermenter is lost in the exhaust gas, since (R)-limonene has a characteristic smell to orange. Limonene 
vapor pressure at 30 °C is approximately 3.4 mmHg (valor estimated from (Perry et al., 1997)), which is lower 
than water vapor pressure at 30 °C (31.8 mmHg from (Perry et al., 1997)). Therefore, its volatility is lower 
than water volatility under fermentation conditions. However, since limonene is poorly-soluble in water and 
there is an inlet air stream, stripping of (R)-limonene occurs. (R)-Limonene is stripped by the gas stream and 
lost in the exhaust gas. Hence, when the conversion of (R)-limonene to (R)-perillic acid reaches a stationary 
phase, it could be because there is no more limonene available in the fermenter and most of it was lost in 
the exhaust gas.  
Regarding product inhibition, Mirata and co-workers have investigated product inhibition in this reaction 
system and they observed that maximum specific activities (μmol perillic acid/min/g cdw) decreased 
exponentially with increasing product concentrations. Already at (R)-perillic acid concentrations as low as 2 
mM, the maximum specific activity of the biocatalyst decreases (Mirata et al., 2009). Therefore, at a 
concentration of 20 mM of (R)-perillic acid the specific activity of the whole-cell biocatalyst is significantly 
impaired, which can contribute to the reduction in conversion rate and the plateau on (R)-perillic acid 
formation. After the second addition of (R)-limonene the conversion of (R)-limonene to (R)-perillic acid takes 
place, but at a much lower rate which might indicate that the whole-cell biocatalyst’s activity has been 
reduced due to a prolonged contact with the product. 
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But since the biocatalyst is a whole-cell there are several different factors influencing the conversion rate 
besides the activity of the enzymes involved in the biosynthetic reaction. During the fermentation the cells 
are under constant stress and its metabolism is overloaded. A high amount of energy is spent in activating 
the solvent tolerance mechanisms to cope with (R)-limonene presence in the cultivation media, in the 
conversion of (R)-limonene to (R)-perillic acid and finally in pumping (R)-perillic acid out of the cells. 
Therefore, it is possible that with time the cells are no longer viable and able to properly function under these 
conditions. The cell’s membrane might be compromised and the cells unable to pump (R)-perillic acid out of 
their membrane, which would be translated in a reduction of the experimentally measured reaction rate. 
The cells might also be unable to properly regenerate the cofactor necessary for the bioconversion, or it is 
also possible that being unable to cope with all these stress factors, a large number of cells die which means 
that in the end of the fermentation only a small number of cells is able to perform the bioconversion. Finally, 
given the fact that the strain that is used is a wild-type strain it is also possible that a large number of cells 
mutate and lose the p-cymene pathway, losing their ability to convert (R)-limonene to (R)-perillic acid.  
The experimental determination of the reaction rate proved to be very useful for the development of the 
process. In the bioprocess for (R)-perillic acid production, the ISPR operation takes place only 24 hours after 
the addition of limonene. But according to the progression curve obtained in this experimental work, the 
ISPR should take place much earlier and be more frequent. If a plateau is reached after 8 hours of reaction, 
the remaining 16 hours until ISPR are merely wasted since there is not a significant improvement on product 
formation. By keeping the reaction always at a steady rate and avoiding that the conversion reaches a 
stationary phase, the space-time yield will be higher. This results in a more efficient use of the equipment, 
namely the fermenter, and can further reduce facility-dependent costs that have been shown to be one of 
the biggest cost contributors in this process.  
 
3.5.2.2 Measurement of substrate loss under fermentation conditions 
 
To further investigate the causes of a reduced reaction rate, (R)-limonene loss under fermentation conditions 
has been investigated. (R)-Limonene loss in the exhaust gas stream affects negatively the reaction yield and 
the conversion rate. Besides, (R)-limonene is very toxic to aquatic life with long lasting effects (H410), so it 
should not t be released to the environment. Hence, experiments were run in order to quantitatively measure 
how much (R)-limonene is lost during the conversion time.  
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In the first set of experiments the aeration time was fixed to 4 hours but the aeration rate was varied. 
Whereas in the second set of experiments, the aeration rate was kept constant at 1 vvm for different periods 
of time (4 hours and 12 hours). The results for both experiments are shown in Figure 3.13. 
 
 
The experimental method showed some practical difficulties and limitations and some variability in the 
measurements was observed (Figure 3.13). Given the variability of the experimental measurements it was 
not possible to quantitatively measure the amount of (R)-limonene that is lost during the bioconversion.  
But nonetheless, it was possible to observe and experimentally show that (R)-limonene stripping under 
fermentation conditions takes place. As expected, the loss of limonene is more pronounced for higher 
aeration rates and when the aeration runs for longer periods of time, i.e. as reaction time goes by more (R)-
limonene is lost in the exhaust gas. However, it was not possible to draw any conclusions on the extent that 
aeration rate or aeration time influence limonene loss under fermentation conditions. Moreover, these 
experiments were run in the absence of cells, but their presence could also influence limonene stripping.  
Even though the accuracy of the experimental method does not allow an accurate quantification of limonene 
loss under fermentation conditions, it clearly shows that stripping of the substrate does occur which confirms 
that substrate availability is a major issue in this reaction system. Since (R)-limonene is stripped from the 
fermentation media over time, it should be fed to the fermenter more frequently than only every 24 hours, 
or possibly in a continuous mode. Given that (R)-limonene stripping is reduced at lower aeration rates, the 
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Figure 3.13 Limonene loss under fermentation conditions. Left: Limonene loss at different aeration rates for a fixed 
period of aeration of 4 hours. Right: Limonene loss at different periods of time for a fixed aeration rate of 1 vvm. 
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possibility of running the reaction at lower aeration rates should also be considered. The current bioprocess 
runs with growing cells, which means that oxygen is required both for cell growth and for the bioconversion 
of (R)-limonene to (R)-perillic acid. Therefore, there is a limit of how much the aeration rate can be reduced 
and alternative methods for oxygen supply, such as supplying enriched air or producing oxygen in situ by the 
decomposition of hydrogen peroxide by catalase, should be considered. Another option to reduce (R)-
limonene stripping would be to run the reaction in a two-phase system. An organic solvent layer could act as 
a (R)-limonene reservoir and in this way stripping could be reduced. This system has also the benefit of 
potentially reducing substrate and product inhibition, but would require some modifications in the process 
operation. 
 
3.6  Strategies for improvement of the bioprocess 
 
In previous sections was shown that space-time yield is the metric that affects the most the production cost. 
After an experimental characterization of the process, it was observed a reduction of the conversion rate 
approximately 8 hours after the start of the reaction. The production of (R)-perillic acid reaches a stationary 
phase where there is no significant increase on its concentration. Investigation on substrate loss under 
fermentation conditions showed that there are problems with substrate availability in the reaction. And 
previous work from Mirata and co-workers showed that the reaction faces product inhibition from very low 
concentrations of (R)-perillic acid (Mirata et al., 2009). All these issues affect negatively space-time yield. 
Space-time yield is a very complex metric which is affected by several different parameters, summarized in 
Table 3.5. Different strategies for improvement of these parameters, including tools for both biocatalyst 
modification and process development, are shown in Table 3.6. These different parameters are reviewed and 
discussed for whole-cell P450 processes by Lundemo and co-workers (Lundemo and Woodley, 2015). 
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Table 3.5 Typical parameters affecting space-time yield. 
Biocatalyst-related 
parameters 
Specific activity 
(U/g cdw) 
Fermentation cell density (g cdw/L) 
Enzyme activity 
Cofactor regeneration 
Electron transport from the cofactor to the active site 
Substrate and product 
related parameters 
Transport of substrate and product across the cell membrane 
Product and/or substrate inhibition 
Process related parameters 
Oxygen requirements 
Transport limitations between phases in a two-phase system 
 
Table 3.6 Different strategies to improve space-time yield. 
Biocatalyst 
specific activity 
(U/g cdw) 
Fermentation cell density (g cdw/L) 
High cell-density fermentation 
Fermentation optimization (media, feeding, 
etc.) 
Enzyme activity Protein engineering 
Cofactor regeneration 
Change operating mode 
Metabolic engineering 
Protein engineering 
Heterologous enzymatic regeneration of the 
cofactor 
Electron transport from the cofactor 
to the active site 
Engineering of redox partners 
Substrate and 
product related 
parameters 
Transport of substrate and product 
across the cell membrane 
Permeabilization of the cell membrane 
(physical or chemical methods) 
Product and/or substrate inhibition 
In situ product removal (ISPR) 
In situ substrate supply (ISSS) 
Substrate solubility Addition of co-solvents 
Process-related 
parameters 
Oxygen requirements Alternative methods for O2 supply 
Transport limitations between 
phases in a two-phase system 
Addition of surfactants or co-solvents 
 
A whole-cell biocatalyst is a very complex system and therefore there are several different parameters 
affecting space-time yield. Regarding the parameters related to the biocatalyst, it is the biocatalyst specific 
activity (U/g cdw) that mostly affects the space-time yield. The biocatalyst specific activity is influenced by 
the cell density in the fermentation, the enzyme activity, in terms of kcat (s-1, turnover per active site and 
second), cofactor regeneration and electron transport from the cofactor to the active site. The bioconversion 
of (R)-limonene to (R)-perillic acid is a multi-enzyme system, with three different enzymes involved in the 
reaction (or four enzymes if the reductase shuttling NADH to the first reaction step is also included). 
Therefore, for improvement of any of the biocatalyst-related parameters affecting space-time yield, such as 
enzyme activity, cofactor regeneration or electron transport from the cofactor to the active site, it is 
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necessary to determine the rate limiting step and improve the enzyme(s) involved in that step. From a 
process engineering point of view it is possible to improve the fermentation cell density by optimizing the 
fermentation conditions, e.g. the fermentation media or the feeding of the carbon source. In order to 
increase the fermentation cell density, a high-cell-density fermentation of Pseudomonas putida GS1 was 
developed and is shown in the following sections.  
Regarding the substrate and product related parameters, this process faces product inhibition and low 
solubility of the substrate in water. One of the strategies to improve problems of product inhibition in the 
reaction is to have ISPR. The ISPR operation of this process was also further investigated in the following 
sections.  
High-cell density fermentation and ISPR were further investigated and tested experimentally and are 
presented as examples of process technologies that can be applied to intensify this bioprocess.  
 
3.6.1 Materials and methods 
 
3.6.1.1 High-cell-density fermentation 
 
The seed culture and the fermentation ran in the same conditions as the ones applied in the base-case 
fermentation. The only difference in this experiment was the feeding profile of the carbon source used in the 
biomass growth phase. The feeding of 40 %(w/v) glycerol was done exponentially, according to Equation 3.2, 
in order to keep a constant specific growth rate of 0.1 h-1. In Equation 3.2 μ0 corresponds to the specific 
growth rate (h-1); YSX is the yield of biomass on carbon source; Sf is the concentration of carbon source in the 
feed stream (g/L); S0 is the concentration of carbon source in the culture vessel at the end of the batch phase 
(g/L); X0 is the biomass concentration in the culture vessel at the end of the batch phase (g/L) and V0 is the 
initial culture volume, before the fed-batch has started.  
 
Equation 3.2 
𝐹(𝑡) =
𝜇0
𝑌𝑆/𝑋 (𝑆𝑓 − 𝑆0)
 𝑋0𝑉0 exp (𝜇0𝑡) 
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In these experiments, YSX was assumed to be 0.26 g cdw/g glycerol based on shake flask fermentations, the 
initial culture volume (V0) was 700 mL, Sf is equal to 0.4 g glycerol/mL; it is assumed that the carbon source is 
entirely consumed by the end of the batch phase (S0 is equal to zero) and X0 was measured after the batch 
phase of 5 hours.  
The exponential feed lasted 24 hours after which the feeding strategy was changed to a constant feeding. 
(R)-Limonene was fed to the fermenter after the exponential feed in order to start the bioconversion of (R)-
limonene to (R)-perillic acid and the reaction was followed for 48 hours.  
 
3.6.2 Results 
 
3.6.2.1 High-cell-density fermentation 
 
As previously mentioned, the cell density in a fermentation affects the biocatalyst specific activity in a whole-
cell process. The cell density can be improved by optimization of the fermentation conditions, e.g. media 
optimization, or by applying different feeding strategies of the carbon source.  
Here a high-cell density fermentation of Pseudomonas putida GS1 was developed by applying an exponential 
feed of the carbon source (Equation 3.2) in the phase for biomass growth.  
Mirata and co-workers have determined the maximum specific growth rate (μmax) of P. putida GS1 to be 1.43 
h-1 in the absence of perillic acid (Mirata et al., 2009). In the first batches of fermentations, μ was set to 0.25 
h-1 based on previous work from Sun and co-workers with a similar Pseudomonas putida strain (Sun et al., 
2006). However, at this growth rate oxygen deprivation occurred approximately 10 hours after the start of 
exponential feed and it was not possible to keep dissolved oxygen concentration above 30% air saturation. 
The growth rate was then lowered to 0.1 h-1 and the progress curve for the fermentation is shown in Figure 
3.14. 
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Figure 3.14 Progress curve for a fed-batch fermentation with exponential feed keeping a constant specific 
growth rate of 0.1 h-1. The vertical lines represent the time points at which the exponential feed started and 
finished.  
 
By having an exponential feed of the carbon source that kept the growth rate constant at 0.1 h-1, it was 
possible to reach an OD600nm of approximately 55, which corresponds to a biomass concentration of 
approximately 19 g cdw/L. According to Equation 3.2, after 24 hours of exponential feeding 18.48 g cdw 
should theoretically be produced in the fermenter. Therefore, it was possible to achieve the expected 
biomass concentration.  
It was possible to successfully increase biomass concentration from an OD600nm of approximately 25 in the 
end of the base-case fermentation, which corresponds to approximately 10 g cdw/L, to an OD600nm of 
approximately 55 at the end of the high-cell density fermentation, which corresponds to approximately 19 g 
cdw/L.  
But even though biomass concentration was considerably increased, it was not possible to verify if this leads 
to a higher space-time yield of the bioprocess since (R)-perillic acid formation was not observed. Even though 
(R)-limonene was added to the fermentation media in the end of the exponential feed, (R)-perillic could not 
be detected in any of the HPLC chromatograms. 
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 3.7 Concluding remarks 
 
In this chapter the biocatalytic conversion of (R)-limonene to (R)-perillic acid by a wild type strain of 
Pseudomonas putida was benchmarked with other possible routes for perillic acid production, namely with 
the chemical synthesis starting from β-pinene developed by Wang and co-workers (Wang et al., 1993). 
Reaction-related green chemistry metrics and EHS hazards of the different chemicals used in the different 
routes proved to be useful tools for benchmarking of the different synthetic routes and showed that the 
biocatalytic route has a greater potential to be a sustainable route for perillic acid production. However, even 
though atom economy and carbon efficiency show that the biocatalytic conversion of (R)-limonene to (R)-
perillic acid by P. putida is a very promising route where the principles of maximizing the incorporation of 
starting materials into the final product are obeyed, reaction mass efficiency revealed how it is still far from 
reaching its full potential. It is not surprising that the reaction yield and volumetric productivity of the 
reaction are still far from the values necessary for industrial implementation given the fact that the strain 
that is used is a wild-type strain, which did not evolve to work in industrially relevant conditions. 
The bioconversion of (R)-limonene to (R)-perillic acid by a whole-cell biocatalyst was further explored by 
means of an economic and environmental assessment. A process model was developed in SuperPro 
Designer® software and a sensitivity analysis on different process metrics and its influence on production 
costs allowed the identification of space-time yield as the most critical process metric.  
Following the identification of low space-time yield as the main bottleneck of this bioprocess, different 
parameters affecting space-time yield and strategies to improve it were reviewed.  
In order to understand the reasons for a low space-time yield some additional experimental work was 
developed. The reaction rate was measured over time and it was seen a considerable decrease in reaction 
rate approximately 8 hours after the start of the reaction. The reduction in reaction rate could be explained 
by product inhibition and substrate loss by stripping of (R)-limonene in the exhaust gas, which was 
demonstrated experimentally. 
The strategies for improvement of space-time yield include both techniques to modify and improve the 
biocatalyst and process technologies. One process technology the development of a high-cell density 
fermentation, was tested experimentally in order to exemplify some of the strategies that can be applied in 
the development of this bioprocess and the improvements that can be obtained with this type of tools. Even 
though the cell density was successfully improved in the fermenter, the improvements in space-time yield 
could not be verified. The fermentation process showed a very high instability and variability on the 
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production levels of (R)-perillic acid, which is a major concern for industrial implementation of this 
bioprocess. 
Several other strategies for improvement of space-time yield should be tested experimentally, including 
protein and metabolic engineering for biocatalyst modification. The bioprocess analyzed in this chapter used 
a wild-type strain of Pseudomonas putida. However, as reviewed in section 1.3 most processes for production 
of natural products that have reached commercial scale use genetically improved microorganisms. The 
genetic modification of the strain could also potentially improve the robustness of the strain, which is an 
important factor for industrial implementation. On the other hand, the natural label of this product is 
important for its application in cosmetic or food industry and the use of genetically modified organisms is 
not well accepted by many consumers, especially in the European market. But could this bioprocess ever 
reach the necessary yields and productivities for industrial implementation without the use of an improved 
biocatalyst? Further experimental work on the process would be necessary to answer this question. 
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4. Case-study II: Fermentation of recombinant Pichia pastoris 
for brazzein production 
 
4.1  Introduction 
 
In this chapter the second case-study that was explored in this thesis is introduced. It corresponds to the 
production of brazzein by fermentation of the yeast Pichia pastoris. Brazzein is a natural sweetener present 
in the wild African plant Pentadiplandra brazzena Baillon that is much sweeter than sucrose by several orders 
of magnitude. It is a protein comprising of 53 amino acid residues, and therefore this case-study differs from 
the first one since the product is a protein associated to cells’ growth. This bioprocess is classified as a 
fermentation process and not a biocatalytic process.  
This chapter is organized in six different sections. First a brief introduction to different sweeteners and its 
productions processes is made in section 4.2. Following that, the fermentation process for brazzein 
production is described in section 4.3. A very brief evaluation of the economy of the process is shown in 
section 4.4 where the key process metrics of this bioprocess are analyzed. But the main focus of this case-
study is on the tools for environmental assessment and on the challenges of comparing the environmental 
profile of different types of processes in different stages of development. In section 4.5 the environmental 
profile of brazzein fermentation process is first benchmarked with different routes for brazzein production 
(extraction from the African fruits and extraction from genetically modified maize), and secondly with 
production processes of other sweeteners, namely stevia and aspartame. Finally, section 4.5.4 presents some 
concluding remarks on this case-study. 
  
4.2  Sweeteners  
 
Sweet-tasting substances, generally designated as sweeteners, have gained increasingly importance in food 
industry over the last decades. This industry has been for long in a demand to substitute sugar by a sweetener 
that has the same taste and texture as sugar but with less calories. The increase in obesity and diabetes in 
industrialized countries has resulted in governmental actions to promote health and wellness, e.g. Mexico 
has introduced a one-peso-per-liter tax on sugar-sweetened soft drinks in 2014. In addition, consumers 
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became more concerned with their health and are increasingly demanding. Nowadays, consumers seek for 
healthier products but with the same tasting and texture characteristics as sugar-sweetened products. 
One of the first sweeteners to be widely applied in several food products was aspartame and it is still today 
the most common intense sweetener with a worldwide consumption of 10,000 tons/year. Aspartame is a 
chemically synthesized sweetener that was discovered in 1965, it is 160 to 220 times sweeter than sucrose 
and its taste is described to be very similar to sucrose, showing no bitter or metallic aftertaste. It is a dipeptide 
composed of two amino acids, L-aspartic acid and the methyl ester of L-phenylalanine. The synthetic route 
of aspartame is represented in Figure 4.1 (Zorn and Czermark, 2014). However, aspartame safety has been 
subject of several controversies and critics have linked aspartame to several health problems, including 
cancer. Even though several scientific publications dismiss the potential health risks of aspartame and it is 
considered as a safe food additive by worldwide health and food organizations, aspartame became a very 
unpopular sweetener and consumers seek new sweeteners preferably from natural sources.  
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Phenylalanine
ProtectionMethylation
Condensation
Deprotection
Methyl L-α-aspartyl-L-phenylalaninate
Aspartic acid 
 
Figure 4.1 Chemical synthesis of aspartame. 
 
So as a result of the current global demand for healthy and natural products, there is a clear market for novel 
sweeteners to be applied in beverages and food products.  
Stevia, a natural sweetener present in high concentrations on the South American plant Stevia rebaudiana 
Bertoni, has become a popular alternative to sugar and is already being used by some of the world’s biggest 
beverage brands, e.g. Coca-Cola Life®. Stevia is the common designation given to steviol glycosides (shown 
in Figure 4.2) that naturally occur in Stevia rebaudiana and has been consumed for centuries in Paraguay and 
Brazil.  
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Figure 4.2 Structure of steviol glycosides. R: mono- or disaccharide residues. 
 
The most abundant glycosides in the plant are stevioside and rebaudioside A, with a content of 4-8.5 % (w/w) 
of stevioside and 1.5-5% (w/w) for rebaudioside A. The ratio of the different components varies depending 
on the plant, and it can be manipulated by breeding aiming at an increase in Rebaudioside A, the product 
with the best sensory properties. Depending on the composition, steviol glycosides are 200-300 times 
sweeter than sugar. However, they have a bitter and licorice aftertaste, which is an undesirable property in 
the food industry. Steviol glycosides have been approved as food additives in 2011 by the European Food 
Safety Authority (European Food Safety Authority (EFSA), 2010). The manufacturing process of stevia, which 
is described in more detail in section 4.5.2.3, consists of three basic steps – i) water extraction from the plant 
leaves, ii) preliminary purification with ion exchange chromatography, and iii) recrystallization from methanol 
or aqueous ethanol. There are several variations of this basic process and several different approaches to 
extract and purify the molecules have been investigated (Puri et al., 2011). A novel process for stevia 
production by fermentation of recombinant yeast has also been developed by Evolva (Mikkelsen et al., 2014) 
and will start commercial manufacturing in a collaboration with Cargill®. 
In this quest for the perfect sweetener with great taste and no calories, brazzein appears to be a very 
promising alternative. It is much sweeter than conventional sucrose and stevia and it does not have the 
undesired licorice aftertaste. Brazzein is a sweet protein from a wild African plant Pentadiplandra brazzena 
Baillon. It is a single chain polypeptide, which is comprised of 53 amino acids residues. It has a molecular 
weight of 6,5 kDa. The protein was discovered and named by Ding Ming and Göran Hellekant in 1994 
(Hellekant and Ming, 1998). The content of brazzein in the fruit is about 0.2 - 0.05 % by weight and mainly 
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placed in the pulp. Pentadiplandra brazzeana grows in central Africa, more precisely from Nigeria east to the 
Central African Republic and south to Democratic Republic of the Congo and Angola. It grows as a shrub or a 
liana. The sweet fruit, and other parts of the plant, have been used for centuries and are still in use by local 
people. But there is not an agricultural cultivation of the plant. The fruits are harvested from wild plants. 
Brazzein is 500 times sweeter than a 10 % (w/v) sucrose solution. In comparison with a 2 % (w/v) solution, 
brazzein is 2000 times sweeter. The taste of brazzein is described as purely sweet, with no sourness, saltiness 
or bitterness, but the mouth feeling differs from the sweetness of sucrose. The sweetness grows slower, is 
easily washed from the tongue and does not last long. Brazzein is a thermo stable protein. The sweetness 
lasts even after incubation at 80 °C for 4 h.  
An obvious possibility for the production of brazzein is the extraction from fruits of Pentadiplandra 
brazzeana. However the large scale production of brazzein from natural sources is described as 
uneconomical. The reasons indicated are limited availability of the fruit and complications associated with 
large-scale production of the native plant (Lamphear et al., 2005). Therefore, the production of brazzein in a 
recombinant host appears to be an interesting approach. The genetic code of brazzein has been sequenced 
in 1994 by Hellekant and Ming (Hellekant and Ming, 1998) and since then there has been several attempts 
to produce brazzein in different hosts.  One of the options, which is further analyzed in this chapter, is the 
expression of the protein in maize which has been demonstrated by Lamphear and co-workers (Lamphear et 
al., 2005). One of the advantages of this option would be that the final product is sweet maize flour which 
simplifies the purification. Assadi-Porter and co-workers have reported in 2000 the production of brazzein in 
Escherichia coli (Assadi-Porter et al., 2000) and the company Natur Research Ingredients Inc. is currently 
working on the commercialization of brazzein produced by fermentation of E. coli under the name Cweet™. 
BRAIN AG has focused on the expression of brazzein in yeast cells from the species Pichia pastoris, and this 
process is further analyzed throughout this chapter.  
 
4.2.1 Intensity of sweetness 
 
As mentioned before sweeteners have different intensities of sweetness. A high intensity sweetener, such as 
brazzein, can be up to thousands times sweeter than sucrose. So the sweetness of a substance is represented 
in terms of sweet potency, also called relative sweetness, which expresses how much sweeter a substance is 
in comparison to sucrose. Sweet potency is correlated on a mass basis, which means that solutions with 
different mass concentrations of the sweetener are compared with sucrose solutions with different 
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concentrations in a dose-response diagram. For example, brazzein has a sweetness potency of 2000 when 
compared to a 2% sucrose solution, which means that brazzein is 2000 times sweeter than a 2% solution of 
sucrose.  
Since sweeteners have different sweetness intensities, it is important to take this into account when 
comparing the environmental impacts of the different sweeteners. Therefore, a comparison in terms of 
sweetness potency was made as shown in section 4.5. 
 
4.3  Bioprocess description 
 
The process flowsheet for the fermentation of Pichia pastoris for brazzein production is shown in Figure 4.3. 
The data used for the process flowsheet and for the mass balances is experimental data from 10 L scale 
experiments run at BRAIN AG facilities. The mass balances for the whole process are shown in detail in the 
Appendices.  
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 6 g Brazzein (98% purity) 
DSP
USP
Fermentation
10.3 L
91 g/L cell dry weight
2.022 g/L Brazzein 
Centrifugation
Clarification
Concentration
Buffer Exchange
Chromatography
Freeze drying
6184.1 g
6275.3 g
2059.6 g
2032 mL
1300 mL
Water 250 mL
18 L running buffer
Cultivation for 10 L:
Medium 5.5 L 
Inoculum 0.5 L 
 Base 615.7 g
 Acid 50.3 g
Antifoam 5 g
Glycerol (80%) 688.4 g
Methanol 2313 g 
Samples 30.6 g
Waste 45.1 g
Waste 4549.2 g
17956.8 g buffer
5900 mL buffer3200 mL running buffer
2000 mL elution buffer
Cells 3701.7 g
 
Figure 4.3 Process flowsheet for brazzein production by fermentation of recombinant Pichia pastoris. 
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The established bioprocess for brazzein production corresponds to a fed-batch fermentation of Pichia 
pastoris, where glycerol and methanol are used as carbon sources. The media composition is shown in Table 
4.1. 1 mL/L of trace metals solution, whose composition is shown in Table 4.2 is added to the fermentation 
broth in the beginning of the fermentation. The fermentation is aerobic and takes place at a constant 
temperature of 30 °C and at a constant pH (balanced with phosphoric acid (17% (v/v) and/or ammonia (25 % 
(v/v)), and lasts for approximately 50 hours. Foam production is controlled through addition of antifoam of 
polypropylene glycol. Brazzein is produced by the cells with a product yield of 0.012 g/g of methanol and 
excreted to the media. 
 
Table 4.1 Composition of the fermentation media for fermentation of Pichia pastoris.  
Component Concentration (g/L) 
Glycerol 40 
KH2PO4 42.9 
(NH4)2SO4 5 
CaCl2 1 
K2SO4 14.3 
MgSO4 11.7 
 
Table 4.2 Composition of the trace metals solution used in the fermentation of Pichia pastoris. 
Component Concentration (mg/L) 
CuSO4 2 
NaI 0.08 
MnSO4 3.0 
Na2MoO4 0.2 
H3BO4 0.02 
CaSO4 0.5 
CoCl2 0.5 
ZnCl2 7 
FeSO4 22 
Biotin 0.2 
H2SO4 1 μL/L 
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Since the product is extracellular, cell lysis is not necessary. After fermentation, there is a centrifugation for 
separation of the cells from the fermentation broth. Following that there is a clarification step through 
filtration at 4 °C and a concentration step at 10 °C by ultrafiltration where proteins and particles bigger than 
50 kDa are removed from solution. Finally there is a diafiltration step for exchanging the product to a different 
buffer of sodium acetate (10 mM) and sodium chloride (50 mM) and an ion exchange chromatography where 
brazzein is selectively bound to the resin. The product is then eluted from the chromatography column using 
a buffer of sodium acetate (10 mM) and sodium chloride (1 M). The last step is drying the product in a freeze-
drying step until a final concentration of 98% is achieved. However, the downstream processing of this 
process is highly inefficient with a yield of 28.8%. Approximately 71.2% of brazzein that is produced in the 
fermentation is lost in the purification steps.  
 
4.4  Bioprocess evaluation 
 
In the same way as for the first case-study the key process metrics described in section 2.1.1 have been 
calculated and are shown in Table 4.3. In this case-study the bioprocess in analysis is a fermentation and not 
a biocatalytic reaction, which means that there is not a reaction yield but a yield of product on carbon source. 
This yield on carbon source should be compared with the maximum theoretical yield calculated from the 
metabolic pathway. However, this comparison was not done since the pathway for brazzein production in 
Pichia pastoris could not be found in literature.  
 
Table 4.3 Process metrics of brazzein production process. 
Product concentration (g/L) 2.02 
Space-time yield (g/L/h) 0.075 
Yield of brazzein on glycerol (g/g) 0.035 
Yield of brazzein on methanol (g/g) 0.012 
 
This process refers to a fermentation for production of a protein and not a chemical. In this case, the 
requirements for the process metrics are lower since normally the selling price of proteins, which are typically 
used for therapeutic purposes, is higher than the price of chemicals. However, brazzein is not a therapeutic 
protein. It is aimed to be applied in the food industry, so its price should be lower than therapeutic proteins. 
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The minimum values for the process metrics that guarantee economic feasibility of the process depend on 
the final selling price of brazzein. 
 
4.5  Environmental assessment 
 
There are only two possible routes for brazzein production, the extraction from natural sources or the 
biosynthesis. The chemical synthesis is not an option since brazzein is a protein.  
In this section of the thesis, an environmental comparison of different production processes was made and 
is graphically summarized in Figure 4.4. In section 4.5.3 the biosynthetic route for brazzein production using 
Pichia pastoris as a production host is benchmarked with two possible extraction routes – extraction from 
the African fruits of Pentadiplandra brazzena and extraction from genetically modified maize. The 
biosynthetic route for brazzein production is then also benchmarked with the production processes for other 
two sweeteners. The two different sweeteners used as a benchmark are stevia and aspartame. The method 
selected for stevia production was stevia extraction from the leaves of Stevia rebaudiana, which is the 
process that is currently used for commercial production of stevia. It would also be interesting to include in 
the assessment a comparison with stevia production by yeast fermentation, since this process should be 
similar to Pichia pastoris fermentation for brazzein production. However, it was not possible to include it due 
to lack of published data. The method selected for aspartame production was the enzymatic reaction, with 
the enzyme thermolysin.  
It is important to note that all these processes are in different stages of development. Stevia and aspartame 
are commercially available and their production processes have gone through an extensive development and 
optimization until commercial production was economically feasible. Brazzein production by fermentation of 
Pichia pastoris or extraction from modified maize are still in research and development and have only been 
applied at laboratory scale. Finally, the production of brazzein by extraction of the African fruits is only a 
conceptual process based on the patent from Hellekant and co-workers (Hellekant and Ming, 1998). 
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Figure 4.4 Graphical summary of the different processes benchmarked in the environmental assessment. 
 
4.5.1 Scope of the environmental assessments 
 
In environmental assessments the first step is to define the scope of the assessment. In general, a more 
holistic approach will give more meaningful results. However, the amount of data required and the 
complexity of the analysis will also increase. Therefore, a compromise between the complexity and the 
significance of the analysis needs to be reached.  
The processes analyzed in this chapter are different types of processes – three of the five processes are 
extraction from natural sources, one process is a fermentation and the last is a chemical synthesis (aspartame 
production). Therefore it is not straightforward to define a common scope for the five processes. Apart from 
the production of aspartame, all the other processes have in common a phase for growing of the biomass, 
where the product is included. This phase corresponds to the growth of yeast cells in the fermentation 
process and to the growth and cultivation of plants in the extraction processes. This phase is the upstream 
processing where the product is formed. The resulting biomass containing the product is then sent to 
downstream processing where the product is separated from the biomass and further purified. A scheme 
representing these different steps that constitute the scope of the assessment is shown in Figure 4.5. 
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In the case of aspartame production, only the chemical synthesis of aspartame is considered in the upstream 
processing. The starting point for the synthesis are the two amino acids, L-aspartic acid and D,L-
phenylalanine. The synthesis of the amino acids as well as all the other reactants is not included in the 
assessment.  
 
 
Figure 4.5 Scope of the environmental assessment. 
 
The system boundaries end at the last step of the manufacturing process, the so called cradle to gate 
approach. Packaging and shipping of the product are not included, neither the use nor disposal of the 
product.  
 
4.5.2 Modeling and inventory of the processes 
 
An extensive literature was made to collect data on all the different processes. In this section all the processes 
are described in detail as well as all the assumptions made, apart from brazzein fermentation which is 
described in section 4.3. The mass balances of all the processes are shown in the Appendices. 
 
4.5.2.1 Brazzein extraction from genetically modified maize 
 
A conceptual process for brazzein extraction from genetically modified maize has been developed based on 
the work from Lamphear and co-workers (Lamphear et al., 2005). One advantage of this process option would 
be that after dry-milling of the seeds, the sweet maize flour could be used directly in food products. However, 
89 
 
for a meaningful comparison with the other processes for brazzein production, a process for brazzein 
purification is assumed. Furthermore, the sweet maize flour could not be used in baking processes at 
temperatures higher than 98 °C, which would limit the options for product formulation. In their work, 
Lamphear and co-workers have proposed a process for purification of brazzein. It was developed for 
analytical purposes but it is very similar to other processes for purification of recombinant proteins recovered 
from plants (Menkhaus et al., 2004) (Ma and Wang, 2012). Therefore, the same conditions were assumed in 
the conceptual process developed for the environmental assessment, whose flowsheet is shown in Figure 
4.6. 
The process starts with the cultivation of the genetically modified maize. It was assumed that the cultivation 
of genetically modified maize would be done in the same conditions as regular maize, with the same yield of 
maize per hectare, fertilizer and water consumption, etc. The amount of fertilizers, pesticides, manure, etc. 
consumed was taken from the Agri-footprint® LCA Food Database available in the LCA software SimaPro. The 
values used are for corn cob mix (CCM) production (CCM consists of the grains and cobs of maize) but it is 
assumed that they are the same as for maize cultivation (Vellinga and Boer, 2012). The yield of maize per 
hectare was taken from the Federal Statistical Office of Germany. The average yield was 10 ton/ha for the 
years 2012-2014. The maize that is harvested needs to be matured and dried. The harvested maize is 
composed of 35% (w/w) of dry mass (Federal Statistical Office of Germany, 2016). Hence 3.5 tons of dry 
weight of maize is obtained per hectare.  
Lamphear and co-workers measured an average brazzein content of 50 μg per gram dry weight of maize. 
Single seeds reach a concentration of brazzein of 400 μg per gram of seed. This is still a process in early stages 
of research, therefore the authors of the work expect an increase in brazzein content through backcrossing 
of lines. Thus, a yield of 400 μg per gram of dry weight of maize was assumed (Lamphear et al., 2005).  
The process for brazzein extraction starts with standard dry milling of the maize. The milling process leads to 
a concentration of brazzein, since the germ of maize which is the part of maize with the highest concentration 
of brazzein is separated from the hulls. The germ-rich fraction of maize is then sent to downstream 
processing, which starts with an extraction step with a buffer of 20 mM of sodium acetate and 30 mM of 
sodium chloride. In the extraction step the ratio solids:buffer is 5:1. After extraction, there is a centrifugation 
and filtration with a 0.2 μm filter to separate the particulate matter. Then a cation exchange chromatography 
separates brazzein from other proteins. Finally, there is an ultrafiltration at 3 kDa for concentration of the 
solution and desalting. The final step is freeze-drying (Lamphear et al., 2005). 
The method described by Lamphear and co-workers does not include the yield of each individual step. Since 
the purification process is very similar to the one from the fermentation of Pichia pastoris, the same yield of 
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28.8 % was assumed for the downstream processing. The conditions in each individual step, e.g. amount of 
buffer used, were also considered to be the same as in the fermentation process unless otherwise stated. It 
was also assumed that the product has the same purity of 98% in the end of the purification process.  
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DSP
USP
Maize cultivation and 
harvesting
Dry milling
Maize grains: 3.5 tons dry weight 
Brazzein: 0.04% of maize dry weight
Extraction with buffer
(pH= 4.0, 4 °C, mixing for 1 h)
700 kg
Germ-rich fraction
Centrifugation
Filtration 
Ion exchange Chromatography
Ultrafiltration
Desalting
Freeze drying
4212 kg
Brazzein: 0.4 g/L
3512 kg
Solids:buffer ratio: 1:5 
Sodium Acetate 5.7 kg
NaCl 6.1 kg
Water 3500 L
Buffer:
NaCl 205 kg
Water 7024 L
403 g brazzein (98% purity)
Cultivation of 1 ha:
N-fertilizer 30 kg 
Lime 400 kg
Manure 170 kg
Pesticides 0.9 kg 
Maize middlings 2800 kg
Waste
Waste
Waste
Waste
700 kg
Waste
Waste
 
Figure 4.6 Process flowsheet for brazzein extraction from genetically modified maize. 
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4.5.2.2 Brazzein extraction from the African fruits of Pentadiplandra brazzeana Baillon 
 
A theoretical possibility for the production of brazzein is the extraction from the African fruits of 
Pentadiplandra brazzeana Baillon. The patent from Hellekant and Ming protects among other things the 
isolation of brazzein from the African fruits and even though the method described is not at industrial scale 
it is here assumed to be a possible method to produce brazzein (Hellekant and Ming, 1998).  
A conceptual process for brazzein production through extraction from the African fruits is proposed and the 
flowsheet is presented in Figure 4.7. 
The production process starts with harvesting the fruits of the plant Pentadiplandra brazzeana Baillon. The 
large scale cultivation of the plant is complicated and it was not possible to find data in literature for the 
agricultural cultivation of this plant. Therefore, it was not included any water for irrigation of the plants, 
pesticides or manure. It was just considered that the fruits are harvested from the wild. The content of 
brazzein in the ripe fruit is described in the range 0.05%-0.2% by weight (Hellekant and Ming, 1998). An 
average value of 0.125% (w/w) of brazzein was assumed in this environmental assessment.  
Brazzein only exists in the soft pulp of the fruit, so the first step is the separation from the seeds which are 
considerably large. Hence this separation would be easy to perform manually or by mechanic means. Given 
the large size of the seeds, it was assumed that the mass of pulp is approximately the same as the mass of 
seeds. The next step is a solid-liquid extraction using an acidic buffer (pH 5) at a ratio of solid:liquid of 1:40 
(w/v). Afterwards, there is a filtration and centrifugation to separate the solids from the liquid phase that 
contains the sweet protein. The proteins are then precipitated with a high salt concentration, which is 
followed by a gel filtration and a cation exchange chromatography. Afterwards there is an ultrafiltration for 
concentration and desalting of the solution. Finally, there is another chromatographic step, this time an anion 
exchange chromatography and the last step is drying. The yield of the purification process is stated by 
Hellekant and Ming as 36%. And it is assumed that the final purity is 98% as in the previous processes. As in 
the previous process, process conditions similar to the process for fermentation of Pichia pastoris have been 
assumed unless otherwise stated.  
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1 kg waste
USP
Harvesting of the fruits
Separation of the soft pulp from 
the epicarb and seeds
2 kg fruits
Brazzein: 0.125 %, 2.5 g
Solid-Liquid extraction
1 kg fruit pulp
Filtration 
Centrifugation 
Salt Precipitation: 
Gel Filtration
Cation Exchange 
Chromatography
Ultrafiltration 
43.4 kg
Brazzein: 0.06 g/L, 2.5 g
42.4 kg
205 g
62.9 g
 
Sodium Acetate 164 g
 Dithiothreitol 0.6 g
 Glycerol  2 kg
 PVP 200 g
Water 40 L
Ammonium sulfate 7132 g
Sodium hydroxide 1,4 g
31.4 g
2 kg fruits
1 kg seeds
DSP
Precipitate
Salt Precipitation: Ammonium sulfate 17550 g
Precipitate 670 g
Anion Exchange 
Chromatography
Drying
0.9 g Brazzein (98% purity)
NaCl 39.2 g 
NaAc 2.3 g
Water 1.34 L
NaAc 0.7 g
NaCl 12 g
Water 0.41 L
Tris-HCl 0.5 g
NaCl 0.4 g
Water 63 mL
 
Figure 4.7 Process flowsheet for brazzein extraction from the African fruits of Pentadiplandra brazzeana. 
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4.5.2.3 Stevia extraction from leaves 
 
Stevia is commercially produced by extraction of the glycosides from the leaves of the plant Stevia 
rebaudiana Bertoni. The process used for the environmental assessment is based on the patent from the 
company PureCircle that commercializes Stevia (Purkayastha et al., 2012). The process described in the 
patent fulfills the European requirements to extract stevioside and rebaudioside A with high purity. The 
process consists of the following main steps – brazzein is extracted with hot water from the dried and 
powered leaves, then there is a pre-treatment with base and iron chloride, filtration and ion exchange 
chromatography and the purification consists of several filtration, drying and crystallization steps.  
The process flowsheet is sub-divided into two parts which are shown in Figure 4.8. 
In the environmental assessment it is also considered the cultivation of the plants. The data for the cultivation 
of the plants is taken from a report on stevia cultivation from the Rural Industries Research and Development 
Corporation (RIRDC) and the Australian Government (Midmore and Rank, 2002). The crop yield is in average 
1.6-2 tons dried stevia leaves/ha/year. The average value of 1.8 tons/ha was used in this assessment. In the 
cultivation of one hectare of stevia, 40 kg of nitrogen, 20 kg of phosphorus and 30 kg of potassium are used 
as fertilizers. Supplementary irrigation is generally assumed to be essential to avoid any water stress on plants 
unless the growing area has reliable rainfall throughout most of the year. However, it is dependent on the 
amount of rainfall on the cultivation site. Therefore, water for irrigation as well as herbicides and pesticides 
were not considered in this analysis, since they are site-dependent. 
The plant leaves contain in average 9.1% of stevioside and 3.8% of rebaudioside A (Purkayastha et al., 2012). 
After harvesting the leaves are dried, separated from the stems and powdered before extraction of the 
glycosides with hot water. Afterwards, the leaf residues are removed by filtration. The following basification 
of the solution to a pH of 10 should flocculate unwanted substances, which are removed by filtration. The 
following step is an ion exchange chromatography that separates the glycosides from remaining substances. 
Afterwards, a concentration and drying steps originate a yellow sweet powder, which is designated as 
“powder 1”. This powder is basically a mixture of different steviol glycosides. This powder is then solvated in 
methanol and filtered. The filtrate contains rebaudioside A and the precipitate contains stevioside. For 
further purification of the stevioside the precipitate is dried and crystallized with ethanol. A series of 
filtration, crystallizations and drying steps are taken until stevioside crystals are recovered with a purity of 
99.3% and rebaudioside A crystals with a purity of 98.9%. The two glycosides are then mixed in the final 
product which contains 29% rebaudioside A and 71% stevioside.  
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DSP
UPS: Cultivation of 1 ha
Powdering the leaves
Stripping the leaves from the 
stems 
1 800 kg
Filtration
Solid-Liquid extraction 
19 800 kg
12,9 g/L of stevia
Water (pH=6,5) 18 000 kg
Water to leaves ratio 10:1 (w/w)
Neutralization
pH=7, room temperature
Basification 
pH=10, 50° C 
Calcium Hydroxide
43.2 kg
FeCl3
95.4 kg
Celite Filtration
Filtration
Concentration and Spray-drying
Deionization and Decolourization
Ion exchange chromatography
Precipitate
Yellow powder of steviol glycosides mixture 
(powder 1)
219.6 kg
64.6% Stevioside. 25.3% Rebaudisoide A.
Drying
1 800 kg
9,1 % Stevioside:  163,8 kg
3,8 % Rebaudisodie A: 68,4 kg
Harvesting Stevia rebaudiana 
Fertiliser : 
N 40 kg
P 20 kg
K 30 kg
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Solvation in Methanol
25° C
Drying
Filtration
134.4 kg
90.6% Stevioside
Precipitate
Methanol 867.4 kg
5:1 v/w
Crystallisation with Ethanol
10-12° C
Vaccum drying
Filtration
Filtrate
268.8 kg Ethanol (90%)
99.3% Stevioside
129.1 kg
Evaporation of the Alcohol
Ultrafiltration (2.5 kDa)
Dilution with water
Concentration and Spray drying
89.6 kg
60% Rebaudioside A
Solvation in Ethanol (50° C)
Drying
Filtration
67.2 kg
89,8% Rebaudioside A
Precipitate
Crystallisation with Ethanol
12° C, slow agitation
Drying
Filtration
Precipitate
98.9% Rebaudioside A
51.8 kg
96,2% Ethanol 
448 kg
5:1 v/w
92% Ethanol 134.4 kg
Water 896 kg
Precipitate
Final product:
180. 9 kg
71%  Stevioside         
29% Rebaudioside A 
Powder 1
219.6 kg
Filtrate
134.4 kg
90.6 % Stevioside
 
Figure 4.8 Process extraction for stevia extraction from the leaves of Stevia rebaudiana Bertoni. 
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4.5.2.4 Aspartame enzymatic production 
 
There are different methods for production of aspartame. The condensation of the two modified amino acids, 
phenylalanine and aspartic acid, can be a chemical or an enzymatic reaction (Hanzawa, 2010). In this case an 
enzymatic production of aspartame was selected.  
The data for the mass balances of this process is taken from a patent from the company Ajinomoto Co., Inc., 
which is one of the major producers of aspartame, and from a synthesis procedure from Lindeberg (Kiyotaka 
Oyama et al., 1985) (Lindeberg, 1987).  
The process flowsheet for the enzymatic production of aspartame is shown in Figure 4.9. 
The process starts with the preparation of the two amino acids. L-aspartic acid needs a protection group for 
the amino group - a Z-protection. So a N-benzyloxycarbonyl group is introduced in alkaline media, to form N-
benzyloxycarbonyl-aspartic acid (ZA). Afterwards, the protected amino acid is washed with an organic 
solvent, toluene, to remove unreacted compounds. DL-phenylalanine is prepared through esterification in 
methanol in acid conditions, to form phenylalanine methyl ester (PM). Afterwards, methanol is evaporated 
through distillation and the amino acid is dissolved in water. 
The aqueous solutions of the two protected amino acids are mixed with the enzyme thermolysin and the 
condensation reaction takes place at 40 °C. The L- form of the methylated phenylalanine, L-phenylalanine 
methyl ester (L-PheOMe) reacts stereo and regio selectively with the N-protected aspartic acid. The reaction 
product, Z-Aspartame, forms an insoluble addition compound with one molecule of remaining D-PheOMe 
and precipitates. When the reaction is completed, the Z-Aspartame-D-PheOMe addition compound is 
collected as a solid product and thermolysin is recovered from the solution. D-PheOMe is then separated 
from Z-Aspartame by acid washing with hydrochloric acid. The protection group, Z- is removed from Z-
aspartame by hydrogenolysis. Finally, aspartame, or α-L-aspartyl-L-phenylalanine methyl ester, is obtained 
by crystallization and drying. D-PheOMe is recycled after racemization by alkaline treatment and 
reesterification in methanol (Hanzawa, 2010).  
For simplification of the mass balances, the reuse of the enzyme and the Pd/C catalyst used in the 
hydrogenolysis step was not considered as well as the recovery of D-phenylalanine methyl ester. It was 
assumed a loss of 10% of product in the purification steps.  
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USP
Condensation (40 °C)
Filtration 
Acidification
Z-Aspartame-D-PheOMe 0.1712 mol
Hydrogenolysis
Crystallization
Drying
Aspartame
45 g
DSP
Protection reaction (0-12 °C,
 pH= 9.5-12)
L-aspartic acid 
29 g
105 g Toluene
Methanol 301.8 g
HCl 39.8 g
NaOH 11.3 g
Water 113.1 g
Esterification reaction
Water 136.4 g
Aqueous PM solution
256 g 
DL-Phenylalanine
90.1 g
Phase separation Distillation
 Thermolysin 7.2 g
Water  265 g
Calicum acetate monohydrate 1.3 g
29.5 g NaOH
 43.6 g Benzyloxycarbonyl chloride
106 g Water
Aqueous ZA solution
198.7 g
Water  510 g
Ammonium formate 21.4 g
Water 4800 g
Catalyst Pd/C (50%) 8.5 g
Methanol 403 g
D-PheOMe (recycle…)
Water 170 g
HCl 6.2 g
Toluene phase Methanol
 
Figure 4.9 Process flowsheet for aspartame production process.  
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4.5.3 Benchmarking of brazzein fermentation process with similar processes 
 
4.5.3.1 Process Mass Intensity 
 
Since PMI is one of the environmental metrics more widely used, it was calculated for the five production 
processes previously described and it is shown in Table 4.4. 
 
Table 4.4 Process mass intensity for the five different processes analyzed in the environmental assessment. 
 
Brazzein 
fermentation 
Brazzein 
extraction 
from maize 
Brazzein 
extraction 
from the 
African fruits 
Stevia 
production 
Aspartame 
production 
Total PMI  
(kg materials/kg product) 
5,647 28,130 76,576 115 155 
 
The PMI values shown in Table 4.4 include water, which is the biggest contributor to total PMI. Water 
intensity of the different processes will be further discussed in section 4.5.3.3. 
From the five different production processes, brazzein extraction from the African fruits of Pentadiplandra 
brazzeana Baillon is the one that shows the highest PMI, approximately 77 kg of materials are required to 
produce 1 gram of brazzein. This demonstrates the fact that brazzein extraction from the fruits is not an 
economically or environmentally feasible process, as it was expected. Furthermore, the process for brazzein 
extraction from the fruits is only a conceptual process, where all the data used in the assessment comes from 
the patent describing the analytical procedure to isolate brazzein. This analytical procedure did not go 
through any development or optimization, so it was expected to have a very high PMI for this process.  
The second highest PMI is for brazzein extraction from maize, with a total PMI of approximately 28 kg/g. This 
process is at laboratory scale like brazzein fermentation, so one can say that they are in comparable stages 
of development. But the fermentation process for brazzein production shows a total PMI 5 times lower than 
brazzein extraction from maize. The fermentation for brazzein production shows a total PMI of 5.6 kg/g, 
which is high as it would be expected for a process that is still under development at laboratory scale. At this 
stage of development, the optimization of materials consumption is not a concern as it is when the process 
is at production scale. However, it also shows how the process of brazzein fermentation still requires some 
work on process development and optimization. It is not uncommon that fermentation processes for 
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chemicals production at commercial scale have a total PMI below 100 kg materials/kg product. Some 
examples are citric acid production, with a total PMI of 17 kg/kg, pyruvic acid production, with a PMI of 53-
35 kg/kg depending on the operations used in the downstream processing, or riboflavin with a total PMI of 
39 kg/kg. But fermentation processes for recombinant proteins production show a much higher PMI, since 
the downstream processing is much more complex and consists of several units of operation. One good 
example is insulin , which shows a PMI of 55 kg/g (Heinzle et al., 2008).  
The relation between total PMI and the stage of development of the process is again verified if one looks at 
the values for PMI of stevia and aspartame production, which show a PMI of 120 kg/kg and 160 kg/kg 
respectively. These two values are higher than the above mentioned values for fermentation processes for 
chemicals production but are in any way 50 times lower than the fermentation process for brazzein 
production. So there is a clear relationship between the development stage of the process and total PMI, 
which would be expected since processes at commercial scale have gone through an intensive research and 
development. Clearly it is not appropriate to compare processes in different development stages, they will 
obviously show values very different for PMI as well as all the other metrics. But on the other hand, how else 
can the benchmarking of novel natural products be made? The benchmarking of novel products with 
products that are already at commercial scale can provide a development target for processes that are still 
under research and development, like brazzein fermentation. 
It is also interesting to put these values into context with sucrose production. For processing of sucrose, total 
PMI is 10-25 kg/kg if water is included and 0.4 kg/kg excluding water (Gerbens-Leenes and Hoekstra, 2009). 
These values exclude the cultivation of the biomass that is used as a source of sucrose, e.g. sugarcane or 
sugar beets.   
But perhaps a more interesting analysis is to see how much can PMI of the fermentation process decrease if 
the process is improved. Therefore, a sensitivity analysis on PMI was performed to analyze how much it is 
affected by the product concentration and the yield of downstream processing and the results are shown in 
Figure 4.10. 
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Figure 4.10 Variation of PMI of brazzein fermentation process for different product concentrations and 
different yields of downstream processing. 
 
It is clear that PMI is very much affected by product concentration in the fermentation broth and by the 
efficiency of DSP. If during the process development and optimization phase product concentration is 
increased to 10 g/L and the efficiency of downstream processing is improved to 80%, PMI would be 10 times 
lower, approximately 400 kg/kg. Even though this is a considerable improvement of the process, it is still not 
enough to reach PMI values comparable to the commercial processes for stevia or aspartame production, so 
further optimization would be required. If product concentration could be improved to approximately 35 g/L 
and downstream processing efficiency kept at 80%, PMI would be 115 kg/kg, which is a comparable value to 
stevia production.  
Hence, one can conclude that both upstream and downstream have a big impact on PMI and it is not enough 
to improve only one of the parts of the process. Both USP and DSP need to be improved to reach the full 
potential of the process. The application of a sensitivity analysis proved to be a valuable tool to define targets 
for process development. 
However, the PMI values previously shown do not take into account the relative sweetness of the different 
sweeteners. Brazzein, stevia and aspartame have different sweetness intensities and are much sweeter than 
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sucrose. Therefore, to have the same sweetness intensity in the final food products, the necessary amount 
of for instance brazzein will be different from the required amount of aspartame or sucrose. Hence, a 
correction of PMI taking into account the relative sweetness of the different sweeteners was done. The 
sweetness potency of the different sweeteners in comparison to a 2% and a 10% solution of sucrose is shown 
in Table 4.5. 
 
Table 4.5 Comparison of the sweetness potency of aspartame, brazzein and stevia components 
(rebaudioside A and stevioside) in relation to sucrose. (SE – Sucrose Equivalent) 
Sweetener 
Sweetness potency in 
relation to a 2% solution 
of sucrose (2% SE) 
Sweetness potency in 
relation to a 10% solution 
of sucrose (10% SE) 
Reference 
Aspartame 250 107 (Walters et al., 1991) 
Brazzein 2000 500 (Hellekant and Ming, 1998) 
Rebaudioside A 320 170 (Mitchell, 2006) 
Stevioside 213 190 (Mitchell, 2006) 
 
Process mass intensity of the different processes corrected on the different sweetness intensities is shown 
in Table 4.6. 
 
Table 4.6 Process mass intensity corrected on sweetness potency for 2% SE and 10% SE (SE – Sucrose 
Equivalent). 
 
Brazzein 
fermentation 
Brazzein 
extraction 
from 
maize 
Brazzein 
extraction 
from the 
African fruits 
Stevia 
production 
Aspartame 
production 
PMI (kg/kg) per sweetness 
potency in relation to 2% SE 
3 14 38 0.5 0.6 
PMI (kg/kg) per sweetness 
potency in relation to 10% SE 
11 56 153 0.6 1.4 
 
Taking into account the relative sweetness of the different sweeteners, PMI values are considerably lower. 
However, PMI for brazzein fermentation is still higher than PMI for stevia and aspartame production. On the 
other hand, PMI values for brazzein fermentation (3 kg/kg per sweetness potency (for 2%SE) and 11 kg/kg 
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per sweetness potency (for 10% SE)) are now on the same range as PMI values for sucrose processing (10-25 
kg/kg). Taking into account that the process is still under development, once the brazzein fermentation 
process reaches its full potential PMI values should be even lower. This shows that the fermentation of Pichia 
pastoris for brazzein production can be an environmentally promising option for sweeteners production if it 
is successfully intensified. 
 
4.5.3.2 Product concentration 
 
The product concentration of the different sweeteners on biomass is shown in Table 4.7, as well as the 
product concentration before DSP.  
 
Table 4.7 Product concentration on biomass in % (w/w) and in solution before downstream processing in 
g/L for the different production processes. 
 
Brazzein 
fermentation 
Brazzein 
extraction 
from maize 
Brazzein 
extraction from 
the African fruits 
Stevia 
production 
Aspartame 
production 
Product 
concentration in 
biomass (% (w/w) 
2.2 0.04 0.125 12.9 na 
Product 
concentration before  
DSP (g/L) 
2.02 0.4 0.06 12.9 40 
 
Looking at the product concentration in biomass and in solution before downstream processing it is clear 
that there is a correlation between product concentration and total PMI. The processes with a lower product 
concentration in biomass and in the solution before DSP, namely brazzein extraction from maize and from 
the African fruits, are the ones with a higher PMI. On the other hand, the processes with a higher product 
concentration show a lower PMI. This again shows the importance of product concentration for both the 
economy and the environmental profile of a process. 
It is also interesting to note that stevia leaves have a quite high concentration of sweetener, which grants a 
natural advantage to the process for stevia production by extraction from natural sources.  
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4.5.3.3 Water Intensity 
 
In Table 4.8 is shown the water intensity and the solvent intensity of the five different processes. 
 
Table 4.8 Water intensity and solvent intensity of the different processes. 
 
Brazzein 
fermentation 
Brazzein 
extraction from 
maize 
Brazzein 
extraction from 
the African fruits 
Stevia 
production 
Aspartame 
production 
WI (kg/kg) 4,932 26,101 46,460 105 130 
Contribution to 
total PMI (%) 
87 93 61 91 84 
SI (kg/kg) na na na 9.2 18.3 
Contribution to 
total PMI (%) 
na na na 8 11.5 
 
In all the five processes water represents 60-90% (w/w) of all the materials used and is therefore the biggest 
contributor to total PMI.  
Solvent intensity, on the other hand is not significant. The three processes for brazzein production do not 
involve the use of any solvent besides water. Stevia production has a solvent intensity of 9.2 kg solvents/kg 
product. The solvents used are ethanol (4.4 kg EtOH/kg product) and methanol (4.8 kg MeOH/kg product). In 
aspartame production process 18.3 kg solvents/kg product are used. The solvents used are methanol (16 kg 
MeOH/kg product) and toluene (2.3 kg toluene/kg product). None of the solvents used are highly hazardous. 
Toluene is classified by McElroy and co-workers as a problematic solvent (McElroy et al., 2015), but it is not 
used in high amounts (it represents 1.5% of total PMI). 
The results clearly show that water contributes in all of these bio-based processes with more than 50% to 
total PMI. Hence, water consumption should not be underestimated and it should be included in the 
calculation of PMI. These results highlight the importance of water consumption on bioprocesses. In a world 
where water scarcity is increasingly problematic, there should be more research focus on water reutilization 
or reduction/optimization of water consumption in biochemical processes. A bio-based industry can have 
several environmental benefits in comparison to conventional petrochemical based industry. However, one 
cannot forget that these bio-based processes have an inherent high consumption of water, in most cases 
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higher than in conventional chemical processes. If water use is not addressed as a topic of high priority, the 
bio-based economy could potentially have a negative environmental impact in terms of water consumption.  
 
4.5.3.4 E-factor 
 
E-factor as defined by Sheldon, i.e. excluding water, was also calculated and is shown in Table 4.9. 
 
Table 4.9 E-factor for the different processes. 
 
Brazzein 
fermentation 
Brazzein 
extraction 
from maize 
Brazzein 
extraction 
from the 
African fruits 
Stevia 
production 
Aspartame 
production 
E-factor  
(kg waste/kg product) 
716 2,028 30,115 11 24 
 
All of the processes for brazzein production show a high value for E-factor, as it would be expected given the 
early stage of development of these processes.  
E-factors of stevia and aspartame production processes are in the range of typical E-factors for the fine 
chemical industry, with an annual production of 102-104 tons/year (Sheldon, 2011).  
It is interesting to compare the E-factor for brazzein fermentation with typical E-factors of fermentation 
processes. However, very few have been reported. Sheldon reports an E-factor of 1.4 kg/kg for the bulk 
fermentation of citric acid. E-factors for the fermentation processes for the production of therapeutic 
proteins (biopharmaceuticals) are much higher. The production of recombinant human insulin has an E-factor 
of 6000 kg/kg, and this value increases to 50,000 kg/kg if water is included in the calculation (Sheldon, 2011).  
 
4.5.3.5 Origin of the raw materials 
 
It is also interesting to look at the origin of the raw materials used in the processes. The raw materials have 
been grouped according to their origin and this categorization is shown in Table 4.10. 
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Table 4.10 Categorization of the origin of the raw materials used in the different processes. 
Category Raw materials 
Renewables Ethanol; glycerol, manure 
Mining 
P-fertilizer; K-fertilizer; calcium hydroxide (Ca(OH)2); Iron (III) chloride (FeCl3); 
sodium chloride (NaCl); phosphoric acid (H3PO4); monopotassium phosphate 
(KH2PO4); calcium chloride (CaCl2); potassium sulfate (K2SO4); magnesium sulfate 
(MgSO4); lime (CaCO3); sodium hydroxide (NaOH); catalyst Pd/C 
Petrochemical 
Methanol; N-fertilizer; ethanol; ammonia; sodium acetate; antifoam; 
polyvinylpyrrolidone; ammonium sulfate; benzyloxycarbonyl chloride; toluene; 
hydrogen chloride; hydrochloric acid; ammonium formate 
Complex substances Pesticides; L-aspartic acid; DL-phenylalanine; thermolysin 
 
The raw materials have been grouped in four different categories: renewables, which include all the natural 
resources that can renew themselves naturally over time or all the materials that are produced from 
renewable resources; mining, which include all the materials that are extracted from ores through mining or 
derive from products extracted from ores; petrochemical are all the materials that are produced from oil or 
gas; and finally complex substances are built up from several different materials. Water was not included in 
this categorization of the raw materials. Since the production of biomass is included in the scope of the 
assessment, stevia leaves, yeast cell or the African fruits of Pentadiplandra brazzeana Baillon are not included 
as raw materials. Ethanol can be produced by conventional means from petrochemical materials or by 
fermentation. Therefore, it was included in both categories and in the processes where ethanol is used it was 
considered that 50% was from renewable sources and 50% from petrochemical sources.  
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Figure 4.11 Distribution of origin of raw materials of the different processes. 
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It is interesting to see in Figure 4.11 that even though all these processes are bio-based, the majority of raw 
materials used are of petrochemical origin. But the fermentation process is the one with a highest percentage 
of renewable raw materials (29%), mainly due to glycerol that is a by-product of biodiesel production. The 
high percentage of petrochemicals in the fermentation process comes mainly from the use of methanol as 
carbon source. 
 
4.5.4 Environmental, health and safety aspects of P. pastoris fermentation  
 
In addition to the comparison with other production processes, it was also made an identification of the 
environmental hotspots of the fermentation process with the aim to draw guidelines for the improvement 
of the environmental profile. Some recommendations regarding the health, safety and environmental 
aspects of the process are given in this section.  
The procedure that was adopted in (R)-perillic acid case-study for assessment of the health, safety and 
environmental aspects of the reactants and solvents used, was also applied in this second case-study. The 
flags system adopted by McElroy and co-workers (McElroy et al., 2015) and based on the H-statements of 
the different chemicals was applied and is shown in Table 4.11. 
 
Table 4.11 Analysis of the health, safety and environmental hazards of the reactants and solvents used in 
the fermentation of Pichia pastoris for brazzein production. 
 Green flag Yellow flag Red flag 
Solvents    
Water  X   
Reactants    
Methanol 
H301: Toxic if swallowed 
H311: Toxic in contact with skin 
H331: Toxic if inhaled 
H370: Causes damage to organs 
 X X 
 
The only solvents used in this fermentation process are water-based buffers which gives to this process a 
“green flag” in terms of solvents use.  
From all the chemicals used in the fermentation media, methanol is the only one that shows some concerning 
H-sentences, namely the H-sentences related to toxicity (H301, H311 and H331) which give a “yellow flag” to 
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the use of this chemical, and the H-sentence H370 which concerns damage to organs and gives a “red flag” 
to this chemical. It could be interesting to consider substituting methanol by another carbon source or to use 
only glycerol as a main carbon source, if cell growth or protein expression are not affected. This substitution 
would avoid using a toxic chemical and would also considerably decrease the contribution of petrochemical 
raw materials to the process. 
It was also verified if any of the chemicals used in the process are in the SIN List and classified as chemicals 
of very high concern. Boric acid (BH3O3) has been classified as carcinogenic, mutagenic and reprotoxic (CMR) 
according to Annex VI of Regulation 1272/2008 and is classified as a chemical of very high concern. It is only 
used in concentrations of nanograms per liter, since it is only added as a trace element to the fermentation. 
Therefore it should not constitute any danger for the safety of the workers.  
 
4.6 Concluding remarks 
 
The five different processes were compared in terms of PMI, water and solvent intensity, E-factor and origin 
of the raw materials. Benchmarking the fermentation of Pichia pastoris with the other processes for brazzein 
production (extraction from genetically modified maize and extraction from the African fruits of 
Pentadiplandra brazzeana Baillon) it is clear that the fermentation process is the most promising option. 
However when comparing it with the processes for production of stevia or aspartame at a commercial scale, 
the fermentation process shows a much higher PMI, E-factor and water intensity which would be expected 
given the early stage of development. In anyway, the benchmarking of the fermentation process with other 
processes revealed itself as a useful tool since it provided some targets for process development and 
optimization. Running a sensitivity analysis on the process mass intensity of the fermentation process, it was 
concluded that product concentration in the fermentation broth needs to be increased to 35 g/L and the 
efficiency of DSP to 80% in order to have a PMI comparable to commercial processes. 
Looking at the origin of the raw materials and the EHS aspects of the chemicals used, some suggestions for 
improvement of the environmental profile of the process could also be drawn. Methanol is a toxic chemical 
and contributes largely to the high proportion of petrochemicals used in the process (58%). Therefore, 
substituting it by another carbon source such as glycerol could be an interesting option. On the other hand, 
glycerol can be produced from propylene or can be a waste product from biodiesel industry. From an 
environmental point of view it would be preferable to use a raw material that is a waste from another 
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industry. The best practice is to make a comparison of different sources of the raw materials and choose the 
one that is preferable from an environmental point of view. This is however a laborious task. 
Some of the environmental metrics that were used in this case-study are different from the (R)-perillic acid 
case-study. Since the process is a fermentation and not a biocatalytic reaction it makes no sense calculating 
atom economy, reaction mass efficiency or any of the reaction-related metrics. In this case there is not a 
single reaction for product formation. The product is a protein that is built from several molecules in the cell. 
Developing a set of metrics specific for the environmental assessment of fermentations would be very 
interesting and a valuable tool, but it is also quite a challenge given the complexity of all the reactions 
involved. 
It is very important to note that the quality of data is critical for an environmental assessment. In this 
assessment it was necessary to make some assumptions for the modelling and inventory of the production 
processes due to lack of data, and the influence of these assumptions on the final results should be analyzed 
in an uncertainty analysis. Furthermore, the fermentation of Pichia pastoris for brazzein production is still at 
laboratory scale and further development and optimization will still be performed. This final process 
optimization, through the adjustment of the operation conditions and equipment sizes, has also an influence 
in the environmental performance (Brunet et al., 2012). 
Since assumptions and estimations need to be made in these environmental assessments, the accuracy of 
the method is limited to a certain degree. These methods for environmental assessment should be seen as a 
valuable supportive tool for process development and not as a tool to accurately measure waste production 
or other environmental-related topics.   
One could also argue that an economic assessment would be sufficient and there is no need to perform 
environmental assessments in early stages of development, given the fact that if the economy of the process 
is improved so is also the environmental profile, e.g. by improvement of PMI. However, the work done in this 
case-study revealed how an environmental assessment can bring a new perspective and different 
information relevant for process development, e.g. information on substitution of chemicals. 
Likewise, one could argue that if we just apply environmental commonplaces such as reducing water 
consumption, avoiding the use of toxic chemicals, etc. the environmental profile would anyway be improved 
without having to do a full environmental assessment involving extensive literature review for collection of 
data. But the environmental assessment allowed a comparison with other similar processes and allows the 
research teams working in R&D to see how far their processes are from commercial processes which can help 
them to define targets for process development and optimization. Obviously, the ideal process would have 
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an E-factor of zero and a PMI of 1. The goal is always to reduce E-factor and PMI, but how much can they 
realistically be reduced? Benchmarking processes in early stages of development, such as brazzein 
fermentation process, puts some realistic targets for E-factor, PMI and other metrics. In this case, for 
instance, a realistic target for brazzein fermentation process would be a PMI in the range of 100 kg/kg. This 
is a very valuable tool for scientists, e.g microbiologists or molecular biologists, working in protein and 
metabolic engineering to improve the expression levels of the proteins in the cells. It puts the values for E-
factor and other metrics into context, and it would otherwise be difficult to find a meaning for them. 
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Part III 
 
Discussion, Conclusion and Perspectives 
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5. Discussion 
 
This chapter aims to connect the different parts of the thesis, the different tools for bioprocess evaluation, 
the two different case-studies and the different strategies for bioprocess improvement. General guidelines 
and recommendations for the successful implementation of processes for production of natural products are 
presented.  
 
5.1 Methodology for development of processes for the biosynthesis of natural 
products 
 
Natural products show an incredible potential for use in several industries - pharmaceutical, cosmetics, food, 
etc. However, its industrial production is hindered by the difficulties in synthesizing these complex molecules. 
Bioprocesses, both biocatalytic or fermentation processes, appear as a promising possibility for the 
biosynthesis of these molecules and there are some examples of natural products that have been successfully 
developed and applied in industrial scale, e.g. artemisin production. Metabolic engineering and protein 
engineering are areas where great development is being achieved and offer great potential for the 
biosynthesis of natural products.  
However, the development of these processes is rather complex and requires a holistic view of the several 
limitations and challenges of these processes, from a production host cell and/or biocatalyst, reaction and 
process perspectives.   
In this thesis two fundamentally different case-studies were assessed. The first case-study corresponds to a 
biocatalytic multi-step reaction for the production of a small molecule, (R)-perillic acid which intends to be 
used in cosmetic industry and could also have potential uses in pharmaceutical or food industry. The second 
case-study corresponds to a fermentation for recombinant protein production. The recombinant protein, 
brazzein is intended to be used in food industry. Therefore, this thesis offers a comprehensive tool for the 
development of natural products by covering different types of bioprocesses, different types of natural 
products and different sectors of chemical industry. As a result of the work developed for both case-studies, 
a general methodology for the development of bioprocesses for natural products production was developed 
and it is shown in Figure 5.1.  
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This methodology is sub-divided into three parts. The first part corresponds to a route selection/process 
screening of the different options for production of a given natural product. It is generally assumed that 
extraction from natural sources is not an economically feasible or sustainable alternative. However, that is 
not always the case and stevia is a very good example of a process where extraction is feasible. The economic 
feasibility of extraction is dependent on the amount of natural product existent in the natural source. In this 
route selection all the possible routes for production of a given natural product must be reviewed and there 
might be several possibilities for chemical synthesis or biosynthesis using different starting materials. This 
literature review is followed by the mass balances and an environmental assessment of all the possible 
options. In the environmental assessment, an analysis of the EHS hazards of all the chemicals used in the 
chemical inventory of each option is required as well as the calculation of some key green chemistry metrics. 
The green chemistry metrics are however dependent on the type of molecule being produced. If the product 
is a small molecule produced in a single or multi-step reaction catalyzed by a chemical catalyst or a 
biocatalyst, as it is the case for (R)-perillic acid, reaction-related metrics (AE, RME and CE) should be used for 
comparison of the two synthetic routes. But these metrics do not make sense for assessment of large 
molecules that are built up in several steps of a metabolic pathway, e.g. brazzein. In this case and also when 
analyzing the extraction from natural sources, process-related metrics such as PMI or E-factor should be 
preferred.  
In case route selection shows that the biosynthetic route is the most promising one, an in silico evaluation of 
this route should be done (part 2 of the methodology) which leads to the identification of the process 
bottlenecks and strategies for its improvement. These strategies, both from a process/reaction and 
biocatalyst or host cell perspectives, should then be tested and further explored in the laboratory (part 3 of 
the methodology). The laboratory work is an essential part of the development of a bioprocess and it should 
not be underestimated or undervalued. But an in silico evaluation of the bioprocess prior to experimental 
work can guide and focus the experiments on the most critical bottlenecks.  
The novelty of this thesis lies on this systematic procedure for route selection and process screening, as well 
as putting the biosynthesis of natural products into context in relation to demands of an industrially feasible 
process. There are several novel bioactive natural products with very interesting properties being discovered. 
But the path to commercialization is rather long and there is not a straightforward procedure for process 
design and process development of these novel products. Developing novel natural products until 
commercialization is a challenge faced by many small-medium sized biotechnology enterprises and this thesis 
tries to understand how these bioprocesses can be developed and offer some guidelines for process 
development.  
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Moreover, it reports the environmental profile of bioprocesses for natural products production, which is not 
often found in scientific literature. The early-stage environmental assessment that was applied in both case-
studies can give very meaningful insight into process development. 
Besides the environmental assessment, different tools for exploring the economy of a process are described 
throughout the thesis. Calculating process metrics, such as product concentration, space-time yield, 
biocatalyst yield or reaction yield, is a simple tool that does not require a big amount of data. But it can give 
very meaningful information on the process, which can guide research and considerably reduce development 
time. Hence, it is recommended to calculate process metrics at the start and throughout process research 
and development.  
But setting targets for the process metrics for product and process development can be quite challenging, 
especially for novel products, such as (R)-perillic acid and brazzein. The demands on process metrics are 
dependent on the product annual production and price. Bulk chemicals, with an annual production in the 
range of 104-106 ton/year and a very low selling price (in the range of 1 €/kg) have much tighter demands on 
process metrics than for instance pharmaceutical chemicals with an annual production of 10-103 ton/year 
and a selling price that can be higher than 100 €/kg. With a selling price as low as 1 €/kg the profit margin is 
very low, therefore the process needs to be fully optimized in terms of reaction yield, product concentration, 
space-time yield or volumetric productivity and/or biocatalyst yield. But for these new natural products it 
can be a challenge to define a reasonable annual production and selling price. Since there are no alternative 
processes commercially implemented and competing with these products, there is more freedom to set the 
selling prices. But this freedom is always limited by the market where the product is to be inserted. In the 
case of these two products, it would be expectable that the fact that they are produced by biotechnological 
means gives some advantage for product marketing and influence positively the selling price. But overall it 
can be a challenge to define targets for process research and development when there are so many variables 
influencing annual production and selling price. This thesis proposes a methodology that can help setting a 
price for novel natural products and guide process development for novel products without a fixed selling 
price or identical competitors in the market.  
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Figure 5.1 General methodology for the development of biosynthetic processes for natural products 
production. 
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Scientific work on the development of novel biosynthetic routes for natural products has been widely 
reported and advances on synthetic biology promise very exciting developments in this field. However, if the 
commercial implementation of these bioprocesses is intended, the economic demands of an industrial 
chemical process should be kept in mind throughout the developments stages.  This thesis attempts to show 
how the successful implementation of a bioprocess for production of natural products is dependent on a 
fundamental knowledge of the biocatalyst or production host cells, reaction and process constraints that 
strongly influence the process viability. The application of an in silico process analysis can be of great benefit 
in guiding experimental work and suggesting guidelines for improvement of the bioprocess aiming at an 
industrial scale implementation of the process. The proposed systematic assessment can support the scale-
up procedure and also shorten the development time by the early identification of potential bottlenecks and 
limitations (Heinzle and Hungerbuhler, 1997). 
The development of bioprocesses for biosynthesis of natural products is a complex task, with several 
different bottlenecks which in most of the times requires improvements both from the biocatalyst and/or 
host cell and the process. Therefore, different areas of expertise are required (microbiology, protein 
engineering, metabolic and genetic engineering, process and chemical engineering, etc.) and the teams 
working in the development of these bioprocesses should be multi-disciplinary. Communication can be quite 
a challenge but looking at these processes from different perspectives can be the key to success.  
 
5.2 Case-study I: Bioconversion of (R)-limonene to (R)-perillic acid by a whole-
cell biocatalyst 
 
The first case-study was the most explored in this thesis, where the whole methodology presented in Figure 
5.1 was applied. In first place, the biosynthetic route for (R)-perillic acid production was benchmarked with 
a chemical synthetic route, which showed that the biocatalytic route is the most interesting one, both from 
an economic and environmental perspectives, to be further explored. Following this route selection, the 
bioconversion of (R)-limonene to (R)-perillic acid by a whole-cell biocatalyst was evaluated in an economic 
assessment, where key process metrics were calculated, a process model was built and a sensitivity analysis 
on some of the process metrics was run, which allowed the identification of the main bottlenecks of the 
process and different strategies for its improvement. 
Calculating the key process metrics proved to be a useful tool, but it only gave information on how far the 
process still is from economic feasibility and industrial implementation. It did not give any insight or 
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guidelines on process development, meaning that it failed to rank and prioritize the different metrics. Process 
modelling and sensitivity analysis of the key process metrics was a very useful tool to further explore the 
different metrics and prioritize them. 
The results emphasized that space-time yield is a metric of high relevance in whole-cell processes. This metric 
is very complex and it is influenced by several different parameters, which can be improved in many different 
ways. Whole-cell biocatalytic processes are extremely complex systems, where several different parameters 
are interconnected and correlated. And addressing one parameter can have positive effects in one bottleneck 
but it can actually aggravate others.  
The overall methodology followed was a valuable tool to identify targets for improvement of the biocatalytic 
process, which should result in a reduced process development time. Improving the economy of the process 
should also be translated in terms of environmental benefits, since economic and environmental 
sustainability are interconnected.  
Unfortunately, it was not possible to experimentally quantify any improvement on space-time yield due to a 
lack of stability of the system. In several fermentation batches no (R)-perillic acid production was observed, 
which revealed a lack of consistency of the strain used. Screening of a different host should also be 
investigated, although Pseudomonas sp. has an inherent competitive advantage which is its natural tolerance 
to solvents. (R)-Limonene bioconversion to (R)-perillic acid has also been demonstrated in yeast Yarrowia 
lipolytica (Ferrara et al., 2013), Mycobacterium sp. HXN-1500, Rhodococcus sp. ALK2-C7 (Duetz et al., 2004), 
recombinant E. coli with cym genes from Pseudomonas putida F1 (Mars et al., 2001) and Pseudomonas 
gladioli (Cadwallader et al., 1989), but all of them with lower productivities than P. putida GS1. Other 
oxyfunctionalizations of (R)-limonene with several different strains were reviewed by Duetz and co-workers 
(Duetz et al., 2003). 
The fact that the strain used in this bioprocess is a wild-type strain also imposes some constraints in the 
process, since wild-type enzymes are in most cases far from being applicable in industrially relevant 
conditions. Product and substrate inhibition at high concentrations is one of the problems they often face. 
Process technologies, such as ISPR or ISSS can partially solve these problems but only to a certain extent. 
There is a limit on how much a process can be improved solely by process technologies and it might not be 
enough to achieve commercial production. Most examples of biosynthetic processes for the production of 
natural products that have achieved commercial scale include genetic improvement of the biocatalyst and/or 
strain (Paddon and Keasling, 2014). But on the other hand, the use of a GMO strain might also have some 
implications particularly on the marketing and consumer’s acceptance of the product.  
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5.3 Case-study II: Fermentation of recombinant Pichia pastoris for brazzein 
production 
 
In the second case-study only the first part of the proposed methodology, represented in Figure 5.2, was 
applied. In case-study II, referring to the production of brazzein by fermentation of Pichia pastoris, only the 
benchmarking of the biosynthetic route with other possible routes was addressed and the process was not 
further evaluated or developed. 
 
 
Figure 5.2 Part 1 of the proposed methodology for the development of biosynthetic processes for natural 
products production. 
 
Besides benchmarking of different routes for brazzein production, the fermentation of recombinant Pichia 
pastoris was also benchmarked against processes for production of different sweeteners, namely stevia and 
aspartame. Even though these two processes are in different development stages than the fermentation 
process and are already implemented in industrial scale, using them as benchmarks allowed the definition of 
development targets for the teams working in process R&D. For instance, if brazzein aims to be 
environmentally and economically competitive with stevia, PMI of the fermentation process needs to be 
reduced to a value in the range of 100 kg/kg, which requires a product concentration of 35 g/L and a 
downstream processing efficiency of 80%. This means that product concentration achieved in the 
fermentation needs to be increase by approximately 17.5 fold and DSP efficiency needs to be improved from 
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approximately 30% to 80%. These might seem very ambitious goals, but setting this type of targets can guide 
and focus research, which can ultimately result in shorter development time.   
The results obtained from the assessment of this case-study illustrate the importance of addressing 
environmental issues from an early time point on process research and development. Even though 
economics is what drives process development, an environmental assessment can also be meaningful and 
give valuable insight for process research and development. For instance, an assessment of the EHS issues of 
the chemicals used can give suggestions for chemicals substitution that can greatly benefit the environmental 
profile of the bioprocess. And this type of questions need to be addressed in an early stage of research and 
development, otherwise it will be costly to make any change in the process. 
Reporting environmental data, such as PMI, RME or E-factor, of processes at lab-scale research can also 
benefit process development and research since it can provide some benchmarking examples for researchers 
working on similar processes. This thesis reports environmental data for two bioprocesses for biosynthesis 
of natural products, which is something that is not often seen in scientific literature.  
The methodology followed and the metrics used to assess the environmental profile of this bioprocess 
proved to be simple and easy to be applied by any researcher, even researchers who are not familiar with 
green chemistry metrics or other tools for environmental assessment of bioprocesses in general. A full LCA 
is not an appropriate method for environmental assessment of bioprocesses in early stages of research since 
it is too complex and requires a lot of data that is difficult to obtain in early stages of research. The strength 
of a LCA is the fact that it provides a holistic view of the environmental profile of a given product, taking into 
account the raw materials production, transportation and the product use and disposal. However, from a 
process development perspective that might not provide any meaningful information. Very often, a full LCA 
“dilutes” the environmental profile of the specific process under development, since its emissions or waste 
produced are insignificant when compared to energy production processes or transportation of the raw 
materials. Therefore, in general terms LCA is not recommended for processes under development. It does 
not support the process developer and it is rather complex and dependent on the experience of the user.  
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5.4 General recommendations for implementation of processes for the 
biosynthesis of natural products 
 
Estimates for the total number of living species ranges from 2 million to 100 million. Therefore, the number 
of natural products and enzymes remaining to be discovered is enormous and there is a great potential for 
discovery of molecules with very interesting properties. Synthetic biology shows the potential to map the 
metabolism of most species and a library of biochemical transformations could be a magnificent tool for the 
design and generation of new products. Just as organic chemists currently plan the total synthesis of a target 
molecule using established reagents and reactions, synthetic biologists might be able in a near future to use 
a vast array of enzymes to rationally synthesize very complex molecules. Directed evolution of enzymes or 
ground-breaking gene editing technologies, such as CRISPR-Cas9, can greatly favor the biosynthesis of novel 
natural products. The resources for natural products discovery are so vast that it is likely to see very exciting 
discoveries in the field of biosynthetic production of natural products (Li and Vederas, 2009).  
However, the development path until industrial scale and full commercialization is rather long. This thesis 
proposes a methodology for addressing economic as well as environmental issues from an early stage of 
research and development that can greatly benefit the implementation of more of these bioprocesses for 
production of natural products. And knowledge sharing between different fields, such as synthetic biology 
and chemical/biochemical engineering, is also crucial for a successful and fast development of these 
biosynthetic processes.  
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6. Conclusions 
 
Natural products show very interesting properties for use in several sectors of chemical industry, namely 
pharmaceutical, food or cosmetics. However, they are extremely difficult to synthesize given their complex 
structure. Synthetic biology offers tools with great potential for the synthesis of natural products and many 
examples of biosynthesis of natural products, either by fermentation of recombinant strains or biocatalytic 
reactions, have been reported in literature. But further development to industrial scale and 
commercialization requires high yields, productivities and product concentrations. The intensification of 
these bioprocesses is not straightforward and it is often a time-consuming process.  
The main goal of this thesis was to establish a methodology for benchmarking of processes for the 
biosynthesis of natural products that can assist the development of these processes. The work developed in 
this thesis allowed drawing some general conclusions regarding the biosynthesis of natural products: 
 In contrast to other molecules, natural products can be produced by different means – extraction of 
natural sources, chemical synthesis or biosynthesis. Route selection should be the first step of 
development of a process for natural products production.  
 In case the biosynthetic route is the most promising option for production of a certain natural 
product, an in silico evaluation of the economic and environmental profile of the process can help 
setting targets for process development and identify the main bottlenecks of the process.  
 The proposed methodology demonstrated that that space-time yield was the biggest economic 
constraint in the first case-study – the bioconversion of (R)-limonene to (R)-perillic acid by 
Pseudomonas putida GS1. A 4-fold improvement of space-time yield could result in a reduction of 
40% on operation costs, which is a very significant reduction. The increase of space-time yield would 
also result in an improved environmental profile of the process given the interconnection of 
economic and environmental performance. 
Substrate loss by stripping on the gas stream and a reduction of reaction rate throughout reaction 
time due to product inhibition were identified as some of the causes for a low space-time yield. 
 In the second case-study, the fermentation of recombinant Pichia pastoris for brazzein production 
was benchmarked with the production processes of two other sweeteners, stevia and aspartame, 
from an environmental perspective. The environmental assessment proved to be a valuable tool to 
define targets for the development of the fermentation process. A sensitivity analysis on some 
process parameters showed that if product concentration is increased to approximately 35 g/L and 
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DSP efficiency to 80% a PMI of 115 kg/kg could be achieved, which would make the fermentation 
process for brazzein production competitive with stevia production.  
 The in silico benchmarking and evaluation of biosynthetic processes for production of natural 
products is a valuable tool to define a selling price for a novel product without an identical competitor 
in the market.  
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7. Future work 
 
To further explore the process development of biosynthetic processes for natural products production, some 
suggestions that would improve this thesis are presented. Guidelines for the development of both case-
studies are followed by some general guidelines for the development of processes for the biosynthesis of 
natural products. 
 
Bioconversion of (R)-limonene to (R)-perillic acid by a whole-cell catalyst 
 
 The reaction system should be further explored experimentally in order to understand the reason(s) 
for the reduction in reaction rate that was observed. There are a lot of factors possibly influencing 
the reaction rate (cofactor regeneration problems, loss of enzyme activity, transport of substrate and 
product across the cell membrane, etc.) and they should be tested experimentally.  
 The operating mode of the biocatalytic reaction should be further explored. 
 The ISPR operating mode should be further developed. 
 The application of a second organic phase that can be used as a substrate reservoir should be tested. 
This could diminish the substrate loss through stripping on the gas phase and potentially also enable 
ISPR. Examples where this was successfully applied are available in literature for similar systems 
(Schewe et al., 2009). Cornelissen and co-workers showed an improvement in productivity when 
running the bioconversion of (S)-limonene to (S)-perillyl alcohol by a recombinant Pseudomonas 
putida strain in a two-liquid-phase system (Cornelissen et al., 2011). 
 Since the biocatalyst is a whole-cell there might be some transport limitations of the substrate and/or 
product across the cell membrane. The reaction rate inside the cell might actually be higher than 
what was measured experimentally. If there are transport limitations in the membrane a lot of 
product might be held inside the cell. This should be tested by disrupting the cells after the 
bioconversion and measure (R)-perillic acid concentration in the cell lysate.  
 The process model could be improved with real price quotes from suppliers. Since facility-dependent 
costs were one of the biggest contributors to the costing of the first case-study, it would be 
interesting to get a real quote from a manufacturing facility for renting their equipment, thereby 
improving the accuracy of the economic assessment and sensitivity analysis. 
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Fermentation of recombinant Pichia pastoris for brazzein production 
 
 In this case-study both upstream and downstream processing need to be improved. Since it is a 
recombinant strain that is used further metabolic engineering of the strain needs to be done in order 
to increase the product concentration in the fermentation. 
 Optimization of the operating conditions in DSP should be done in order to improve the efficiency of 
DSP. Design of experiments is a tool that can help and accelerate this experimental work.  
 
General guidelines for the development of processes for the biosynthesis of natural products 
 
 The development of more in silico tools for predicting properties at operating conditions could 
reduce experimental work and facilitate and accelerate process development. Natural products are 
complex molecules, whose properties, e.g. solubility, pKa or log P, are not easily found in scientific 
literature. Experimentally measuring all these physicochemical properties is a time-consuming 
process. Therefore, having predictive tools for prediction of pKa, partition coefficients, etc. could 
reduce experimental work and assist process design and development.  
 The application of design of experiments tools can also be a valuable way to acquire more process 
knowledge and could benefit the development of these biosynthetic processes. 
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Appendices 
 
Mass balances for the chemical route for (R)-perillic acid synthesis from β-pinene 
 
 
- The data on reagents consumption for the chemical synthesis of perillic acid was based on (Wang et 
al., 1993). 
 
Reaction Step 1 
Reaction yield: 35% (based on benzonitrile) 
Input Mass (g) Output Mass (g) 
β-pinene 5.88 β-pinene epoxide 2.24 
H2O2 (30%) 9.52 Unreacted reagents 17.44 
Benzonitrile (PhCN) 4.28   
Sum 19.68 Sum 19.68 
 
Reaction Step 2 
Reaction yield: 65% 
Input Mass (g) Output Mass (g) 
β-pinene epoxide 2.24 Perillyl alcohol 1.52 
NH4NO3 0.15 Unreacted reagents 0.87 
Sum 2.39 Sum 2.39 
 
ii 
 
Reaction Steps 3 and 4 
Overall reaction yield of 77% from perillyl alcohol 
Input Mass (g) Output Mass (g) 
Perillyl alcohol 1.52 Perillic acid 1.28 
MnO2 17.4 Unreacted reagents 17.64 
AgNO3 1.7   
NaOH (aq.) 0.40   
Sum 18.92 Sum 18.92 
 
iii 
 
Calibration curve for HPLC measurements of (R)-perillic acid 
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Calibration curve for the UV-VIS measurements of (R)-limonene at 254 nm 
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Mass balances for the processes assessed in case-study II 
 
1. Brazzein extraction from the fruits of Pentadiplandra brazzeana Baillon 
 
Separation of the pulp from the epicarp and seeds and solid-liquid extraction 
Input Mass (g) Output Mass (g) 
Fruits of Pentadiplandra 
brazzeana 
2,000 
Solution after the 
extraction 
43,364 
Sodium acetate 164 Fruit pulp (Waste) 1,000 
Dithiothreitol 0.6   
Glycerol 2,000   
Polyvinylpyrrolidone (PVP) 200   
Water 40,000   
Sum 44,364.6 Sum 44,364 
 
Purification of the extraction solution 
Input Mass (g) Output Mass (g) 
Extraction solution 43,364 Product 0.9 
Ammonium sulfate 24,682 Waste 70,914.6 
Sodium hydroxide 1.4   
Sodium chloride 51.6   
Sodium acetate 3   
Tris hydrochloride 0.5   
Water 1,813   
Sum 70,915.5 Sum 70,915.5 
  
vi 
 
2. Brazzein fermentation 
 
Fermentation 
Input Mass (kg) Output Mass (kg) 
Glycerol 770.7   
Methanol 2,313   
Monopotassium 
phosphate 
236 Fermentation broth 10,304.6 
Ammonium sulfate 27.5   
Calcium chloride 5.5   
Potassium sulfate 78.7   
Magnesium sulfate 64.4   
Copper sulfate 1.1x10-2   
Sodium iodide 4.4x10-4   
Manganese sulfate 1.65x10-2   
Sodium molybdate 1.1x10-3   
Boric acid 1.1x10-4   
Calcium sulfate 2.75x10-3   
Cobalt chloride 2.75x10-3   
Zinc chloride 3.85x10-2   
Iron sulfate 0.121   
Biotin 1.1x10-3   
Sulfuric acid 9.9x10-6   
Inoculum 500   
Phosphoric acid 8.6   
Ammonia 154   
Antifoam (Propylene 
glycol) 
5   
Water 6,141.2   
Sum 10,304.6 Sum 10,304.6 
 
 
vii 
 
Cell removal 
Input Mass (kg) Output Mass (kg) 
Fermentation broth 10,304.6 Cells 4,120.5 
  Supernatant 6,184.1 
Sum 10,304.6 Sum 10,304.6 
 
Clarification 
Input Mass (kg) Output Mass (kg) 
Supernatant 6,184.1 Waste 156.8 
Water 250 Clarification solution 6,275.3 
Sum 6,434.1 Sum 6,434.1 
 
Concentration 
Input Mass (kg) Output Mass (kg) 
Clarification solution 6,275.3 Waste 4,215.7 
  Concentration solution 2,059.6 
Sum 6,275.3 Sum 6,275.3 
 
Buffer exchange 
Input Mass (kg) Output Mass (kg) 
Concentration solution 2,059.6 Waste 18,094.9 
Sodium acetate 14.76 Solution 2,032 
Sodium chloride 52.56   
Water 18,000   
Sum 20,126.9 Sum 20,126.9 
 
 
 
viii 
 
Chromatography 
Input Mass (kg) Output Mass (kg) 
Solution 2,032 Waste 6,062.4 
Sodium acetate 4.2 Elution solution 1,300 
Sodium chloride 126.1   
Water 5,200   
Sum 7,362.4 Sum 7,362.4 
 
Freeze Drying 
Input Mass (kg) Output Mass (kg) 
Elution solution 1,300 Product 6 
  Waste 1,294 
Sum 1,300 Sum 1,300 
 
  
ix 
 
3. Brazzein extraction from GMO maize 
 
Cultivation of 1 hectare of maize 
Input Mass (kg) Output Mass (kg) 
Nitrogen fertilizer 30 Maize 3,500 
Lime 400   
Manure 170   
Pesticides 0.9   
Sum 600.9 Sum 3,500 
 
Dry milling 
Input Mass (kg) Output Mass (kg) 
Maize 3,500 Maize middlings (waste) 2,800 
  Germ-rich fraction 700 
Sum 3,500 Sum 3,500 
 
Solid-liquid extraction 
Input Mass (kg) Output Mass (kg) 
Maize, gem-rich fraction 700 Extraction solution 4,211.8 
Sodium acetate 5.7   
Sodium chloride 6.1   
Water 3,500   
Sum 4,211.8 Sum 4,211.8 
 
 
 
 
 
x 
 
Purification 
Input Mass (kg) Output Mass (kg) 
Extraction solution 4,211.8 Product 0.403 
Sodium chloride 205 Waste 11,440.4 
Water 7,024   
Sum 11,440.8 Sum 11,440.8 
 
  
xi 
 
4. Stevia production 
 
Cultivation of stevia in one hectare of land in one year 
Input Mass (kg) Output Mass (kg) 
Nitrogen fertilizer 40 Dried stevia leaves 1800 
Phosphorus fertilizer 20   
Potassium fertilizer 30   
Sum 90 Sum 1800 
 
Solid-liquid extraction 
Input Mass (kg) Output Mass (kg) 
 Dried leaves 1,800 Extraction solution 19,800 
Water 18,000   
Sum 19,800 Sum 19,800 
 
Preliminary purification 
Input Mass (kg) Output Mass (kg) 
Extraction solution  19,800 Product powder 1 220 
Calcium hydroxide 43.2 Waste 19,719 
Iron hydroxide 95.4   
Sum 19,939 Sum 19,939 
 
Preparation of Stevioside 
Input Mass (kg) Output Mass (kg) 
Product powder 1 220 Product powder 3 129 
Methanol 867 Waste 1227 
Ethanol 242   
Water 26.9   
Sum 1356 Sum 1356 
 
xii 
 
Preparation of Rebaudioside A 
Input Mass (kg) Output Mass (kg) 
Water 909.4 Product powder 6 52 
Ethanol 255.3 Waste 1113 
Sum 1165 Sum 1165 
 
  
xiii 
 
5. Aspartame production 
 
Preparation of L-Aspartic acid 
Input Mass (kg) Output Mass (kg) 
L-Aspartic acid 319.4 Aqueous ZA solution 2185.5 
Sodium Hydroxide 324 Waste 1261.5 
Benzyloxycarbonyl 
chloride 
480   
Toluene 1154   
Water 1170   
Sum 3447 Sum 3447 
 
Preparation of DL-Phenylalanine 
Input Mass (kg) Output Mass (kg) 
DL-Phenylalanine 991.5 
Aqueous DL-PM 
solution 
1007.1 
Methanol 3320 Waste 6501 
Hydrogen chloride 437.4   
Sodium hydroxide 124.3   
Water 2634.7   
Sum 7508 Sum 7508.1 
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Condensation 
Input Mass (kg) Output Mass (kg) 
ZA aqueous solution 192.43 Z-APM.D-PM 1217 
Aqueous DL-PM 
solution 
250.98   
Thermolysin 7.2   
Calcium acetate 
monohydrate 
1.3   
Water 765   
Sum 1217 Sum 1217 
 
Purification 
Input Mass (kg) Output Mass (kg) 
Z-APM.D-PM 0.267 Aspartame 0.265 
Hydrogen chloride 0.04   
Ammonium formate 0.126   
Methanol 2.4   
Catalyst Pd/C 0.05   
Water 28   
Sum 30.88 Sum 30.62 
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